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HEALTHCARE UTILIZATION FOR BEHAVIORAL HEALTH DISORDERS: POLICY 
IMPLICATIONS ON NATIONWIDE READMISSIONS, AND OUTCOMES IN THE 
STATES OF NEBRASKA AND NEW YORK 
 
Rajvi J. Wani, Ph.D. 
University of Nebraska, 2018 
ABSTRACT 
Supervisor: Fernando A. Wilson, Ph.D. 
The main goal of this dissertation was to estimate national-level inpatient readmissions and state-
level hospital-based emergency department (ED) visits with behavioral health (BH) conditions in 
the states of Nebraska and New York. The dissertation aims to assess the impact of the policy 
mandates under the Patient Protection and Affordable Care Act on these state and national 
estimates. The Nationwide Readmissions Database and the State Emergency Department 
databases maintained by the Healthcare Cost and Utilization Project were used for this 
dissertation. US Adult population with high-risk of readmissions in the inpatient departments for 
alcohol-related disorders (ARD) and of visiting ED for BH conditions were identified. Prediction 
of economic burden due to 30-day readmissions, specifically for recurrences of ARD, patient and 
hospital-level rates, costs, and predictors of 30-day readmissions were derived at the national-
level. Region-level data on ED facilities and BH workforce in Nebraska were obtained from the 
Health Professionals Tracking Services. In addition, the location of substance abuse treatment 
centers and ED facilities in New York were procured from the National Survey of Substance 
Abuse Treatment Services and the National Emergency Department Inventory, respectively. To 
identify BH conditions, International Classification of Diseases, Ninth Revision, Clinical 
Modification codes were used. Estimates of total charges for ED visits in Nebraska and New 
York were performed along with an assessment of the availability of substance abuse treatment 
centers, BH workforce, and EDs. The dissertation underlines the need for integrated behavioral 
health services at primary level and development of preventative health programs tailored 
specifically for high-risk populations.   
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CHAPTER I: BACKGROUND 
Burden of behavioral health-related problems 
Behavioral Health disorder are comprised of mental illnesses and substance use disorders. 
American Psychiatric Association defined mental illnesses as health conditions involving changes 
in thinking, emotion or behavior (or a combination of these) (American Psychiatric Association, 
2015). Also, mental illnesses are related with distress and/or problems functioning in social, work 
or family activities (Substance Abuse and Mental Health Services., 2015). The Substance Abuse 
and Mental Health Services Administration defined substance use disorders as conditions that 
occur when the recurrent use of alcohol and/or drugs causes clinically and functionally significant 
impairment, such as health problems, disability, and failure to meet major responsibilities at 
work, school, or home. Behavioral health (BH) disorders are health conditions that are 
characterized by alterations in thinking, mood, and behavior that are associated with impaired 
functioning (Centers for Disease Control and Prevention, 2013; Substance Abuse and Mental 
Health Services., 2015; World Health Organization, 2014a). 
BH is an important public health issue globally and in the US. Worldwide, the number of 
years lived with disability due to BH problems has been greater than any other medical conditions 
in the past two decades (World Health Organization, 2004). In the US, one in every four adults 
and one in ten children experience BH illnesses (Centers for Disease Control and Prevention, 
2013; Leong, Ph, & Kalibatseva, 2011; Nayar et al., 2016; Nguyen, Trout, Chen, Madison, & 
Watkins, 2016). The National Comorbidity Survey estimated that overall 57.4 percent of US 
adults have experienced some form of diagnosable mental illness in their lifetime (Leong et al., 
2011).  
Approximately 75 percent of those who suffer from BH disorders-related disabilities are 
unemployed and 15 percent of those BH conditions patients who are diagnosed with 
schizophrenia, bipolar disorder, or depression are homeless (World Health Organization, 2010). 
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In addition, unmet BH care needs can create social problems (e.g., unemployment, poverty, 
disruption of family relations and social life) that may increase crime and political instability 
(Ngui, Khasakhala, Ndetei, & Weiss, 2011). Unfortunately, only a third of those who suffer from 
mental illnesses and substance abuse actually receive community-based behavioral health 
treatment such as outpatient pharmacological and psychotherapeutic treatments (Doren, 
Grimsley, Noone, & Neese, 2016).  
Previous literature suggests that undiagnosed, untreated and delayed diagnoses of BH 
conditions can lead to emergency department (ED) (Doren et al., 2016; Grupp-Phelan, Harman, 
& Kelleher, 2007). Many of these ED visits could have been prevented if the patient had an 
adequate access to the community-based BH care. Because state and federal laws mandate EDs to 
screen, diagnose and treat patients 24 hours daily, EDs have become de-facto BH care facilities at 
a high cost (Grupp-Phelan et al., 2007). The Kaiser Family Foundation found that 18% of 
frequent ED users (i.e., those who use the ED four or more times in a two-year duration) had a 
BH condition compared to only 6% of the total study population (Peppe, Mays, & Chang, 2007).  
Because of the state and federal laws, ED physicians and staff are required to care for 
people with BH conditions with their limited experience in detecting and treating BH conditions, 
which leaves them ill-prepared for the responsibility (Bernstein & Onofrio, 2013; Doren, 
Grimsley, Noone, & Neese, 2016; Johnson et al., 2015; Little, Clasen, Hendricks, & Walker, 
2011; Owens, Mutter, & Stocks, 2010; Rhodes, 2008; Rn, Nurse, Dip, & Icu, 2007). Also, BH 
diagnoses are not usually meant to be conducted in the ED, and hence, they may conduct an 
incomplete and/or inaccurate assessment prognosis and may not direct the patient to the right 
psychotherapy services (Doren et al., 2016). Also, there are no standardized protocols to follow 
up with patients after the discharge from the ED (Doren et al., 2016). 
 The economic and social costs associated with BH are substantial, which underscores the 
importance of treating these conditions (American Hospital Association, 2012). In the US, the 
indirect costs of BH conditions is estimated to be over $79 billion (Ngui, Khasakhala, Ndetei, & 
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Weiss, 2011). In addition, the national expenditures for BH services and substance use disorder  
treatment from all public and private sources was estimated at $172 billion in 2009 (Smith, 
Stocks, & Santora, 2015; Substance Abuse and Mental Health Services., 2013). A study by 
Stranges et al. suggests that the cost for 1.8 million inpatient stays for mental health and 
substance abuse conditions was $9.7 billion in 2009 (Smith et al., 2015; Stranges, Levit, Stocks, 
& Santora, 2011). 
The total costs for hospitalizations reflect on the aggregate use of services, resources, and 
time invested by the healthcare workforce in providing BH services. Findings from studies that 
estimate the total cost allow hospital administrators to make decisions about planning, prioritizing 
and funding new programs (Stensland, Watson, & Grazier, 2012). Also, hospital charges are set 
within the context of the hospitals’ competitors, payers, and customers (Dobson, DaVanzo, 
Doherty, & Tanamor, 2005). Furthermore, uninsurance and under-insurance for treatment of BH 
conditions may lead to a substantial difference between charges and received reimbursements and 
cost shifting between payers (Anderson, 2007; Stensland, Watson, & Grazier, 2012). 
 Length of stay (LOS), a quantitative performance indicator, is measured as the number of 
days of hospitalization for selected conditions and procedures. It is a proxy for inpatient resource 
usage and roughly relates to efficiency of inpatient hospital services (Kroch, Duan, Silow-carroll, 
& Meyer, 2007; Ormel et al., 2007). However, some researchers have been using LOS as a 
qualitative outcome measure to grade performance in improvement programs (Brasel, Lim, 
Nirula, & Weigelt, 2007). LOS is a significant marker to observe reduction in risk-adjusted LOS. 
Risk-adjusted LOS is defined as actual LOS rate divided by the mean expected LOS (expected 
rate) which is then multiplied by the national observed LOS (Agency for Healthcare Research and 
Quality, 2012). LOS also reflect the financial pressures on hospitals to reduce costs, discharge 
patients quickly or treat them in outpatient departments (Kroch et al., 2007). The availability of 
BH prescribers and professionals can prevent delayed-diagnoses of psychiatric illnesses and 
thereby avoid sudden ED visits and reduce the average LOS due to BH disorders. In a study by 
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Saba, Levit, and Elixhauser, the average LOS for hospitalizations principally for mental health 
was greater than for all other stays (8.2 days versus 4.6 days, respectively) (Saba, Levit, & 
Elixhauser, 2008). Hence, it is not only important to study the clinical, demographic, county, and 
patient-level factors that regulate the LOS of inpatient hospitalizations, but also understand the 
extent to which the supply of BH workforce affects LOS.  Efficiency of hospital services and 
LOS are essential parameters that help policymakers design effective BH-related policies, such as 
the expansion of benefits for BH conditions under the Patient Protection and Affordable Care Act 
(ACA). Therefore, it is important to assess the economic implications of admitting BH patients in 
EDs and inpatient departments. 
 Undiagnosed, untreated and delayed diagnoses of BH conditions can lead patients to ED 
visits. Although EDs were designed to treat life-threatening conditions, over the years, EDs have 
been used to treat chronically ill patients, including psychiatric patients. Also, because state and 
federal laws mandate EDs to screen, diagnose and treat patients 24 hours daily, EDs have become 
an important unit for treating BH conditions and at a high cost (Grupp-Phelan, Harman, & 
Kelleher, 2007). The Kaiser Family Foundation found that 18% of frequent ED users (those who 
use the ED four or more times in the two-year duration) had a BH conditions compared to only 
6% of the total study population (Peppe, Mays, & Chang, 2007). Hence, we intend to assess the 
economic implications of admitting BH patients in the EDs, after accounting for factors such as 
the supply of BH professionals, existing co-morbidities, and location of the hospital. We 
anticipate that this project will estimate the expenditures of admitting BH patients in EDs and 
provide estimates for extended LOS in areas with a shortage of practicing BH professionals. 
The Nebraska Behavioral Health Needs Assessment of 2016 showed that 114,000 (7.6%) 
individuals 12 older suffer from alcohol abuse or dependence, out of which only 5.3% received 
treatment (Braun et al., 2016). Further, approximately 32,000 (2.2%) of individuals in Nebraska 
have shown dependence on illicit drugs and only 9.3% of these individuals received treatment. 
Statistically, based on poverty rates, the ratio of youth to adult population, and/or the ratio of 
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elderly to the adult population, 78 of the 93 counties in Nebraska are facing shortages of BH 
professionals. More importantly, 32 counties in Nebraska have no BH providers of any kind. 
Further, 71 counties do not have a psychiatric prescriber (psychiatrist, psychiatric nurse 
practitioner, or psychiatric physician assistant) (Braun et al., 2016). Over the last few years, 
Nebraska has made progress in supplying psychologists, nurse practitioners, physician assistants, 
independent mental health practitioners and addiction counselors, as shown in Table 1. However, 
the number of licensed mental health practitioners (LMPHs), licensed alcohol and drug abuse 
counselors (LADACs)  was reduced by 21% between 2010 and 2016 (Braun et al., 2016).  
 There is a concern that the growing BH needs of the US population are not being met by 
the healthcare system in many parts of the country (Becker & Kleinman, 2013; M. Prince et al., 
2007). The former First Lady, Michelle Obama, advocated for changing the conversation around 
‘Mental Health’ and raised the need to expand benefits for BH and substance use disorders under 
the ACA (Office of the First Lady, 2015). The literature on BH epidemiology and services points 
towards the rising burden of BH conditions in the US, including adverse effects on social and 
financial well-being, associated stigma and the impact on education and employment 
opportunities (Becker & Kleinman, 2013; Centers for Disease Control and Prevention, 2013; 
World Health Organization, 2014b). Thus, current efforts to reduce the societal costs of BH 
conditions have been limited (Becker & Kleinman, 2013; Vos, Flaxman, & Naghavi M, 2012). 
 In general, there is a lack of literature that estimates the current supply of the behavioral 
workforce at state and county-level. However, one study suggested that the number of active 
doctoral-level psychologists in the US was about 83,142, or on a per capita basis, 1 per 3,802 
people (Olfson, 2016). The number of psychiatrists was 37,296, or 1 per 8,476 people in 2013 
(Olfson, 2016). These per-capita rates of psychologists and psychiatrists may not be sufficient to 
address current and future treatment needs for behavioral health patients. Additionally, the 
national shortage of psychiatrists and psychologists is further compromised by geographic 
maldistribution (Olfson, 2016). The designed models of BH service delivery in urban areas are 
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often unsuitable and challenging to implement in rural settings (Elhai, Baugher, Quevillon, 
Sauvageot, & Frueh, 2004). For illustration, urban settings are more likely to offer a variety of 
treatment options that can serve diverse urban population including minorities, HIV positive 
patients, etc. For successful outcomes, urban health services provide auxiliary services like 
detoxification. Moreover, the rural areas have fewer primary care settings that are dispersed and 
located at greater distances. This poses a threat to patients’ adherence to treatment and also may 
mean a lack of anonymity with higher recognition in group-based settings (Pullen & Oser, 2014).  
There are studies that suggest that rural residents may have a lower risk of recurrent 
mental distress than urban residents (Probst et al., 2006; Rohrer, Borders, & Blanton, 2005). 
However, contradicting these studies was a study by Fontanella et al. that stated that suicide rates 
for adolescents were higher in rural than in urban areas (Rohrer et al., 2005). Other studies also 
provided evidence that there are considerable unmet needs for BH services in most rural areas, 
especially among men (Chou & Cheung, 2013; Gfroerer, Larson, & Colliver, 2007; Hedeker, 
2003). Results from Deen and Bridges showed lower rates of utilization of specialty BH services, 
including psychiatrists, psychologists, counselors, and social workers in rural areas compared to 
urban areas (Deen, 2011). Similarly, Ziller et al. estimated that BH-related spending was lower 
among rural residents than those living in urban areas (Ziller, Anderson, & Coburn, 2010). They 
attribute this finding to the lower cost of psychotherapy in rural versus urban areas (Ziller et al., 
2010). 
 Likewise, many health conditions increase the risk for psychiatric disorders, and the 
existence of diagnosed or undiagnosed comorbidities complicates the processes of seeking help, 
screening and diagnosis, treatment, and prognoses (M. Prince et al., 2007;  Diefenbach & Goethe, 
2006). The current healthcare system does not provide health services equitably to people with a 
spectrum of BH disorders, and it is important to mention that the quality of care for both mental 
and physical health conditions for such patients need to be improved (M. Prince et al., 2007). 
Intervention programs often fail to assess comorbid BH disorders, which is a crucial marker to 
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manage a multi-drug dosage treatment or to develop specific lines of treatment to cure 
comorbidities (Chou & Cheung, 2013; Diefenbach & Goethe, 2006; Ormel et al., 2007). The 
common comorbidities with BH conditions are diabetes, cardiovascular disorder or pulmonary 
disease (Ormel et al., 2007).  
The high prevalence of BH diagnoses among people with chronic medical conditions 
raises the need for healthcare administrators and policymakers to help in the integration of care 
for BH and physical health (Druss & Walker, 2011). Treating comorbid conditions is expensive. 
For example, about 80% of the annual increased costs are due to non-behavioral medical services 
for comorbid psychological disorders in the US (Melek & Norris, 2011). Also, the average total 
monthly spending for a person with a chronic disease and a depression diagnosis is $560 more 
than for a person without depression (Melek & Norris, 2011). Bipolar disorders are associated 
with high costs of health services and utilization of services due to comorbidities (Melek & 
Norris, 2011; Rajagopalan et al., 2006). 
Financial cost projections estimated that lost earnings and public disability insurance 
payments associated with behavioral disorders were at least $467 billion in the US (Leong, Ph, & 
Kalibatseva, 2011). Specifically, $400 billion annually in crime, health, and lost productivity are 
incurred for substance misuse and substance use disorders, with $249 billion spent on alcohol-
related disorders (U.S. Department of Health and Human Services (HHS), 2016). These costs are 
even higher than other major health problems such as diabetes ($245 billion) (U.S. Department of 
Health and Human Services (HHS), 2016). In a report by Substance Abuse and Mental Health 
Services Administration, public payers accounted for 59% of spending on mental health 
treatment, whereas 41% of this spending was accounted by private payers (Substance Abuse and 
Mental Health Services Administration., 2016). 
  In 2002, President Bush initiated the President’s New Freedom Commission on Mental 
Health to endorse policies meant for adoption by federal, state, and local governments to improve 
existing BH services (Leong, Ph, & Kalibatseva, 2011). The commission decided to focus on six 
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goals that would transform the existing BH system: (1) accepting that BH is essential to overall 
health; (2) offering family-driven mental health care; (3) eliminating disparities; (4) focusing 
interventions for early detection, assessment, and treatment; (5) implementing evidence-based 
research into practice; and (6) using technology while providing care and access to information. 
Moreover, the federal government had started making calls for expanding workforce research and 
workforce development initiatives for better BH delivery. States such as North Carolina, Idaho, 
Alaska, Hawaii, and Colorado planned workforce development activities (Nayar et al., 2016). 
In the State of Nebraska, the legislature passed the Legislative Bill 1083, the Nebraska 
Behavioral Health Systems Act of 2004. This act assesses the ability of the BH system in 
Nebraska by analyzing the geographic and demographic availability of the state’s BH 
professionals (including psychiatrists, social workers, community rehabilitation workers, 
psychologists, substance abuse counselors, licensed mental health practitioners and behavioral 
analysts) (Nayar et al., 2016). More recently, with the passage of the Patient Protection and 
Affordable Care Act (ACA), the financing and delivery of behavioral healthcare and addiction 
care are expected to benefit (Barry & Huskamp, 2011). The ACA requires parity in coverage, 
thereby making behavioral healthcare equivalent to all other medical and surgical benefits. Also, 
the ACA’s implementation is likely to improve access problems and system fragmentation that 
will be of assistance to people suffering from BH disorders (Barry & Huskamp, 2011; Leong et 
al., 2011). Consequently, the ACA will increase the demand for BH services and, hopefully, 
reduce the ED admissions for BH disorders. In addition, we can expect the inclusion of BH- 
related benefits and services to be covered by private insurance plans, and also offer protection 
for insurance access for patients identified with pre-existing BH conditions (Olfson, 2016).  
Available evidence gathered from individual health professionals, health agencies and 
medical associations show that there is a critical shortage of BH  professionals and services in 
inpatient and outpatient departments, causing the patients to seek help from EDs (S. D. Case, 
Case, Olfson, Linakis, & Laska, 2011; Mulkern, Raab, Potter, Raab, & Potter, 2007; L. Thomas, 
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2003). For example, in predominantly rural Nebraska, 81 of Nebraska’s 93 counties have been 
state-designated as shortage areas for behavioral health professionals and services (Nayar, 
Nguyen, Apenteng, & Shaw-Sutherland, 2011). The shortage of psychiatric prescribers and BH 
professionals in Nebraska can result in missed or late BH diagnoses. This can prove to be 
detrimental, especially for patients suffering from existing co-morbidities such as diabetes and 
cardiovascular diseases, leading to an increase in their length of stay and total hospital charges 
(Galski, Bruno, Zorowitz, & Walker, 1993; Kim, Hwang, Oh, & Kang, 2013; Kwok et al., 2012). 
A longer LOS also places patients at risk of contracting nosocomial infections (Hoover, 
Sambamoorthi, Walkup, & Crystal, 2004). However, little is known about the impact of BH 
disorders on the Nebraskan healthcare system resulting from shortages of BH services, 
particularly in rural communities. The absence of Medicaid expansion under the ACA in 
Nebraska also may mean that many individuals with BH disorders will remain uninsured, 
increasing the likelihood of undiagnosed disorders. 
Conversely, in a predominantly urban state of New York (NY), Medicaid expansion was 
adopted, and Medicaid Managed Care Plans provide some mental health and substance use 
services to their enrollees. However, even though 1.8 million residents of NY are suffering from 
substance use disorder, only 15% receive treatment (The New York State Office of Alcoholism 
and Substance Abuse Services, 2012). Also, among all states, NY spends the most for treating 
and preventing substance use disorder (The Pew Charitable Trusts and the John D. and Catherine 
T. MacArthur Foundation, 2015). Thus, for policymakers, hospital administrators, and planners 
of community outreach, accurate estimates of the frequency of ED visits for substance use 
disorder, total ED charges, and geographic assessment of available primary and ED-level access 
to care are crucial but understudied. 
At the national-level, it has been found that hospitalizations for BH-related disorders, 
especially alcohol-related disorders (ARD) are among the top ten principal diagnoses that result 
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in 30-day readmissions. As of 2013, readmission rates for index hospitalizations for ARD were 
about 19% (Fingar & Washington, 2015). The ACA introduced two recent programs that focus on 
reducing readmission rates beginning 2014. One of the two programs mandated in 2013 is called 
the Hospital Readmissions Reduction Program (HRRP), which requires hospitals with greater 
rates of readmissions to pay penalties designated under the Medicare reimbursement system 
(Boccuti & Casillas, 2017; Cutler, 2010). Another program is called the Bundled Payments for 
Care Improvement Initiative, which ensures that hospitals receive a single payment for a 
complete episode of care, cumulative of index hospitalizations and all the following readmissions 
(Cutler, 2010; Medicare Payment Advisory Commission, 2011). Hence, for hospital 
administrators to monitor spending their budget, especially considering that most hospitals do not 
budget for readmission encounters, estimates such as readmission rates, costs, and relapses of 
ARD would be helpful. Additionally, policymakers that revise and amend programs under the 
ACA must evaluate outcomes of readmissions to understand the sustainability of the programs. 
Knowledge gap 
The objective of this study is to address knowledge gaps by evaluating the differences in clinical, 
demographic and county-level factors, among rural and urban hospitalizations (i.e., ED 
admission) for BH-related conditions in Nebraska and NY, which impact not only health 
outcomes but also associated charges. Moreover, plotting county-level availability of BH 
providers, community-based substance abuse treatment centers, and ED will help us map access 
to care. By understanding the national-level prevalence of index inpatient hospitalizations for 
ARD, the resulting 30-day unplanned all-cause readmissions, and corresponding costs, rates, 
relapses of ARD, hospital administrators and policymakers may improve the allocation of 
resources for such cases. In addition, our findings will help providers design and adopt better 
protocols to follow-up with patients at the primary-level after index hospital discharges.  
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The central hypothesis is that diagnoses of BH-related conditions, patient-and county-level 
factors, and the supply of BH providers are associated with healthcare outcomes such as length of 
stay, total charges TC and rates of index hospitalizations and readmissions. This hypothesis is 
based on a national level literature review that shows evidence of delayed BH diagnoses in rural 
areas due to shortage of BH professionals, ED, and treatment centers. Also, it can be anticipated 
that incidence of hospitalizations and costs may be associated with hospital-level characteristics 
such as locations, teaching status, and ownership, as well as patient-level socioeconomic factors.  
Motivation of the study 
The following are the influential factors that drive the findings of this study: (1) access to BH 
care is a major concern; (2) lack of studies that examine BH-related ED visits using state-specific 
samples; (3) states vary in their adult Medicaid policy for BH services and rural-urban 
distribution (NE & NY); and (4) rates of readmissions have been reported to increase, especially 
post-ACA implementation 
Innovation of the study 
The proposed study will be the first study to systematically examine the economic impact of 
treating BH in the EDs in Nebraska and New York. In addition, this study provides national-level 
estimates of rates and costs of readmissions following index hospitalizations due to ARD. This is 
an innovative study that could lead to advances in an overall understanding of available BH 
services and estimate the proportion utilized by rural and urban residents in the US. With the 
proposed new American Health Care Act of 2017 and the President’s Commission on Combating 
Drug Addiction and the Opioid Crisis established by President Trump, these findings could help 
identify gaps for BH services and suggest recommendations that could be incorporated in the 
healthcare system. Hereby, it is anticipated that the results from this study will be able to provide 
a direction for policymakers to amend, update and/or implement BH policies. 
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Specific Aims 
Descriptive statistics such as the prevalence of BH-related disorders in the US have been 
reported. However, hospital-based ED visits and the associated charges for BH conditions within 
the state of Nebraska are not well understood. In addition, with New York State adopting 
Medicaid expansion and annual increases in public funding to treat substance use disorder, the 
impact on hospital-based ED visits and associated charges for substance use disorder is unclear. 
Finally, providers, hospital administrators, and policymakers are struggling to understand the 
rates and costs of readmissions following index hospitalizations due to ARD. The specific aims of 
the dissertation are as follows: 
Study 1: 
Aim 1: Examine the 30-day readmission due to ARD and identify predictors of 30-day 
readmission for ARD 
Hypothesis 1.1: The 30-day readmission rate for ARD would be significantly lower during the 
post-ACA period compared to pre-ACA period 
Hypothesis 1.2: At least one-third of readmissions for ARD occur within 7 days of the discharge.   
Aim 2: Examine the costs of hospitalization due to ARD and identify factors related to higher 
costs of hospitalization due to ARD  
Hypothesis 2.1: The average cost of index hospitalization due to ARD would be significantly 
lower during the post-ACA period compared to pre-ACA period 
The goal of the first study of this dissertation is to identify patient- and hospital-level factors that 
are associated with 30-day readmissions following the index inpatient stays for ARD. The ACA-
mandated provisions such as the Hospital Readmissions Reduction Program and the Bundled 
Payments for Care Improvement Initiative focus on all-cause readmissions but are likely to 
impact admissions related to ARD. The findings from this study will help us better understand 
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patient and hospital-level factors that are associated with readmissions, subsequent readmission 
costs, and the overall economic burden attributed to ARD.  
Study 2:  
Aim 1: Examine ED admission rates due to BH conditions and identify factors associated with 
ER admission and discharge against medical advice. 
Hypothesis 1.1: Individuals with less access to care (e.g., rural, uninsured, lower SES) are more 
likely to be admitted to ED than those with more access.  
Hypothesis 1.2:  Individuals with less access to care (e.g., uninsured, low-income) are more likely 
to be leave against medical advice 
 
Aim 2: Examine the charge for ED admission due to BH conditions and identify factors 
associated with higher ED charges 
Hypothesis 2.1: Individuals with less access to care (e.g., uninsured, low-income) and with 
comorbidities (e.g., elderly) are will have higher ED charges.  
 
Aim 3: Investigate a relationship between BH workforce supply and distribution of ED with ED 
visits. 
The goal of the second study of this dissertation is to provide characteristics of BH-related ED 
visits and charges between the years 2011 to 2013 within Nebraska at the region-level. To 
understand the reason for ED visits and discharge against medical advice, we linked the 
availability of BH professionals at the region-level, which will help measure supply of BH 
workforce in predominantly rural Nebraska. Correspondingly, knowing the distribution of ED at 
the region-level will help explain the higher proportions of ED visits that may be due to lack of 
integrated behavioral health services at the primary level. Results from this study will enable 
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policymakers to improve access to care, introduce incentives for BH professionals to provide 
care, and identify high-risk groups that have unmet BH needs. 
Study 3: 
Aim 1: Investigate ED admission for substance use disorders (SUDs) and describe the 
characteristics of individuals admitted to ED for SUDs in New York.  
Hypothesis 1.1: Individuals who are urban poor (e.g., urban, uninsured, low-income) are more 
likely to be admitted to ED than those with more access.  
Aim 2: Investigate the time trend of the ED admission for SUDs and the ED charge for SUDs  
Hypothesis 2.1: Post-Medicaid expansion, ED charges and number of visits would reduce. 
Aim 3: Identify factors that explain higher ED charges for SUD 
Hypothesis 2.1: ED charges will be higher for those with less access to care (e.g., rural, 
uninsured) and with multiple comorbidities 
Aim 4: Investigate a relationship between substance abuse treatment facilities and distribution of 
ED with ED visits. 
The goal of this third aim of this dissertation project is to characterize ED visits and charges for 
SUD between the years 2011 to 2013 within New York State at the county-level. We mapped the 
distribution of EDs and substance use treatment centers at the county-level. We then estimated 
the correlation of these geographical findings to rates of SUD-related ED visits in New York 
State. We anticipated that the findings from this study would help identify counties with no or 
few specialty care facilities that have higher rates of ED use for SUD.  
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Table 1: Trend of behavioral health professionals in Nebraska from 2010 to 2016. 
2010 2012 2014 2016
Diff. 2010-
2016
% Diff. 2010-
2016
   Psychiatrists 162 156 156 164 2 1%
   APRNs Practicing Psychiatry 78 75 98 113 35 45%
   PAs Practicing Psychiatry 9 12 16 15 6 67%
Total 249 243 270 292 43 17%
   Psychologists 318 335 366 355 37 12%
   LIMHPs 589 703 814 1034 445 76%
   LMHPs 991 1028 918 783 -208 -21%
   LADACs 132 152 143 105 -27 -21%
Total 2030 2218 2241 2277 247 12%
Grand Total 2279 2461 2511 2569 290 13%
Prescribers
Non-Prescribers
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CHAPTER II: CONCEPTUAL FRAMEWORK 
 
To analyze the factors that are associated with service utilization as well as the quality and cost of 
care for BH conditions, a structured framework that explains an individual’s access to and use of 
health services needs to be considered (Andersen, 1995; Phillips, Morrison, Andersen, & Aday, 
1998). This dissertation uses the Aday and Andersen model (Aday & Andersen, 1974).  The 
model incorporates three main domains of determinants that contribute to utilization of health 
services: predisposing characteristics, enabling resources, and healthcare needs. These domains 
have patient and hospital-based characteristics and have a linear relationship with each other, as 
shown in Figure 1. 
The structure of the healthcare system includes its organizational structure, resources 
such as the supply of providers necessary for delivering health services, financial arrangements 
that impact accessibility and availability, and acceptability (standard) of medical care services 
(e.g., physician supply) (Phillips et al., 1998). These factors are important to examine because 
studies have shown that they play a role in healthcare utilization (Phillips et al., 1998). Philips et 
al. also suggest that utilization patterns differ based on the structure of managed care. Also, the 
authors state that researchers and policymakers are curious to understand the influence of health 
policies or organizations on consumption of healthcare services (Phillips et al., 1998). Hence, the 
conceptual model should not only focus on population-level characteristics but also on hospital-
level characteristics. Amendments to policies impact the economic climate and sustainability of 
hospitals and healthcare stings, which in turn affects financial standing of the system such as 
politics. As illustrated in Figure 1, it is noteworthy that outcomes such as readmission 
possibilities, costs, and utilization of health services are interdependent. An individual’s health 
behavior is based on his/her personal health practices, for example, whether they have a regular 
source of care and go for regular check-ups. Personal health practices and population 
characteristics, together influence one’s use of health services, which include the type of services 
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(physical, dental or behavioral), purpose, length of stay in inpatient and emergency departments, 
costs borne and time investment (Andersen, 1995; Fenta, Hyman, & Noh, 2006; Phillips et al., 
1998). 
An adaptation of the Aday and Andersen framework suggests an association between 
population and hospital characteristics and health behavior with health outcomes. Studies have 
suggested using a complex correlation between perceived health status and health care utilization 
with consuming medical care. This method may indicate that individuals perceive their health 
status ‘worse’ if they have been visiting facilities numerous times. (Fenta, Hyman, & Noh, 2006; 
Jahangir, Irazola, & Rubinstein, 2012; Maguen et al., 2007; Rebhan, 2011). Conversely, 
individuals who have a poor perception of their own health may also seek medical care more 
frequently. Thus, it is challenging to assess causation, but one cannot infer causality between 
perception and utilization. Likewise, evaluated health status by physicians is also relative, for 
example, those who visit the physician more frequently either are sick and being treated or 
utilizing the insurance coverage to stay healthy (Andersen, 1995; Fenta et al., 2006). However, 
we cannot make conclusions about those who do not visit the physicians as they may be healthy, 
in denial of help or without insurance. Additionally, another health outcome parameter that 
measures for ED inpatient department-related charges, costs of index hospitalizations and the 
probable readmissions. This comprehensive factor can be measured by evaluating the access, 
cost, and quality of the behavioral health services provided while controlling for patient and 
hospital characteristics. 
Predisposing characteristics  
These are socio-cultural factors of individuals that exist before the individual develops a specific 
health condition. The major predisposing factors include demographics (e.g., age and sex) that 
represent the biological imperatives that indicate the probability that people will need health 
services and, thereby, help in identifying the ‘high-risk’ population.    
Enabling factors 
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Enabling factors include income, location, and insurance status. Individuals with more financial 
resources, have health insurance and live in an area with sufficient access to health care are more 
likely to seek and use health care services. These variables play an important role in estimating 
the consumption of BH services because of the associated stigma towards such conditions (Fenta 
et al., 2006). 
 Need 
Individuals who have multiple health conditions are in greater need for health care services. 
Patients that have greater needs for BH services if they also suffer from comorbidities because 
various physical conditions are treated using prescriptions containing antidepressants, sedatives, 
hypnotics, opioids, and laxatives. Improper, prolonged and overuse of such drugs can result in 
such patients seeking care for BH conditions including non-dependent type substance use 
disorders. About 68% of adults with serious mental disorders have medical conditions such as 
diabetes, cardiovascular diseases, pulmonary diseases (Druss & Walker, 2011; Lagisetty, Maust, 
Heisler, & Bohnert, 2017). Hyperlipidemia, HIV, Hepatitis C, and hypertension were found to be 
common comorbidities with SUDs. Also, patients with SUD had a significantly higher percentage 
of psychiatric comorbidities of depression, bipolar disease, and anxiety. Recently, an increased 
level of attention has been paid on an opioid epidemic stemming from the over-use of 
prescription medications. This is one example of the need for BH care driven by providing 
integrated behavioral health services. Patients suffering from BH diseases might benefit from 
novel care models to co-manage BH and common chronic medical conditions. Also, in the 
presence of more comorbidities, individuals are likely to seek help in various healthcare settings 
including EDs.  
 In general, the above conceptual framework controls for probable confounding factors 
such as income and insurance status, presence of comorbid conditions including chronic illnesses 
that could affect the correlation between inpatient and emergency admissions due to behavioral 
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health disorders. Age and sex also tend to act as confounding factors and hence, the research 
methods should include multivariate analyses.  
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Figure 1: Framework for the dissertation based on the Aday and Anderson model of 1974. 
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CHAPTER III: PREDICTORS AND COSTS OF THIRTY-DAY READMISSIONS 
AFTER HOSPITALIZATIONS FOR ALCOHOL-RELATED DIRORDERS IN US 
ADULTS 
Introduction 
Thirty-day readmissions have been accepted as a gold standard indicator to measure the quality of 
care delivered in US hospitals (Axon & Williams, 2011) mainly because of the high prevalence, 
costs (McCarthy, Johnson, & Audet, 2013), and preventability of some readmissions. Two health 
policies introduced under the Patient Protection and Affordable Care Act (ACA) of 2010 are 
meant to strengthen the US healthcare system by incentivizing hospitals to reduce readmission 
rates and their corresponding costs. First, starting the fiscal year 2015, the Hospital Readmissions 
Reduction Program of 2013 mandates financial penalties to hospitals with greater rates of 
readmissions for certain conditions (e.g., heart attack, heart failure, pneumonia).  These penalties 
are implemented as part of the Medicare reimbursement system (Boccuti & Casillas, 2017; 
Centers of Medicare & Medicaid Services, 2014; Cutler, 2010). Implementation of this program 
compelled healthcare administrators to emphasize effective post-discharge case management in 
order to reduce unnecessary and preventable readmissions. Another program initiated by the 
ACA is the Bundled Payments for Care Improvement Initiative to regulate the payment method. 
With this program, hospitals receive a single payment for an entire episode of care, including 
both index hospitalizations and subsequent readmissions (Cutler, 2010; Medicare Payment 
Advisory Commission, 2011). Hence, understanding the excess costs of care incurred by 
hospitals for readmissions becomes essential and a driving factor for hospital strategic 
management. The salaried providers receive no additional incentive to readmit patients and 
certain hospitals functioning within an annual budget (e.g., Veterans Health Administration-based 
hospitals) do not allocate additional budget to treat readmissions (Carey & Stefos, 2016). These 
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ACA programs have motivated the health care systems to more accurately forecast rates and costs 
of readmissions, especially for the preventable readmissions.    
 Nationally, among all other medical conditions, hospitalization due to alcohol-related 
disorders (ARD) resulted in the highest  7-day (the second rank) and 30-day (the fourth rank) 
readmissions (Fingar & Washington, 2015). Alcohol-induced disorders, acute alcohol 
intoxication, unspecified alcohol dependence, alcohol abuse, alcoholic polyneuropathy, alcoholic 
cardiomyopathy, alcoholic gastritis, liver damage due to alcohol abuse, alcohol affecting fetus or 
newborn via placenta or breast milk, and toxic effects of ethyl alcohol are some types of ARD. 
Readmissions due to ARDs are potentially preventable (Patterson, Lindsey, & Roohan, 2009; 
Viggiano, Pincus, & Crystal, 2012). While overall economic costs and hospital (index stay) costs 
for excessive alcohol consumption (Bouchery, Harwood, Sacks, Simon, & Brewer, 2011; 
Gryczynski et al., 2016; Mukamal et al., 2006; Shepard, Daley, Ritter, Hodgkin, & Beinecke, 
2002) and their association with clinical factors including comorbidities, and patient-level 
characteristics have been examined, these studies to do not provide comprehensive data on 
ARDs. Other studies estimated the hospital spending for primary diagnosis of mental illnesses 
(e.g., schizophrenia, depression) with ARD as a comorbidity (Bouchery et al., 2011; Gryczynski 
et al., 2016; Mukamal et al., 2006; J. D. Prince et al., 2008; Sacco, Unick, Zanjani, & Camlin, 
2015; Shepard et al., 2002; G. Singh, Zhang, Kuo, & Sharma, 2016; Slaughter, Farris, Singer, 
Smyth, & Singer, 2017). Hinde et al measured hospital costs and proportion of readmissions in 
Arizona after the state started to mandate screening for ARD in trauma centers (Hinde, Bray, 
Aldridge, & Zarkin, 2015). Fingar and Washington studied readmission costs for ARD in US 
between 2009-2013 and reported an aggregate spending of $366 million (Fingar & Washington, 
2015). 
Importantly, all of these studies were conducted before the implementation of the ACA.  
Because the two mandates under the ACA can have a large impact on the readmission rate and 
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the associated cost, it is necessary to use more recent data to understand the potential impact of 
the ACA.  Finally, few studies have fully explored the combined impact of patient and hospital-
level characteristics on probabilities of 30-day unplanned all-cause readmissions following index 
hospitalizations primarily for ARD. The analysis of readmission rates and costs post-ACA is 
essential for policymakers, hospital administrators, insurance analysts, patients, and providers. 
To our knowledge, nationally representative 30-day readmission rates and their 
corresponding costs following index hospitalizations with ARD as the primary diagnosis have not 
been studied. Moreover, besides clinical factors and patients’ socio-economic characteristics, 
non-clinical factors and other factors such as hospitals’ location, teaching status, bed-size, and 
ownership could be important in impacting readmission rates and costs. The aims of this study 
were to expand the existing literature by using post-ACA data for a nationally representative 
sample of patients with primary diagnosis of ARDs. Five aims of the study are to: (a) determine 
the incidence of index hospitalizations for patients with principal diagnosis of ARD, (b) estimate 
the distribution of the proportion of 30-day unplanned all-cause readmissions across the number 
of days after the index discharge, (c) identify patient and hospital-level predictors of 30-day 
unplanned all-cause readmissions, (d) predict incremental cost of 30-day readmissions, and (e) 
evaluate costs due to repeated diagnosis of ARD at the first immediate 30-day readmission. 
Methods 
Data source 
Nationwide Readmissions Database 
The Healthcare Cost and Utilization Project (HCUP), sponsored by the Agency for Healthcare 
Research and Quality (AHRQ), has drawn the 2014 Nationwide Readmissions Database (NRD) 
from the same sample of discharges as the HCUP State Inpatient Databases (SID). This study 
utilizes information from the NRD that contains reliable data from 22 states and hospital 
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readmissions for all types of payers and the uninsured (Healthcare Cost and Utilization Project, 
2017). These states are geographically dispersed and account for 51.2 percent of the total US 
resident population and 49.3 percent of all the US. A verified patient linkage number helps track a 
patient across hospitals within a state. AHRQ has computed encrypted identifiers that helps flag 
discharges per patient throughout the year 2014 (Healthcare Cost and Utilization Project, 2017). 
The 2014 NRD is comprised of 14,894,613 unweighted discharges collected from 2,048 hospitals 
that amount to 35,306,427 discharges with weighting. We used the visit linkage variable to query 
the number and days to readmission by patients (Healthcare Cost and Utilization Project, 2017). 
The NRD also provides a hospital identifier that traces patients across hospitals within a state. 
Moreover, hospital discharges in the NRD database are stratified and a single stage cluster sample 
with variables for weights that help quantify nationally representative estimates of index 
hospitalizations and readmissions.  
Study sample 
Recommendations made by CMS, the National Committee for Quality Assurance (NCQA), 
Healthcare Effectiveness Data and Information Set (HEDIS), and National Quality Strategy 
Annual Reports, were followed to design the inclusion and exclusion criteria for the study 
(Horwitz et al., 2014; National Committee for Quality Assurance, 2015; National Quality 
Strategy, 2012). The study population included those discharges in which the patient were adults 
(over 18 years of age), did not die in the hospital, with one or more days in length of stay (LOS), 
and discharges between January and November. The study excluded those discharges for the 
month of December; patients admitted in an out-of-residency state at index stay; transferred to 
acute care facilities, left against medical advice, discharged to unknown location; and/or had 
primary diagnoses for (1) cancer, (2) rehabilitation, (3) pregnancy, (4) condition originating in the 
perinatal period. Only the first readmission is counted within the 30-day period because the 
outcome measure assessed in this study is percentage of admissions with a readmission.  
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The following steps that were taken to create the sample. As shown in Row 1 of Table 1, 
a total of 14,894,613 discharges among 10,203,006 patients were identified. For the calculation of 
30-day readmission counts, discharges made after November were excluded because their 30-day 
follow-ups cannot be observed in the NRD. Row 2 shows that based on CMS and HCUP 
recommendations, those discharges where the patients were transferred to acute-care facilities 
(n=131,761), left against medical advice (n=189,690) or had missing information on disposition 
status (n=15,186) were omitted from the study cohort. Similarly, we excluded from index 
hospitalizations any discharges for cancer (n=572,679) and rehabilitation (n=21,332) from index 
hospitalizations (Rows 3 and 4) because they would likely be deemed as ‘planned readmissions’.  
In addition, we excluded admissions that took place in a state that was not the patient’s state of 
residency (n=569,766). This is because these patients would most likely be readmitted in their 
state of residence, which would not be captured in the NRD (Row 5). Individuals who died during 
their initial hospitalization and those with missing LOS (n=16) and with zero LOS (n=198,287) 
(Row 6) were excluded so as to be able to calculate the number of days to a subsequent 
readmission. Lastly, following NCQA and HEDIS guidelines, the analyses excluded hospital 
stays for acute inpatient discharge with a principal diagnosis of pregnancy (n=1,846,607) (Row 7) 
or of a condition originating in the perinatal period (n=731,439) (Row 8). Moreover, a principal 
diagnosis of organ transplant (Kidney Transplant, Bone Marrow Transplant Organ Transplant 
Other Than Kidney) and potentially planned procedures without principal acute diagnosis were 
also queried for deletion but no such cases were found in the study sample. Because disease 
development and comorbidities vary between children/adolescents and adults, and both these 
groups have different risk factors; this study excluded patients under the age of 18 years 
(n=414,844). 
The 2014 NRD was queried for ARD using the International Classification of Diseases 
(ICD) Clinical Classification Software (CCS) Code 660 (Appendix 1). The ICD-9-CM 
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(International Classification of Diseases, Ninth Revision, Clinical Modification) was used to 
identify hospitalizations with primary diagnoses for alcohol-induced disorders (291.00-291.90), 
acute alcohol intoxication (303.00-303.03), unspecified alcohol dependence (303.90–303.93), 
alcohol abuse (305.00-305.03), alcoholic polyneuropathy (357.5), alcoholic cardiomyopathy 
(425.5), alcoholic gastritis (535.30, 535.31), liver damage due to alcohol abuse (571.00-571.30), 
alcohol affecting fetus or newborn via placenta or breast milk (760.71) and toxic effects of ethyl 
alcohol (980.00) (Healthcare Cost and Utilization Project (HCUP), 2015). Although the study 
includes those discharges for patients with primary diagnoses of ARD, the readmissions to these 
hospitalizations were all-cause and unplanned. Because NRD is built on information mentioned 
on the discharge form, index hospitalizations were classified according to primary diagnoses on 
discharge. A hospitalization with primary diagnoses for ICD code of 660 as per CCS was 
considered as an index hospitalization and each qualifying hospital stay was counted as a separate 
index admission. Therefore, a patient can have multiple index stays during the January to 
November observation period. 
Measures 
Independent variables 
Patient-level characteristics included age, sex, length of stay, median household income national 
quartile for patient’s home ZIP code, payer, disposition status, patient location, utilization of 
emergency services, and number of chronic and comorbid conditions at discharge. Age was 
stratified into five categories (18-24, 25-44, 45-64 and > 65 years old). NRD includes insurance 
status as the primary payer listed for the index hospital discharge without listing information on 
the secondary payer. It is important to note that for patients over the age of 65 years, Medicare 
was coded as their primary payer, given their eligibility to enroll in Medicare. Also, NRD 
presents all Medicare beneficiaries, whether they use the fee-for-service or Medicare Advantage, 
into one common category called Medicare. Categories including Worker's Compensation, 
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TRICARE/CHAMPUS, CHAMPVA, Title V, and other government programs are grouped as 
‘other’ insurance (Healthcare Cost and Utilization Project (HCUP), 2017c). NRD does not 
provide information on patients’ race, ethnicity, and state of residency. 
The variable ‘utilization of services’ indicates records that have evidence of ED services 
reported on the HCUP record. Some of the ED services included were ED revenue (ICD-9-CM 
code of 450-459) or any positive ED charge, Current Procedural Terminology (CPT) code of 
99281-99285, condition code of P7 (point of origin in emergency room), and admission source of 
ED. A non-negative value specifies that there is evidence of ED services, whereas a value of zero 
means that no ED services has been used.  
  We used a variety of hospital-level characteristics including the ownership, location, 
teaching status, hospital volume, the number of beds, and the length of hospital stays. The 
ownership or hospital control is based on mission, vision and values of the organization and 
include categories like government nonfederal (public), private not-for-profit (voluntary) and 
private investor-owned (proprietary). NRD also entails hospital location variable that is based on 
urban-rural designation of the hospital depending on the county of the hospital; and information 
on teaching status of hospital defined based on approval of the American Medical Association for 
their residency program. The hospital volume was measured by the annual admissions and 
divided into equal thirds based on the number of admissions for ARD through 2014 (< 41, 42-98, 
and > 99). The hospital bed size variable was categorized specific to the hospital's location and 
teaching status. Moreover, the length of inpatient hospital stays (LOS) in days was used in the 
analysis. 
 To capture the overall health of the patients, this study constructed variables measuring 
their comorbid conditions using HCUP Comorbidity Software Version 3.7 (Healthcare Cost and 
Utilization Project (HCUP)., 2017). All comorbid conditions used the ICD-9-CM codes. This 
comorbidity software utilizes 29 binary indicators for calculating the Elixhauser Comorbidity 
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Index (ECI) (Elixhauser A, Steiner C, Harris DR, 1998). To avoid collinearity and to follow the 
norms of constructing the ECI measure, we removed alcohol-related comorbidity and categorized 
the remaining 28 conditions into two groups. Drug-related conditions, depression, and psychoses 
were categorized as “related” comorbid conditions. The remaining conditions were categorized as 
“unrelated” comorbid conditions. An ECI measure of 0, for both related and unrelated comorbid 
conditions, indicates an absence of any comorbid condition.  
Outcomes 
Index hospitalizations for ARD and 30-day all-cause unplanned readmissions are the units of 
analysis. It is difficult to determine which readmissions are preventable and which are not. 
Additionally, from the hospitals’ perspective, an all-cause readmission is an important quality 
improvement metric that drives their strategies to contain high healthcare expenditures.  Hence, 
we included all-cause and unplanned 30-day readmissions (Horwitz et al., 2014). Also, we used 
the nearest in time or the immediate 30-day readmission, measured as a binary indicator (0/1), 
that occurred following an index hospitalization between January 1, 2014 to November 31, 2014 
for ARD, which is the commonly used method by the CMS (Krumholz et al., 2000; Strom et al., 
2017). All subsequent re-hospitalizations that occur after the first readmission and beyond 30-
days from the first index hospitalization is considered as a new index hospitalization for the same 
patient. Because the average rate of readmissions through 2014 per patient following an index 
hospitalization due to ARD is 1.11, patient-level clustering of readmissions would not have a 
statistically significant impact on the resulting estimates (Strom et al., 2017). 
The incurred inpatient hospital costs in dollars for index hospitalizations and first 
readmissions in 2014 are the desired primary outcomes. The NRD contains data on inpatient 
hospital charges. HCUP’s Cost-to-Charge Ratio (CCR) files were used to convert the charges into 
actual costs, which provides the cost in dollars of resources used for providing inpatient care for 
all hospitals and conditions (“HCUP Cost-to-Charge Ratio Files (CCR).,” 2017). The CCR files 
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include neither any information on who ultimately paid for inpatient services nor how much of 
these costs were covered by the insurance provider. However, estimates of inpatient costs by all 
payers are validated by HCUP. Moreover, NRD is sampled such that using the weights, strata and 
cluster variables, nationally representative estimates of hospital costs and readmission costs can 
be derived (Healthcare Cost and Utilization Project (HCUP), 2015). 
Analytical approach 
Index hospitalizations for ARD and all-cause and unplanned first 30-day readmissions were the 
units of analysis. Descriptive statistics were calculated for the number of inpatient index 
hospitalizations for ARD and the proportion of them that led to immediate 30-day readmissions, 
stratified by various patient and hospital-level characteristics. The categorical variables were 
expressed as frequencies and percentages while the continuous variables were expressed as means 
(with standard deviations) and medians. Univariate analyses were performed using the Student t-
test for continuous data. Chi-square tests at significance level of 0.05 were used to determine 
differences in grouping variables to estimate the proportions of index hospitalizations for ARD 
that were and were not followed up by 30-day readmissions. By definition, each patient can have 
multiple index hospitalizations. Therefore, descriptive statistics are performed at the discharge-
level with ARD.  
The distribution of the proportion of 30-day readmissions across the number of days after index 
hospitalization for ARD was estimated. To identify the predictors for an all-cause 30-day 
readmission, this study performed multivariate logistic regression while adjusting for patient 
demographics, hospital characteristics, and comorbidities. Simultaneously, a forest plot 
demonstrating adjusted odds ratios for readmission for key patient and hospital-level 
characteristics was drawn. 
30 
 
  A two-part model (2PM) was used to link the probability of readmission to the 
corresponding readmission cost to determine patient- and hospital-level estimates for the 
expected readmissions for overall index hospitalizations with ARD. In short, the 2PM linked the 
readmission probability model to a readmission cost model. This two-part model based on mixed-
discrete-continuous variable regressions was used to not only account for zero costs of 
readmission visits but to also estimate incremental costs of inpatient readmissions (Manning & 
Mullahy, 2001). Because this model evaluates individual cost data that typically includes a 
substantial proportion of zero value costs and, consequently, have skewed distribution (heavy 
right-side tail) of non-zero values of costs, (Mullahy, 1998) it is an appropriate choice for the 
analyses.  
The first part of 2PM helps evaluate the probability of non-zero costs of readmissions 
distinctly different from level of costs which are conditional on non-zero readmission costs using 
a logit link function. This method has been used for hospital-cost analyses in previous studies 
(Carey & Stefos, 2016; Kang & Barner, 2017; Li, Cairns, Fotheringham, & Ravanan, 2016; Ruhl 
et al., 2017). This part applies a logistic regression for the binary distribution of the cost variable. 
The second part of the model uses the generalized linear model with a log-link to estimate 
conditional costs only for those discharges that had positive costs of readmissions (Belotti, Deb, 
& Norton, 2015). The expected cost of readmission following an index hospitalization with ARD 
was calculated as a product of the predictions obtained from estimating each part of the model, 
i.e., the probability that any given readmission had an inpatient cost and their mean cost. This 
study adjusted for all the predisposing, enabling and need factors of the Anderson model (Aday & 
Andersen, 1974). Post-regression estimation of the 2PM enabled us to predict readmission costs, 
estimate average and incremental costs in readmission for ARD. Additionally, analyses to 
estimate readmission costs for readmissions that had primary diagnoses of ARD for the index stay 
as well as 30-day readmission (called recurrence of ARD diagnoses at readmission, for this 
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study). The estimates of readmission costs for recurrence of ARD at readmission were compared 
to those that had primary diagnoses of ARD for that index stay but not the immediate 30-day 
readmissions. 
 SAS version 9.4 was used for all the descriptive analyses, multivariate logistic regression 
and plotting the forest plots (SAS Institute Inc, Cary, NC). However, analyses for the 2PM were 
performed using the user-built ‘twopm’ command in Stata (Stata Corp, College Station, TX). 
Also, post-regression estimates for the average and incremental costs were computed using the 
‘margins’ command. To account for the complex survey design, we used sampling weights, 
clustering and stratification of all patient and hospital-level analyses to produce national estimates 
of readmission costs for index hospitalizations due to ARD. 
Results 
Readmission rates of patient- and hospital-level characteristics 
Out of 10,203,006 discharges recorded from 2,048 hospitals in the NRD 2014, 285,767 index 
hospitalizations occurred for ARD. About 18.9% (54,083) of these index hospitalizations for 
ARD were readmitted within 30-days. Patient- and hospital-level characteristics of ARD index 
hospitalizations (weighted) are shown in Table 2. The mean age of patients who had 30-day 
readmissions was 49.8 years. Patients who were 45-64 years old had the majority (57.90%) of 
index hospitalizations for ARD, followed by those aged between 25-44 years (31.17%). Males 
contributed the majority (71.9%) of index hospitalizations. Medicaid (34.9%), private insurers 
(23.9%), and Medicare (19.4%) were the top three payers for index hospitalizations for ARD. The 
majority of hospitalizations resulted in routine discharges (overall (86.6%). Also, most 
hospitalizations were for urban residents (87.1%). About half (41.7%) of hospitalized individuals 
had at least one related comorbid conditions and 82% had at least one unrelated comorbid 
conditions. The majority (90.8%) of hospitalized individuals had non-elective admission and 
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78.48% used emergency services. The mean LOS was 5.3 days and the mean cost of the index 
hospitalization was $8,188. The majority (74.1%) of individuals were admitted to non-profit 
private hospitals. Over half of the individuals were admitted to large hospitals. The majority 
(66.7%) of them were admitted to metropolitan teaching hospitals.  
All of the patient- and hospital-level variables were significantly associated with the re-
admission status mainly due to the large sample size. The notable associations include age, 
primary payer, unrelated comorbid conditions, and teaching status. For example, 62.3% of re-
admitted individuals were between 45 and 64 years of age while 56.7% of individual without 
readmission were in that age group (<.0001). The proportion of Medicare (23.3% vs. 19.2%) and 
Medicaid (41.4% vs. 33.7%) coverage was higher among individuals with at least one 
readmission compared to those without readmissions. Patient who were readmitted had higher 
proportion patients lived in low-income areas (the first quartile: 32.6% vs. 29.4%) than those that 
were not readmitted. A higher proportion of hospitalizations with 4 or more comorbidities (20.5% 
vs.16.4%) resulted in readmissions in contrast to those that did not have 30-day readmissions. 
Among those who were readmitted, 70.7% of hospitalizations were at metropolitan teaching 
hospitals while 65.8% of the hospitalizations without readmissions were admitted at such 
hospitals. 
The distribution of the proportion of readmissions was plotted across the number of days 
(within 30-days) after the index discharges for ARD. As shown in the Figure 1, a higher 
proportion (3.5-4.5%) of the readmissions occurred during the first 8 days. 
 The multivariable logistic regression, adjusted for comorbidities as well as patient and 
hospital characteristics, was performed to identify predictors for all-cause 30-day readmission 
occurring on index hospitalizations for ARD (Table 3) and Figure 2 visually illustrates the results. 
Males were slightly less likely to be readmitted than females (OR=0.94; 95% CI: 0.90-0.98). 
Compared to patients between 18-24 years, those aged between 25-44 years (OR=1.93; 95% CI: 
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1.62-2.29), and 65 years and older (OR=1.48; 95% CI: 1.22-1.80), were much more likely to be 
readmitted but the odds of readmission were highest among those 45-64 years old (OR=2.14; 
95% CI: 1.80-2.54). Hospitalizations in rural areas were less likely to result in readmissions than 
those in urban areas (OR=0.83; 95% CI: 0.75-0.91). Individuals living in higher-income areas 
(the third quartile: OR=0.92; CI: 0.86-0.98; and the fourth quartile: OR=0.92; CI: 0.86-0.98) were 
less likely to be readmitted when compared to those living in low-income areas (the first quartile). 
The likelihood of being readmitted increased with increase in the index measure for unrelated 
comorbidity. In contrast to individuals with no unrelated comorbidity, those with one (OR=1.09; 
CI: 1.03-1.5), two (OR=1.19; CI: 1.12-1.27), and three (OR=1.29; CI: 1.20-1.38) had higher 
readmissions, but the odds of readmissions were highest among those with four or more 
(OR=0.91; CI: 0.85-0.98) unrelated comorbidities. Small metropolitan areas (OR: 0.89; CI: 0.83-
0.96), micropolitan (OR: 0.76; CI: 0.65-0.89), areas classified as neither metropolitan nor 
micropolitan areas (OR: 0.72; CI: 0.60-0.87) had lower odds of readmissions due to ARD when 
compared to the large metropolitan areas. Individuals admitted to hospitals with medium (OR: 
1.10; CI: 1.02-1.20) and large number of beds (OR: 1.19; CI: 1.10-1.29) had a higher likelihood 
of readmissions due to ARD when compared to those admitted in hospitals with small bed size.  
Costs of readmissions for ARD 
The estimated coefficients for patients who revisited the hospital for ARD diagnosis; those with 
one or more unrelated comorbidities as per ECI measure; and hospitals with large bed-size are 
positively associated with the increased costs of readmissions in the 2PM model and statistically 
found to be significant at the 1% level (Appendix 2). Individuals admitted for ARD as a primary 
diagnosis at readmissions are likely to cost more than those whose primary cause of readmission 
is other than ARD, which is conditional on spending any amount. The probability of readmissions 
costs following an index hospitalization for ARD increases with the number of unrelated 
comorbidities. Also, the probability of readmissions costs for patients admitted at hospitals with a 
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large number of short-term acute care beds set up and staffed in a hospital (bed-size) will likely 
be more than hospitalizations at hospitals with smaller number of short-term acute care beds. 
Similarly, the estimated coefficients for females; those hospitalizations that were 
uninsured and not charged; and admitted in hospitals built in small metropolitan, micropolitan 
and not metro or micropolitan areas; are negative in both parts and statistically found to be 
significant at the 1% level (Appendix 2). This indicates that those patients who paid for self and 
not charged will have lower readmission costs than those who are covered by Medicare. Also, 
hospitalizations not in metropolitan areas are likely to have less readmissions costs than those in 
metropolitan areas. 
Predicted and incremental readmission costs following index stays for ARD 
The mean cost was predicted to be $2,520 per recurrence of ARD diagnoses, $918 more than the 
cost of readmission without recurring ARD. Readmissions by males were predicted to cost an 
average of $1,754, about $44 more than that for females. The highest average cost of $1,908 was 
predicted to be incurred by those between the ages of 45-64 years, which is $1,018 more than the 
readmissions costs for young adults (18-24 years). The cost of readmissions was the highest for 
those covered by Medicare ($2,133). Readmission costs increase with the number of unrelated 
comorbidities increases. For example, the mean cost was $2,414 among patients with 4 or more 
conditions, which is $1,170 more than those with no unrelated comorbidities. Because the 
average length of stay for index and revisit hospitalizations for ARD is about 5 days, predicted 
marginal effects were measured at 5 days and found to be $1,966, which would increase by $295 
for every additional day.  
The predicted mean readmission cost for hospitals located in large metropolitan areas is 
$2,032, which is $485, $930 and $1,002 more than readmissions occurring in hospitals located in 
small metropolitan, micropolitan, and neither metro nor micropolitan areas, respectively. The 
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readmission cost in hospitals with large number of bed in short-term acute care hospitals is 
predicted to be an average of $1,964, which is $413 more than hospitals with smaller number of 
beds. Readmissions in non-federal government hospitals (predicted mean costs: $2,109) costs 
more by $337 and $567 than readmissions in private not-for-profit (voluntary) and private 
investor-owned hospitals, respectively. Hospitals experiencing lower volumes of cases for ARD 
are predicted to cost more to patients for their rehospitalizations. For example, readmission costs 
are predicted to be the least ($1,666) in hospitals that experience high volume of ARD cases by 
$488 than those experiencing low volume of ARD cases. 
Incremental costs of readmissions with and without recurrence of ARD 
Table 5 represents an estimation of incremental costs for readmissions with and without 
recurrence of ARD (primary diagnoses of ARD at index discharge and readmission). The initial 
analyses found that 25.7% of readmissions to index hospitalizations for ARD also had primary 
diagnosis of ARD. This is a huge population of ‘frequent users’ who get hospitalized in inpatient 
departments within 30-days for the same diagnoses. We estimated that average marginal costs of 
readmissions were statistically and significantly greater through all age groups of adults in the 
group of patients that were readmitted for ARD as recurring diagnoses versus those that were 
readmitted for other primary diagnoses. For illustration, as compared to young adults, the costs 
for the elderly with recurrence of ARD was $1,003 (P<0.0001) higher while that for the elderly 
with no recurrence for ARD was higher by $641 (P<0.0001). Compared to individuals covered by 
Medicare and readmitted for recurrence of ARD; the privately insured (-$1,040 vs.-$718), not 
charged (-$1,176 vs. -$784) and using other insurances compared to Medicare (-$939 vs. $570) 
incurred lesser costs when compared to those who were not readmitted for recurrence of ARD. 
However, individuals who were uninsured and had a recurrence for ARD (-$1,154 vs. -$779) paid 
the least readmission costs compared to those covered by Medicare and without recurrence of 
ARD. Incremental readmission costs for recurrences of ARD increase significantly with increase 
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in the number unrelated comorbidities than those readmissions without recurrence of ARD. 
However, the incremental readmission costs for recurrence of ARD was significantly higher by 
$419 for every extra day of stay while that for readmissions without recurrence of ARD was 
increased by $264 only. Compared to readmission costs without recurrence of ARD, costs for 
treating recurrence of ARD at hospitals in smaller areas was much higher. For example, costs of 
treating recurrence of ARD in hospitals located in neither metropolitan nor micropolitan areas 
than those located in large metropolitan areas is less by $1,389 (-$905 less for readmissions 
without recurrence of ARD at hospitals in neither metropolitan nor micropolitan areas). Similarly, 
rehospitalizations with higher number of beds incurred more incremental readmissions costs than 
those with small number of beds for readmissions with recurrence of ARD versus those without 
recurrence of ARD ($564 vs.$375). Readmissions at non-federal government hospitals incurred 
more incremental readmissions costs than private not-for-profit (voluntary) (incremental cost: -
$473 with recurrence of ARD vs. -$302 without recurrence of ARD) and private investor-owned 
hospitals (-$804 vs. -$498 without recurrence of ARD) for readmissions due to ARD versus those 
without ARD. Lastly, readmissions at hospitals experiencing medium (-$424 vs. -$272) and high 
(incremental cost: -$693 vs. -$441) volume of cases for recurrence of ARD cost significantly less 
than readmissions at hospitals that experience low volume of cases, especially for readmissions 
with ARD versus without ARD at primary diagnosis. 
Estimated burden of ARD in the US 
Based on the weighted number of index hospitalizations for ARD (N=285,767), the estimated 
total costs of hospitalizations among patients with primary diagnosis of ARD is $2.3 billion 
(Table 1) per year in the US. Moreover, $512 million (Table 1) is spent on the first 30-day 
unplanned and all-cause readmissions following these index hospitalizations to ARD, of which it 
is predicted that $136 million (Table 4) is spent on those readmissions whose primary diagnoses 
is ARD.  
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Discussion 
To our knowledge, this study is the first to provide nationally representative estimates of the rates 
of unplanned all-cause 30-day readmissions to index hospitalizations for patients with primary 
diagnoses of ARD. Previous studies have looked at predictors of readmissions following index 
hospitalizations where ARD and other psychiatric disorders were comorbidities (Baumeister, 
Haschke, Munzinger, Hutter, & Tully, 2015; Sacco, Unick, Zanjani, & Camlin, 2015; G. Singh, 
Zhang, Kuo, & Sharma, 2016; Slaughter, Farris, Singer, Smyth, & Singer, 2017) and not as the 
primary cause of hospitalizations. Despite the fact that readmissions for ARD are potentially 
preventable (Patterson et al., 2009; Viggiano et al., 2012), we found that even after the ACA 
implementation about 19% of index hospitalizations with ARD resulted in 30-day readmissions. 
The difference in readmission rate maybe because the number of Americans that received access 
to care increased post-ACA while quality of care and discharge protocols remained mostly 
unchanged. Also, consistent with pre-ACA findings by Fingar and Washington (2015) for the 
period 2009-2013 (Fingar & Washington, 2015), our study shows that readmissions following the 
index discharge due to ARD occur within the first 8 days. Suicidality and social problems have 
been regarded as the commonest immediate reason behind readmission (N. Chakraborty & 
Aryiku, 2008). These preventable readmissions may be due to untimely discharge without 
adequately stabilizing patients and poor transition; failure to continue care after discharge; or 
insufficient communication among hospital staff, patients, caregivers and community-based 
clinicians (Viggiano et al., 2012). Furthermore, consistent with previous studies, our study 
identified high-risk patients that included those who were males, between the age of 45-64 years 
(B. J. Clark et al., 2013; Weiss, Barrett, Heslin, & Stocks, 2016), covered by Medicaid (Hines, 
Barrett, Jiang, & Steiner, 2014), residing in urban but low-income areas (Weiss et al., 2016), had 
utilized emergency departments before inpatient admissions, and having 3 or more chronic 
conditions and up to 2 unrelated comorbidities (H. Chakraborty et al., 2017; Smith, Stocks, & 
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Santora, 2015; Walley et al., 2012), were more likely to be hospitalized for ARD which can result 
in 30-day unplanned readmissions. Additionally, patients who were males, 25 years old and 
above, with Medicare coverage, 2 or more unrelated comorbidities (Barker et al., 2017; 
Campbell, Bahorik, Kline-simon, & Satre, 2017; J. D. Prince et al., 2008), residents of urban, and 
low-income areas have higher odds of readmission. Our results also show that patients were more 
likely to be readmitted within 30-days than those without unrelated comorbidities, which is 
consistent with existing literature. 
To the best of our understanding, this is the first published study that incorporated 
patient- as well as hospital-level characteristics to estimate the rates, probability and costs of 30-
day readmissions. Our study shows that readmission rates were higher for those hospitalizations 
that occurred in those hospitals that were not-for-profit private, with large numbers of beds, 
located in metropolitan areas, had a metropolitan teaching status, and experienced high volume of 
cases for ARD. This is comparable to results found in the literature (J. D. Prince et al., 2008; 
Sacco et al., 2015). Patients admitted at hospitals with medium and large bed-size also had higher 
odds of 30-day readmissions, thereby, indicating that such facilities must improve delivery of 
integrated treatment and ensure consistent communication across the care team. Like previous 
literature, we found that readmissions occurring in hospitals located in large metropolitan areas 
cost higher than those in rural areas. Higher wages for providers, provision of graduate medical 
education, payer and case mix, higher probability of competition, and treatment of poor, 
uninsured and Medicaid patients were the reported reasons for the differences in costs of 
treatment between rural and urban hospitals (iVantage Health Analytics, 2016; Thorpe, 1988). 
This issue indicates that urban hospitals need to offer less fragmented care, emphasize on 
continuity of care together with home follow-up visits, and increase education to patients 
including teaching them self-management of care. These strategies may also be applied by those 
hospitals where patients incur higher costs of hospitalizations and had large bed-size, were non-
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federal public/government hospitals, and had experienced lower volume of ARD cases. Reports 
which evaluated treatment costs for other diseases also had similar associations between costs of 
hospitalizations and hospital-level factors (Brinjikji, Rabinstein, & Cloft, 2012; Chen, Jha, 
Ridgway, Orav, & Epstein, 2010; Walkey & Wiener, 2014). However, this study shows that 
hospitals that were non-federal government, located in large metropolitan areas and have a larger 
number of beds, may offer comparatively lower hospitalizations costs to those who had 
recurrences of ARD at readmissions than without recurrence of ARD. Hence, this indicates that 
rehospitalizations for the same diagnoses may be treated at lower costs than for different 
diagnoses at these hospitals. Because there is paucity of similar studies to compare findings on 
recurrences of ARD, future research needs to be conducted on estimating differences in costs of 
readmissions with and without recurrences of ARD by patient and hospital-level characteristics. 
It is noteworthy that the average cost of index inpatient stays for ARD we found was 
$8,188, which was almost twice that from findings on all substance abuse-related inpatient 
hospital stays ($4,600) in 2008 (Stranges et al., 2011). With the absence of recent statistics and 
comparable studies performed on a national-level on readmissions following index discharge with 
ARD, our results provide useful, detailed information on possible cost drivers among patient and 
hospital characteristics. After the implementation of the ACA and other health policies that 
increase access and coverage for mental health and substance use-related disorders, outpatient 
services offering follow-ups for ARD should render reduction of readmission rates and costs. 
Also, we anticipated reduced readmission costs for treating recurrence of ARD because certain 
elements of treatment such as costs for diagnostics and pathology tests would not be repeated 
within 30 days. Compared to results of pre-ACA estimated aggregate costs of readmissions ($366 
million between 2009-2013) (Fingar & Washington, 2015), our study shows that post-ACA in 
2014 alone, a cost of $512 million was incurred for immediate 30-day readmissions. There are 
only two other studies in our understanding that have attempted to provide similar estimates but 
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at state-level. The first study used Ontario, Canada’s population to derive and validate sex-
specific models to predict 30-day psychiatric readmissions (Barker et al., 2017). The second used 
inpatient data from the San Francisco General Hospital to measure 30-day readmission rates for 
alcohol dependence to evaluate the discharge protocol (Wei et al., 2015) without estimating costs 
of readmissions. In the advent of healthcare policy reform, such a comprehensive analysis of 
rates, costs, and predictors of 30-day readmissions following index stay for ARD provides 
evidence to the US healthcare policymakers indicating high healthcare utilization for preventable 
conditions. 
Because recurrence of ARD as primary diagnoses was seen frequently (among one in 
every four 30-day readmissions), cost analyses for readmissions is important. This study is 
exclusive in evaluating the incremental costs of readmissions with and without recurrence of 
ARD. Our study showed that the cost of treating recurrence of ARD ($2,520 vs. $1,601) was 
higher than treating other diagnoses. This result emphasizes the need to provide integrated 
behavioral health services which can reduce the costs of recurring hospitalizations for ARD. Our 
findings show that readmissions costs increased with an increase in age and ECI for unrelated 
comorbidities for those with and without recurrences of ARD at readmissions. However, 
incremental differences in readmission costs with and without recurrences of ARD were not 
found to be significantly associated with sex, patient location, and income status for those 
patients. Therefore, our study highlights that hospital administrators and providers have an 
opportunity to reduce costs of readmissions by regulating factors that have higher incremental 
costs for readmissions with recurrence of ARD. 
Using health information technology; increasing patient outreach via telephone reminders 
for outpatient follow-ups; introducing protocols for best practices in discharge planning; and 
proactively scheduling the first outpatient session after discharge may help reduce readmission 
rates (Kripalani, Theobald, Anctil, & Vasilevskis, 2014). In a randomized study by Jack et al.,  
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reports that medication reconciliation, reviewing test results and pending tests, discussion related 
to action plans of future treatments, and sharing post-discharge plans in both written (patient 
education) and verbal (instructions in plain language) formats have helped reduce readmissions at 
inpatient and emergency departments (Jack et al., 2009). Author Coleman et al. conducted ‘Care 
Transitions Intervention’ by utilizing nurses to be coaches of transitions to offer home visits 
within 48-72 hours of discharge to significantly reduced 30-day readmissions (Coleman, Parry, 
Chalmers, & Min, 2006). A few recommendations and interventions are specifically suggested to 
reduce readmission rates among these patients with multiple comorbid and chronic conditions. 
Patients who are not provided holistically managed care must be referred to suitable intensive 
services. Also, by offering peer coaching for transitioning from ARD and managing other 
comorbidities; and implementing clinical interventions to encourage adherence to treatment, 
readmission rates may be reduced (Hudali, Robinson, & Bhattarai, 2017; Kripalani, Theobald, 
Anctil, & Vasilevskis, 2014; Pincus, 2014) 
In summary, this national-level study contributes to the knowledgebase on economic 
burden of primary diagnoses by using sophisticated analysis of several types of patient and 
hospital-level characteristics that are predictors of readmissions, the cost of index stays and 
readmissions. Also, our study provides robust estimates on readmission costs by simultaneously 
addressing the problem of zero costs of readmissions and thus skewed (to the right) distribution 
of hospital and readmission costs, which is novel for studies with ARD as a primary or even 
secondary diagnosis. Policymakers and hospital administrators can benefit from the findings and 
may implement protocols for hospitals that monitor and bridge care after index hospitalizations to 
outpatient settings. Local and state public health departments must contrive for community-based 
outreach programs to educate high-risk patients to curb readmission rates for ARD which are 
comparatively top ten in volume but also preventable. 
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Conclusions  
One in five index hospitalizations for ARD in the US results in unplanned all-cause 30-day 
readmission, with a major proportion occurring within the first 8 days. One in 4 of these 
readmissions chances to be for a principal diagnosis for ARD. Readmissions rates, an 
international indicator of healthcare quality, are fund to be more likely among those patients who 
are 45-64 years old and suffer from multiple comorbidities. Overall, readmissions costs are found 
to be higher in hospitals located in large metropolitan areas, with high number of beds, of not-for-
profit government status, and treat low volume of ARD cases per year. However, in contrast, 
these hospital characteristics render lower costs for treating readmissions for recurrence of ARD. 
The estimated burden of ARD-driven index hospitalization in the US in 2014 was $2.3 billion of 
which approximately $474 million were costs on the hospital stays that led to readmissions. 
Nationally, $512 million were spent on treating the first readmissions following the index 
hospitalizations for ARD of which $136 million is predicted to be spent on relapse visits for 
principal diagnosis for ARD. These exorbitant costs on index stays and readmissions indicate the 
fragmented behavioral care offered currently, despite the advent of value-based care, and 
highlight the need for integrated behavioral health services, which can curb these preventable 
readmissions for ARD. An ecological, multifaceted, and combined effort by patients and 
hospitals can together reduce factors that propel preventable readmissions and steep costs for 
ARD. Future studies must analyze patient-level predictors and costs of treating patients with 
ARD in the outpatient departments or other healthcare settings after index discharge and before 
being readmitted within 30 days. Such analysis will help in understanding the extent to which 
patients are utilizing follow-up care before being readmitted.   
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Table 1: Flow chart of exclusion criteria for numbers of observed hospital discharges per 
unique patients applicable to index admissions and readmissions from the NRD, 2014. 
Observed  
discharges (n) & 
unique patients (N) 
Excluded 
discharges (n) & 
unique patients 
(N) 
Explanations 
n = 14,894,613   All discharges in NRD 
N = 10,943,999     
n=14,557,976 n=336,637 Excluded if discharge status is: 
N= 10,727,851 N=216,148 a) Transfer to acute (n=131,761; N= 90,467)  
  b) Left against medical advice (n=189,690; N= 
116,738)  
    c) Unknown (n=15,186; N= 8,943) a 
n=13,985,297 N=572,679 
Excluded if discharges for primary diagnoses of 
Cancer b 
N=10,178,040 N=549,811   
n=13,963,965 n=21,332 
Excluded if discharges primary diagnoses of 
Rehabilitation b 
N=10,162,858 N=15,182   
n=13,394,199 n=569,766 Exclude who were not residents of the state in 
which the initial hospitalization took place were 
excluded since they would most likely be 
readmitted in their state of residence and this 
would not be captured in the NRD. 
N=10,031,591 N=131,267 
    
n=13,195,896 n=198,303 Excluded if LOS is:c 
N=9,894,825 N=136,766 a) LOS is missing (n= 16; N= 16) 
    b) LOS=0 (n=198,287 and N=136,750)  
n=11,349,289 n=1,846,607 Acute inpatient discharge with a principal 
diagnosis of pregnancy.d N=8,153,943 N=1,740,882 
n=10,617,850 n=731,439 Acute inpatient discharge with a principal 
diagnosis of a condition originating in the 
perinatal period. 
N=7,441,110 N=712,833 
n=10,203,006 n= 414844 
Excluded children and adolescents from the 
study 
N= 7,108,419 N=332691   
NRD, Nationwide Readmissions Database; n, number of observed discharges; N= unique number 
of patients; LOS, length of stay.  
a Healthcare Cost and Utilization Project (HCUP). (2017). Nationwide readmissions database description of data 
elements. Retrieved from https://www.hcup-us.ahrq.gov/db/vars/nrd_visitlink/nrdnote.jsp 
b Horwitz, L., Grady, J., Lin, Z., Nwosu, C., Keenan, M., Bhat, K. R., … Drye, E. (2014). 2014 Measure Updates and 
Specifications Report : Hospital-Wide All-Cause Unplanned Readmission. Centers for Medicare & Medicaid 
Services (CMS). 
c Yoon, F., Sheng, M., Jiang, H., Steiner, C., & Barrett, M. (2017). Calculating Nationwide Readmissions Database 
(NRD) Variances. HCUP Methods Series Report # 2017-01. ONLINE. January 24, 2017. U.S. Agency for 
Healthcare Research and Quality. Available: http://www.hcupus.ahrq.gov/reports/methods/methods.jsp   
 d National Committee for Quality Assurance. (2015). Proposed Changes to Existing Measure for HEDIS ® 2015: Plan 
All-Cause Readmissions (PCR). 
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Table 2: Characteristics of patients and hospitals registered in the NRD 2014 with an index hospitalization for alcohol-related 
disorders based on 30-day all-cause readmissions. 
Characteristics  
Overall N=285,767 (100%) 
Readmissions  No Readmissions  
P value  N= 54,083 (18.93%) N= 231,684 (81.07%) 
Number  Percent Number  Percent Number  Percent 
PATIENT-LEVEL CHARACTERISTICS 
Age in years       
18 to 24 6,124 2.1 503 0.9 5,622 2.4 <.0001 
25 to 44 89,087 31.2 15,357 28.4 73,730 31.8  
45 to 64 165,458 57.9 33,723 62.4 131,736 56.9  
65 and over 25,097 8.8 4,500 8.3 20,597 8.9  
 Mean age + SD 48.9 ± 0.11 49.8 ± 0.15 48.7 ± 0.11  
 
       
Sex       <.0001 
Male 205,366 71.9 39,811 73.6 165,554 71.5  
Female 80,401 28.1 14,271 26.4 66,130 28.5  
 
       
Primary payer*      <.0001 
Medicare 57,164 19.9 12,580 23.3 44,584 19.2  
Medicaid 100,181 34.9 22,374 41.4 77,807 33.5  
Private 
Insurance 
68,582 23.2 9,475 17.5 59,107 25.4  
Uninsured 39,763 13.8 6,320 11.7 33,443 14.4  
No charge 6,870 2.4 1,267 2.3 5,603 2.4  
Other 12,786 4.5 1,989 3.7 10,797 4.6  
 
       
Admission Day      0.0014 
Weekday 219,108 76.7 40,973 75.8 178,135 76.9  
Weekend 66,658 23.3 13,109 24.2 53,549 23.1  
 
       
Disposition status      <.0001 
Routine 247,328 86.6 46,813 86.6 200,516 86.6  
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Transfer to 
Nursing, 
intermediate or 
other facility 
26,299 9.2 4,371 8.1 21,927 9.5  
Home Health 
Care (HHC) 
12,140 4.2 2,899 5.4 9,241 4.0  
 
       
Median household income national 
quartile for patient ZIP code** 
     <.0001 
First quartile 85,736 30 17,615 32.6 68,121 29.4  
Second quartile 71,798 25.1 13,541 25.0 58,257 25.2  
Third quartile 63,405 22.2 11,347 21.0 52,058 22.5  
Fourth quartile 60,454 21.15 10,791 20.0 49,663 21.4  
 
       
Patient location*      <.0001 
Urban 249,709 87.11 48,384 89.5 201,325 86.6  
Rural 32,893 11.47 4,870 9.0 28,023 12.1  
 
       
Number of chronic conditions     <.0001 
0 16 0.01 0 0.0 16 0.0  
1 10,274 3.6 1,311 2.4 8,963 3.9  
2 27,853 9.75 4,220 7.8 23,633 10.2  
3 or more 247,624 86.65 48,552 89.8 199,072 85.9  
 
       
Elixhauser Comorbidity Index measure      
Related comorbid conditions a    <.0001 
0 160,174 56.05 28,620 52.9 131,554 56.8  
1 119,179 41.7 23,927 44.2 95,252 41.1  
2 6,332 2.22 1,506 2.8 4,826 2.1  
Unrelated comorbid conditions b    <.0001 
0 53,551 18.74 8,357 15.5 45,194 19.5  
1 69,762 24.41 12,190 22.5 57,572 24.9  
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2 65,630 22.97 12,623 23.3 53,007 22.9  
3 47,846 16.74 9,828 18.2 38,018 16.4  
4 or more 48,977 17.14 11,084 20.5 37,893 16.4  
 
       
Elective       <.0001 
 Non-elective 
admission 
258,955 90.78 50,275 93.2 208,680 90.2  
 Elective 
admission 
26,312 9.22 3,679 6.8 22,633 9.8  
 
       
Utilization of emergency services    NA 
Yes 224,357 78.48 44,159 81.6 180,198 77.5  
No 61,410 21.52 9,924 18.4 51,486 22.5  
 
       
Length of stay 
in days, mean ± 
SD (median)  
5.3±0.11 (3.01) 5.3 ±0.10 (3.18) 5.3 ±0.12 (2.98) NA 
 
       
Total cost of 
index 
hospitalizations 
$2,316,239,719.00  $473,917,432.00  $1,842,322,287.00   
Cost of index 
hospitalization 
in dollars, 
mean + SD 
(median) 
$8,188.28 ± 204.78 
($5,012.08) 
$8,839.60 ± 344.91 
($5,271.74) 
$8,035.97 ± 182.51 
($4950.55) 
NA 
Total cost of 
immediate 
readmission 
  $512,763,105.00     
HOSPITAL-LEVEL CHARACTERISTICS 
Hospital control/ ownership     0.3893 
Government, 
nonfederal 
36,468 12.76 7,253 13.4 29,215 12.6  
Private, non-
profit 
211,842 74.13 39,637 73.3 172,206 74.3  
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Private, invest-
own 
37,456 13.11 7,193 13.3 30,263 13.1  
 
       
Bed-size of hospital      0.0006 
Small 47,737 16.7 8,191 15.2 39,546 17.1  
Medium 87,472 30.61 16,189 29.9 71,282 30.8  
Large 150,557 52.69 29,702 54.9 120,855 52.2  
 
       
Hospital location        
Large 
metropolitan 
areas  
165,264 57.83 33,320 61.6 131,944 57.0 <.0001 
Small 
metropolitan 
areas  
98,560 34.49 17,665 32.7 80,895 34.9  
Micropolitan 
areas 
16,680 5.84 2,443 4.5 14,236 6.1  
Not 
metropolitan or 
micropolitan 
5,263 1.84 654 1.2 4,609 2.0  
        
Teaching status       <.0001 
Metropolitan 
non-teaching 
73,209 25.62 12,726 23.5 60,483 26.1  
Metropolitan 
teaching 
190,615 66.7 38,259 70.7 152,356 65.8  
Non-
metropolitan 
hospital 
21,942 7.68 3,097 5.7 18,845 8.1  
 
       
Hospital volume c      0.0041 
Low 50,055 17.52 8,667 16.0 41,388 17.9  
Medium 70,117 24.54 13,328 24.7 56,789 24.5  
High  165,496 57.93 32,064 59.3 133,432 57.6   
NRD, Nationwide Readmissions Database. 
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P-value in the last column represents the significance of difference of characteristics between index hospitalizations without readmission 
group and index hospitalizations with at least one readmission group. 
 
*The sum of individual counts may not add up to the total number of visits because of missing information for certain variables.  
**Median household income quartiles of residents in the patient’s ZIP code for 2014 are defined as: (1) $1 - $39,999; (2) $40,000 - 
$50,999; (3) $51,000 - $65,999; and (4) $66,000 or more.    
a Count of related comorbid conditions including drug-related, depression, and psychoses. 
b Count of non-related comorbid conditions which comprises of a count of one for congestive heart failure, valvular disease, pulmonary 
circulation disease, peripheral vascular disease, paralysis, other neurological disorders, chronic pulmonary disease, diabetes without 
chronic complications, diabetes with chronic complications, hypothyroidism, renal failure, liver disease, peptic ulcer bleeding, acquired 
immune efficiency syndrome, lymphoma, metastatic cancer, solid tumor without metastasis, rheumatoid arthritis, coagulopathy, obesity, 
weight loss, fluid and electrolyte disorders, chronic blood loss anemia, and deficiency anemia. 
c Computed based on the tertile cutoff values of (1) up to 41, (2) 42-97, and (3) 98 and over index admissions at each facility for ARD.
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Figure 1: Proportions of 30-day readmissions (all-cause) against number of days after 
discharge from index hospitalization for alcohol-related disorders using NRD, 2014. 
 
NRD, Nationwide Readmissions Database 
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Table 3: Logistic regression for 30-day readmissions on index hospitalizations for alcohol-
related disorders, NRD 2014. 
Variable Estimate Odds ratio 
95% confidence level 
P-value 
Lower limit Upper limit 
Intercept -2.076    <.0001 
Sex      
Male Reference  
Female -0.067 0.935 0.896 0.976 0.002 
Age      
18 to 24 Reference  
25 to 44 0.655 1.926 1.620 2.290 <.0001 
45 to 64 0.760 2.138 1.803 2.535 <.0001 
65 and over 0.394 1.482 1.222 1.797 <.0001 
Primary payer      
Medicare Reference  
Medicaid -0.053 0.948 0.894 1.005 0.073 
Private Insurance -0.572 0.564 0.529 0.602 <.0001 
Uninsured -0.452 0.636 0.579 0.699 <.0001 
No charge -0.318 0.727 0.641 0.826 <.0001 
Other -0.444 0.641 0.557 0.738 <.0001 
Patient location      
Urban Reference  
Rural -0.188 0.829 0.754 0.911 <.0001 
Median household income national quartile for patient ZIP code** 
First quartile Reference  
Second quartile -0.006 0.994 0.936 1.057 0.851 
Third quartile -0.087 0.916 0.861 0.975 0.006 
Fourth quartile -0.089 0.915 0.855 0.979 0.010 
Elixhauser Comorbidity Index for unrelated comorbid conditions 
0 Reference  
1 0.085 1.089 1.032 1.149 0.002 
2 0.177 1.194 1.124 1.268 <.0001 
3 0.252 1.287 1.201 1.379 <.0001 
4 or more 0.368 1.445 1.346 1.551 <.0001 
Hospital urban-rural designation 
Large metropolitan areas Reference  
Small metropolitan areas -0.114 0.893 0.830 0.960 0.002 
Micropolitan areas -0.272 0.762 0.653 0.889 0.001 
Not metro or micro -0.328 0.720 0.596 0.871 0.001 
Bedsize of hospital      
Small Reference  
Medium 0.099 1.104 1.017 1.198 0.018 
Large 0.177 1.193 1.104 1.290 <.0001 
NRD, Nationwide Readmissions Database; metro, metropolitan; micro, micropolitan. 
**Median household income quartiles of residents in the patient’s ZIP code for 2014 are defined 
as: (1) $1 - $39,999; (2) $40,000 - $50,999; (3) $51,000 - $65,999; and (4) $66,000 or more. 
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Figure 2: Forest plot demonstrating adjusted odds ratio for 30-day readmissions on index 
hospitalizations due to alcohol-related disorders for comorbidities, key patient and hospital 
characteristics using NRD, 2014.  
 
 
NRD, Nationwide Readmissions Database. 
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Table 4: Post-regression estimates for predicted and incremental costs for readmissions with index hospitalizations for alcohol-
related disorders using the NRD 2014.  
Characteristics 
Predicted marginal 
costs 
Average 
marginal 
effects (dy/dx) 
SE P>z 
95% confidence interval 
Mean SE Lower limit Upper limit 
Recurrence of ARD diagnoses 
     
No $1,601.67  $33.50  Reference 
Yes $2,519.89  $73.32  $918.22 71.32 <.0001 778.45 1,057.99 
Sex 
       
Male $1,798.31  $37.04  Reference 
Female $1,754.46  $49.09  -$43.85 49.822 0.379 -141.50 53.80 
Age 
       
18 to 24 $890.09  $162.38  Reference 
25 to 44 $1,636.67  $46.27  $746.58 168.42 <.0001 416.48 1076.67 
45 to 64 $1,908.29  $39.81  $1,018.20 164.15 <.0001 696.47 1339.93 
65 and over $1,603.48  $88.12  $713.38 184.50 <.0001 351.78 1074.99 
Primary payer 
    
 
  
Medicare $2,132.53 $64.47 Reference 
Medicaid $2,112.33 $51.61 -$20.20 79.09 0.798 -175.20 134.81 
Private Insurance $1,350.67 $50.24 -$781.86 76.28 <.0001 -931.37 -632.36 
Uninsured $1,279.42 $50.99 -$853.11 79.72 <.0001 -1009.36 -696.86 
No charge $1,271.25 $96.98 -$861.28 114.22 <.0001 -1085.14 -637.41 
Other $1,429.62 $127.48 -$702.91 135.54 <.0001 -968.57 -437.25 
Patient location 
       
Urban $1,781.07  $33.61  Reference 
Rural $1,841.36  $143.78  $60.29 144.98 0.678 -223.87 344.44 
Median household income national quartile for patient ZIP code** 
First quartile $1,735.07  $49.39  
 
Second quartile $1,807.45  $52.29  $72.38 63.73 0.256 -52.53 197.30 
Third quartile $1,745.86  $58.67  $10.79 68.62 0.875 -123.70 145.27 
Fourth quartile $1,876.69  $67.17  $141.62 81.47812 0.082 -18.08 301.31 
Elixhauser Comorbidity Index for unrelated comorbid conditions 
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0 $1,244.17  $44.37  Reference 
1 $1,478.73  $43.98  $234.57 58.28 <.0001 120.35 348.79 
2 $1,733.70  $51.45  $489.53 61.42 <.0001 369.16 609.90 
3 $2,075.12  $68.83  $830.96 78.31 <.0001 677.48 984.44 
4 or more $2,414.64  $86.39  $1,170.47 98.46 <.0001 977.50 1363.45 
Length of stay a $1,966.15  $49.57  $295.28 41.19 <.0001 214.54 376.015 
Hospital urban-rural designation 
Large metropolitan areas  $2,032.20  $53.42  Reference 
Small metropolitan areas  $1,547.50  $51.05  -$484.70 69.64 <.0001 -621.19 -348.22 
Micropolitan areas $1,102.39  $97.64  -$929.81 121.32 <.0001 -1167.59 -692.02 
Not metro or micropolitan $1,030.69  $123.30  -$1,001.51 139.81 <.0001 -1275.54 -727.49 
Bed-size of hospital 
       
Small $1,551.04  $62.86  Reference 
Medium $1,627.36  $48.82  $76.32 75.50 0.312 -71.66 224.29 
Large $1,964.03  $53.25  $412.99 82.99 <.0001 250.34 575.64 
Hospital control/ ownership 
       
Government, nonfederal $2,109.25  $96.71  Reference 
Private, non-profit $1,772.75  $39.41  -$336.50 103.57 0.001 -539.49 -133.50 
Private, invest-own $1,542.12  $64.50  -$567.13 114.28 <.0001 -791.11 -343.15 
Hospital volume b 
       
Low $2,154.79  $80.36  Reference 
Medium $1,852.60  $62.58  -$302.19 93.03 0.001 -484.52 -119.85 
High  $1,665.99  $44.90  -$488.80 92.80 <.0001 -670.69 -306.91 
NRD, Nationwide Readmissions Database; SE, Standard error 
** Median household income quartiles of residents in the patient’s ZIP code for 2014 are defined as: (1) $1 - $39,999; (2) $40,000 - 
$50,999; (3) $51,000 - $65,999; and (4) $66,000 or more.  
a Predicted marginal costs are computed using the mean length of stay of 5 days.  
b Computed based on the tertile cutoff values of (1) up to 41, (2) 42-97, and (3) 98 and more index admissions at each facility for ARD.
54 
 
Table 5: Post-regression estimates for average marginal effects among individuals with and without readmissions with recurrence 
of alcohol-related disorders, NRD 2014. 
Characteristics 
Readmission with recurrence of ARD 
N=13,906 (25.71%) 
Readmission without recurrence of ARD 
N=40,177 (74.29%) 
Average 
marginal 
effects 
(dy/dx) 
Std. Err. P>z 
95% Conf. Interval Average 
marginal 
effects 
(dy/dx) 
Std. Err. P>z 
95% Conf. Interval 
Lower 
limit 
Upper 
limit 
Lower 
limit 
Upper 
limit 
  PATIENT CHARACTERISTICS 
Sex 
          
Male Reference Reference 
Female -$53.09 $69.08  0.442 -188.48 82.30 -$41.62 $45.01 0.355 -$129.85 $46.60 
Age 
          
18 to 24 Reference Reference 
25 to 44 $1,022.29 $245.33  <.0001 541.46 1503.12 $677.89 $149.46  <.0001 384.96 970.82 
45 to 64 $1,391.33 $240.81  <.0001 919.36 1863.30 $925.27 $145.57  <.0001 639.96 1210.58 
65 and over $1,002.47 $265.75  <.0001 481.61 1523.34 $641.06 $164.46  <.0001 318.72 963.40 
Primary Payer 
          
Medicare Reference Reference 
Medicaid -$20.76 $107.71  0.847 -231.87 190.36 -$20.09 $72.04  0.780 -161.28 121.10 
Private Insurance -$1,040.37 $107.00  <.0001 -1250.08 -830.66 -$718.12 $69.48  <.0001 -854.30 -581.94 
Uninsured  -$1,153.71 $112.04  <.0001 -1373.3 -934.12 -$778.89 $72.67  <.0001 -921.33 -636.45 
No charge -$1,176.13 $160.00  <.0001 -1489.73 -862.53 -$783.48 $103.61  <.0001 -986.56 -580.40 
Other -$939.41 $188.69  <.0001 -1309.24 -569.59 -$644.57 $122.77  <.0001 -885.20 -403.93 
Patient location 
          
Urban Reference Reference 
Rural $108.62 $204.18  0.595 -291.57 508.81 $47.89 $130.15  0.713 -207.19 302.97 
Median household income national quartile for patient ZIP code** 
First quartile Reference Reference 
Second quartile $103.31 $87.55  0.238 -68.29 274.90 $64.60 $57.81  0.264 -48.70 177.89 
Third quartile $26.75 $94.49  0.777 -158.45 211.95 $6.66 $62.16  0.915 -115.18 128.49 
Fourth quartile $211.77 $112.68  0.06 -9.08 432.62 $123.86 $73.73  0.093 -20.64 268.36 
Elixhauser Comorbidity Index for unrelated comorbid conditions 
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0 Reference Reference 
1 $326.85 $81.63  <.0001 166.85 486.85 $211.73 $52.62  <.0001 108.61 314.86 
2 $678.33 $86.09  <.0001 509.59 847.07 $442.84 $55.77  <.0001 333.54 552.15 
3 $1,149.65 $116.22  <.0001 921.86 1377.45 $752.16 $69.87  <.0001 615.23 889.10 
4 or more $1,608.78 $139.56  <.0001 1335.25 1882.32 $1,062.19 $89.83  <.0001 886.14 1238.25 
 
          
Length of stay $418.59 $57.16  <.0001 306.55 530.63 $264.27 $37.45  <.0001 190.87 337.67 
  HOSPITAL CHARACTERISTICS 
Hospital urban-rural designation    
Large 
metropolitan areas  
Reference Reference 
Small 
metropolitan areas  
-$671.17 $94.26  <.0001 -855.91 -486.43 -$438.02 $63.89  0 -563.24 -312.80 
Micropolitan 
areas 
-$1,290.99 $175.88  <.0001 -1635.7 -946.276 -$839.34 $108.50  0 -1052.00 -626.69 
Not metro or 
micropolitan 
-$1,388.80 $200.82  <.0001 -1782.39 -995.2 -$904.54 $125.38  0 -1150.28 -658.80 
Bed-size of 
hospital 
          
Small Reference Reference 
Medium $97.94 $104.00  0.346 -105.89 301.78 $70.99 $68.39  0.299 -63.06 205.04 
Large $563.39 $114.55  <.0001 338.87 787.91 $375.40 $75.33  0 227.77 523.04 
Hospital control/ ownership 
Government, 
nonfederal 
Reference Reference 
Private, non-profit -$473.39 $140.78  0.001 -749.32 -197.45 -302.12 94.49 0.00 -487.31 -116.93 
Private, invest-
own 
-$803.85 $156.14  <.0001 -1109.88 -497.81 -507.62 104.26 0.00 -711.95 -303.28 
Hospital volume 
          
Low Reference Reference 
Medium -$424.10 $128.67  0.001 -676.29 -171.91 -271.56 84.25 0.00 -436.69 -106.44 
High  -$693.28 $128.50  <.0001 -945.13 -441.42 -437.36 84.19 0.00 -602.37 -272.35 
ARD, Alcohol-related disorders; NRD, Nationwide Readmission Database; SE, Standard error. 
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**Median household income quartiles of residents’ ZIP code for 2014 are: (1) $1 - $39,999; (2) $40,000 - $50,999; (3) $51,000 - $65,999; 
and (4) $66,000 or more. a Predicted marginal effects of length of stay was measured at 5 days (average length of stay) to treat both index 
hospitalizations and readmissions for ARD.  
b Computed based on the tertile cutoff values of (1) up to 41, (2) 42-97, and (3) 98 and more index admissions at each facility for ARD.
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CHAPTER IV: EMERGENCY DEPARTMENTS UTILIZATION FOR BEHAVIORAL 
HEALTH CONDITIONS AND DISTRIBUTION OF BEHAVIORAL HEALTH 
WORKFORCE AND EMERGENCY DEPARTMENTS IN NEBRASKA, 2011-2013 
Introduction 
Previous literature has shown that patients suffering from behavioral health (BH) and comorbid 
conditions frequently visit the emergency departments (EDs), which often become an entry point 
for treating such conditions (Crane, Collins, Hall, & Rochester, 2012; Curran et al., 2003; Doupe, 
Palatnick, Day, Chateau, & Soodeen, 2012; Mulkern et al., 2007; Owens et al., 2010; Pines et al., 
2011; Smith, Stocks, & Santora, 2015). Reports suggest that patients seeking psychiatric care 
account for between 6 to 9% of all ED visits (Hazlett, McCarthy, Londner, & Onyike, 2004; 
Larkin, Claassen, Emond, Pelletier, & Camargo, 2005; Owens et al., 2010; Zeller, Calma, & 
Stone, 2014) and that 18% of frequent ED users had BH conditions compared to only 6% of the 
total study population (Peppe et al., 2007). Hence, it has become necessary to evaluate the 
reasons for patients to utilize the ED for BH-related conditions. Some communities lack access to 
general health services and specialty care. Under such circumstances, patients tend to visit and 
treat the ED as an ‘open door' for uncomplicated and routine BH care (Clarke, Dusome, & 
Hughes, 2007; Doren et al., 2016). It should be noted that many EDs have few BH services to 
offer, which compels patients to wait or “board” while the ED staff searches for an open inpatient 
psychiatric bed. This results in two issues: (i) the patient’s condition might worsen, eventually 
requiring more psychiatric care, and (ii) an ED visit incurs a high cost ($2,264 per visit) (Korn, 
Currier, & Henderson, 2000; Nicks & Manthey, 2012; Zeller et al., 2014). 
 In 2014, the Kaiser Family Foundation reported that about 30.2% of Nebraska’s residents 
suffer from some form of BH condition, (Kaiser Family Foundation, 2014) leading to $167 
million in expenditures (Insel, 2008). But in Nebraska, 88 out of 93 counties have been 
designated as Mental Health Professions Shortage Areas and 32 counties have no BH provider of 
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any kind (Liu & Khan, 2017). It has been well-documented that there exists a health disparity 
between rural and urban areas, which is associated with residents’ ability to access BH specialists 
(Edelstein, Pater, Sharma, & Albert, 2014). BH service delivery models in urban areas might 
often be unsuitable and challenging to implement in rural settings (Elhai et al., 2004). It is widely 
thought that rural residents experience severe living circumstances, such as low income, lack of 
employment, and scarcity of health services, which result in a higher prevalence of BH disorders 
(Probst et al., 2006; Rohrer, Borders, & Blanton, 2005; Ziller, Anderson, & Coburn, 2010). In 
addition, because of the long distances between rural homes and primary care clinics, EDs in 
rural hospitals have become the closest point of health services (Greenwood-Ericksen, Tipirneni, 
& Abir, 2017). Previous literature has shown increased mortality among adults living in rural 
areas due to suicide and substance use disorders (A. Case & Deaton, 2015; Joynt, Nguyen, 
Samson, & Snyder, 2016).  However, there is limited research at the state-level to investigate the 
economic impact due to a shortage of BH workforce and existing rural-urban disparities on 
hospital-based EDs. Nebraska is in the unique position to conduct this type of study because it 
implements an active surveillance of health professionals, which provides county-level data on 
BH professionals. 
 ED outcomes include routine release upon treatment, transfer to short-term 
hospitals/skilled nursing facility (SNF), discharge with commencement of home health services 
(HHC), and discharge against medical advice. Those patients who leave against medical advice 
have a higher likelihood of not adhering to treatment, participating in follow-up care at 
rehabilitation centers or outpatient clinics with specialty care for BH disorders. Also, such 
patients may not use preventative services for existing BH disorders and may not monitor the 
severity of the BH condition for which they were admitted in the ED.  Previous studies analyzed 
impact of BH disorders on the ED outcome of discharge against medical advice among specific 
classes of patients. For example, one study examined impact of discharge against medical advice 
among those suffering from HIV (B. Choi, DiNitto, Marti, & Choi, 2016), while another focused 
59 
 
on older adults (Choi, Dinitto, Marti, & Choi, 2015). O’Toole and group studied the impact of 
leaving against medical advice in a hospital’s outpatient substance abuse treatment unit. 
However, to our knowledge, little information is available on the association of patient-related 
factors such as age, sex, insurance and income statuses, and existing comorbidities with being 
discharged against medical advice following an ED visit for primary diagnosis of BH disorders. 
With an increase in prevalence of BH disorders in both rural and urban areas across all age 
groups (Reynolds, Pietrzak, El-Gabalawy, Mackenzie, & Sareen, 2015; Robinson et al., 2017), 
these disorders are an important public health issue that affect the well-being of individuals and 
the healthcare system in terms of use of services and the corresponding costs. Hence, 
identification of the high-risk groups who leave ED against medical advice following primary 
diagnoses for BH can help public health practitioners, hospital administrators, and BH clinicians 
to create unique programs, especially for patients in rural areas with less access to care and find 
ways to encourage such patients to comply with treatments.  
 This study aims to estimate hospital-based ED visits, ED outcomes, and associated 
charges for BH conditions within the state of Nebraska. The objectives of this study were four-
fold. First, we characterized ED visits for BH conditions from 2011 to 2013 within Nebraska at 
the regional-level. Second, we mapped the distribution of BH workforce, availability of EDs, and 
patient BH-related ED visits at the region-level. Third, we determined patient-related 
characteristics associated with ED visits for BH. Finally, we estimated the association of patient-
level factors with being discharged against medical advice. We anticipate that findings from this 
study will help to guide policy recommendations for predominantly rural states such as Nebraska 
to address specific BH-related treatment needs by increasing workforce and access in such areas. 
We expect that such health policies will improve patient outcomes and reduce rates of costly 
revisits and ED visits. 
Methods 
Data Sources 
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State Emergency Department Database  
This study utilizes the Nebraska State Emergency Department Database (SEDD) from the 
Healthcare Cost and Utilization Project (HCUP) for the years 2011 to 2013, which contains de-
identified patient information. SEDD belongs to the family of databases sponsored by the Agency 
for Healthcare Research and Quality (AHRQ). SEDD provides census data on treat-and-release 
emergency department visits, which include more than 80% of all emergency department visits. 
(Healthcare Cost and Utilization Project, 2015) It must be noted that SEDD contains information 
on only those emergency visits that did not eventually result in hospitalizations. Important patient 
and hospital-related variables available in SEDD include age, sex, the presence of co-morbid 
conditions, charges, disposition status, patient location, the number of ED visits, and insurance 
and median household income. 
Health Professions Tracking Service annual survey database 
We used data obtained from the University of Nebraska Medical Center’s College of Public 
Health, Health Professions Tracking Service (HPTS) annual survey database for 2013 to calculate 
the number of EDs and BH professionals available in Nebraska at county-level (Appendix 3). 
HPTS builds a database from licensure data of Nebraska’s healthcare professionals, which is 
continuously updated through extensive data collection and data exchange activities. 
 BH professionals are categorized as psychiatric prescribers, independent BH 
professionals, and other BH professionals. Based on the ability of these professionals to prescribe 
within the state of Nebraska, psychiatric prescribers consist of three licensed professionals: 
psychiatrists, advanced practice registered nurses, and physician assistants. Similarly, those 
professionals who held board-certified licenses and were actively practicing within the state, such 
as psychologists and independent mental health practitioners, were classified as independent BH 
professionals. Additionally, alcohol and drug counselors, as well as other BH professionals that 
practiced as a mental health practitioner in the state of Nebraska and held a license, were included 
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in the group as other BH professionals. For this study, we included all seven sub-types of BH 
professionals. All patients within Nebraska who had visited the ED for BH disorders comprised 
the study population. 
Measures 
All hospital-based ED visits for patients with BH conditions in the State of Nebraska in 2011 to 
2013 were selected. Appendix 4 presents the list of all primary diagnoses and surgical codes for 
each patient that has been used in this study. The codes 290–294 for psychotic conditions; 295–
299 for other neurotic disorders; 300–316 for neurotic disorders, personality disorders, substance-
use-related and other nonpsychotic mental disorders; and 317–319 for intellectual disabilities 
have been identified by the International Classification of Diseases, Ninth Revision, Clinical 
Modification (ICD-9-CM).  
 The independent variables included in the study were patient-related demographic 
characteristics such as age and sex. Patient location includes categories such as urban, large rural, 
small rural, and isolated rural towns defined upon by the ZIP codes using population, primary 
destination of commuting information from the Census. Based on the patients’ disposition at 
discharge (routine, transfer to another hospital, died, etc.), a variable called the disposition status 
was classified and used. Income status was defined using a quartile classification of the estimated 
median household income of residents in the patient's ZIP Code. The variable “insurance status” 
in our study indicated the primary payer who was expected to cover charges for the ED visit, for 
example, Medicaid, Medicare, private insurance. SEDD also included information on those 
patients who paid for themselves, were uninsured, or not charged. 
The comorbid burden was estimated using the Elixhauser Comorbidity Index (ECI) 
measure, which was computed by summing up the 29 binary Elixhauser comorbidity variables 
available in the current HCUP Elixhauser Comorbidity Software, Version 3.7 (HCUP 
Comorbidity Software, Version 3.7.,” 2017). An ECI measure of 0 indicates the absence of co-
morbid conditions. All comorbidity variables were determined by the ICD-9-CM codes. Clinical 
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conditions primarily responsible for the emergency visits such as depression, psychoses, alcohol 
and drug-related abuse were not considered comorbidities, as per the standard norms of 
computing ECI measure using the Elixhauser Comorbidity Software (Elixhauser A, Steiner C, 
Harris DR, 1998; H. B. Mehta et al., 2017; Moore, White, Washington, Coenen, & Elixhauser, 
2017; Sarfati, 2016; Strom et al., 2017). The remaining conditions called ‘unrelated comorbid 
conditions’ comprise of congestive heart failure, valvular disease, pulmonary circulation disease, 
peripheral vascular disease, paralysis, other neurological disorders, chronic pulmonary disease, 
diabetes without chronic complications, diabetes with chronic complications, hypothyroidism, 
renal failure, liver disease, peptic ulcer bleeding, acquired immune deficiency syndrome, 
lymphoma, metastatic cancer, solid tumor without metastasis, rheumatoid arthritis, coagulopathy, 
obesity, weight loss, fluid and electrolyte disorders, chronic blood loss anemia, and deficiency 
anemia. 
Outcomes 
One of the primary outcome variables for this study was the incurred hospital ED charges (in 
dollars). Here, total charges represent the amount billed for each hospitalization reported by the 
facilities. Data on cost of care provided to patients or the amount of reimbursement for services 
rendered were not available. These charges were adjusted for inflation to the value of 2013 US 
dollars, using the Bureau of Labor Statistics Consumer Price Index.  
The outcome variable of discharge against medical advice was coded as a binary variable 
(0/1). Disposition statuses such as routine discharge, transfer to a short-term hospital; transfer to 
other facilities (e.g., SNF); and initiation of HHC were categorized as those ED visits which were 
not discharged against medical advice.  
Behavioral Health Regions in Nebraska 
Nebraska has been divided into six behavioral health regions and have a total of 13 major cities 
(Appendix 4). They are combined local units of the governments that plans and implements 
services by partnering with the state. The regions also purchase services from the providers that 
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serve the areas and if needed, also from other service providers across the state. Hence, for our 
study, we conducted descriptive and geographical analyses of ED visits for BH disorders in 
Nebraska by region. 
Analytical Approach 
An individual ED visit was the unit of analysis. Descriptive statistics included the number of BH-
related ED visits per 10,000 population in Nebraska, number of ED visits stratified by clinically 
diagnosed for BH conditions, and patient characteristics. The population-based incidence rates of 
BH conditions per 10,000 people were calculated using the 2013 US Census population estimates 
for each county. ED visits in Nebraska were stratified at the county-level using the five-digit 
Federal Information Processing Standard code.  
 The main interest of our study was to identify important patient-related factors associated 
with ED charges. In this study, charges have non-negative values (> 10% have zero values), a 
distribution with a longer right tail, and outliers when compared to a normal distribution. Using 
ordinary least square regression might provide biased estimates of means and 
marginal/incremental effects (Manning, 2006; Partha, Manning, & Norton, 2010). Therefore, we 
estimated total charges using a generalized linear model (GLM) with a gamma distribution and 
log-link function, which best fits this particular data structure and is a common method in cases 
where the log-transformed dependent variables do not have heavy tails (N. G. Choi, Dinitto, 
Marti, & Choi, 2015; J. A. Singh & Yu, 2016; Thompson & Nixon, 2005). The log-link function 
accounts for the non-normal distributional characteristics of the total charges data (Kazley, 
Simpson, Simpson, & Teufel, 2014; Malehi, Pourmotahari, & Angali, 2015; Manning, Basu, & 
Mullahy, 2005). To examine the distributional characteristics of the residuals, we selected the 
gamma distribution (λ = 2) based on the Modified Park Test, a diagnostic test recommended for 
the GLM family (S. D. Case et al., 2011; Malehi, Pourmotahari, & Angali, 2015; Manning et al., 
2005). For interpretability, we converted coefficients to average marginal effects (AME), which 
is measured as the difference in adjusted predicted outcome between the reference group and the 
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comparison group after adjusting for other covariates. Statistical significance was assessed at a 
level of 0.05. 
  By categorizing disposition status into those ED visits that were discharged against 
medical advice and those that were discharged otherwise, a multivariate logistic regression 
analysis was used to estimate association of discharge against medical advice following ED visits 
for primary diagnoses of BH disorders on patient characteristics. 
 All descriptive statistical analyses were performed using SAS software, version 9.4 (SAS 
Institute, Cary, NC). The log-linked gamma distributed GLM analyses were conducted using the 
Stata (StataCorp, College Station, TX). The average marginal effects of health care charges due 
to ED visits were calculated using the ‘‘margins’’ post-regression command in Stata software. 
Geographic information system maps were created using ArcGIS software, Version 10.4 (Esri, 
Redlands, CA). The University of Nebraska Medical Center’s Institutional Review Board deemed 
this study exempt. 
Results 
SEDD reported 52,035 BH-related conditions in Nebraska from 2011 to 2013. Anxiety (23.4%), 
nondependent use of drugs (17.0%), episodic mood disorders (15.6%), depressive disorders 
(7.8%), and having a history of mental disorders accompanied by family-based problems and 
suicidal ideation (6.2%) were the most common BH conditions (Table 1).  
 Table 2 presents characteristics of patient with primary diagnoses for BH conditions 
stratified by the State-designated BH regions. There has been almost 5% increase in BH-related 
ED visits from 15,756 in 2011 to 18,297 in 2013. From 2011 to 2013, all regions had an 
increasing number of ED visits for BH conditions, except Region II. Overall, males represented 
over half of ED visits for all the BH disorders. The mean age of patients ranged from 35.5 to 41.2 
years with the younger age groups residing in the urban regions V and VI. Across all regions, 
those between 24 to 44 years old made the highest proportion of ED visits for BH conditions 
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(35.5%), followed by patients between 45 to 64 years old (23.78%) and younger adults between 
18 to 24 years of age (18.1%). 
 About 40% of patients that visited an ED for BH-related conditions were covered by 
private insurance, followed by 23.1% of patients that were uninsured. Only 17.9% and 14.9% of 
the ED visits related to BH were covered by Medicare and Medicaid, respectively. The 
predominantly rural Regions I to IV (24.0 to 30.4%) had higher proportion of ED visits made by 
Medicare enrollees when compared to the urban regions V (19.4%) and VI (15.2%). In contrast, 
the uninsured patients residing in urban regions of V (21.4%) and VI (26.8%) made higher ED 
visits for BH disorders than most rural regions of I, III and IV (10.0, 15.0, and 17.1%, 
respectively), except for region II (19.2%) that had comparatively higher visits by the uninsured. 
Interestingly, a sizeable proportion of the visits for BH-related conditions occurred on weekdays 
(71.6%), and about 81.2% of the visits were routinely discharged.  
 Table 2 also presents ED visits by patient location. Overall, approximately  
71.0% of the ED visits were in urban areas, followed by large rural towns (15.7%), small rural 
towns (7.5%) and, finally, isolated rural areas (6%). Specifically, Region I - III being rural areas 
had no visit made by urban residents and the converse was true for the primarily urban regions V 
(77.5%) and VI (93.3%). Also, nearly a third of ED visits due to BH conditions were for patients 
residing in zip codes with low median household incomes. Interestingly, about 95% of the ED 
visits in region II belonged to the low-income areas with no visits from the high-income 
population whereas over one-third of ED visits in Regions V and VI were made by high-income 
populations.   
As shown in Table 2, eighty-two percent of the ED visits related to BH conditions were 
not concurrent with comorbid conditions. ED visits made by patients with 1 or more unrelated 
comorbidities were higher in the rural regions I (26.3%), II (25.7%) and III (31.6%) whereas the 
urban regions V (85.0%) and VI (83.7%) had higher proportion of patients without any unrelated 
comorbidities. After adjusting for inflation, mean hospital ED charges per visit were $1,854 with 
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a total of approximately $96.4 million in ED charges due to BH-related conditions during the 
study period. Among the rural regions, region II had higher ED charges of $1,717.25 while the 
most charges were made by residents from region VI ($2,120.44). 
Table 3 shows the number of BH-related ED visits per 10,000 population made by 
region, and the availability of ED facilities and BH providers by region. The highest number ED 
visits were made by residents of rural region II (11,805 per 10,000 population), followed by the 
urban region V (3,015 per 10,000 population) while, conversely, the least visits were made by 
those residing in region VI (1,394 per 10,000 population). Regions IV (21) and V (22) had the 
highest number of EDs whereas region I had the least number of EDs (8). Interestingly, 
comparatively lower ED admission rates were observed in regions III and IV (2,538 and 1,908 
per 10,000 population, respectively) which had higher number of BH providers (94 and 89, 
respectively). 
 Figure 1 represents the distribution of population estimates of BH-related ED visits and 
BH professionals in Nebraska by BH regions. This map depicts that ED admission rates could be 
higher in rural regions (scarcely populated rural regions I, II and IV) where BH workforce supply 
is low and vice-versa. For illustration, region II had access to 37 BH providers and had the 
highest ED admission rates of 11,805 per 10,000 population. Also, the converse is also true 
because region IV had access to higher (89) BH providers which was found to be correlated to 
reduced ED admission rates (1,908 per 10,000 population) for BH disorders. On the other hand, 
in the urban region VI, despite the lower supply of BH providers, the ED admission rate is lower 
which maybe because of sufficient access to primary-level behavioral healthcare services. 
However, for the other urban Region V, despite the moderate supply of BH providers (83), the 
ED admission rate was found to high (3,015 per 10,000 population). 
 Figure 2 represents that the EDs in rural regions of Nebraska had higher ED admission 
rates. For example, region I had lower number of EDs (8) which accommodated 2,072 visits per 
10,00 population for BH disorders. Similarly, region II had only 9 EDs which provided 
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emergency behavioral services to 11,805 BH-related visits per 10,000 population. Moreover, 
region III had 2,538 visits per 10,000 population at 18 EDs for BH disorders despite having the 
highest supply of BH professionals (94) in the state. 
 Table 4 shows the results of regression using a multivariate log-linked Gamma 
Distributed Generalized Linear model that evaluates the effect of patient-related factors on 
hospital-based ED charges. The AME indicates that the total charges for females was 
significantly lower compared to for males (by $105 per visit).  Older age groups were associated 
with higher charges than younger age groups. Compared to children and adolescents under the 
age of 18 years, those aged 18 to 24 years, 25 to 44 years, and 45 to 64 years incurred 
significantly higher ED charged by $408, $473, and $678, respectively, but the elderly (65 years 
and older) incurred the highest ED charges by $1,120. Patients who were covered by Medicare 
had significantly lower ED charges than those who were covered by self, Medicaid, private, and 
other insurance types by $318, $240, $213, and $205. The patient’s location was also significantly 
associated with ED charges. Patients residing in large rural towns, small rural towns, and isolated 
rural areas had lower ED charges per visit by $123, $527, and $378, respectively, than patients 
residing in urban areas. Patients whose median household income at the ZIP code level fell into 
the fourth quartile had significantly higher ED charges by $314. ED charges were significantly 
increased with an increase in ECI. In contrast to those with 0 unrelated comorbidities, those with 
2 and 3 comorbidities had significantly higher ED charges by $549 and $930. However, ED visits 
made by those with 3 or more unrelated comorbidities to BH disorders incurred $2,015 more than 
those with no unrelated comorbidity. 
 Table 5 displays the results from the multivariate logistic regression that was conducted 
to evaluate the associations between patient-level factors and discharged against medical advice. 
Females (OR: 0.63; CI: 0.82-0.98, P<.001) are significantly less likely to be discharged against 
medical advice than males. Compared to those up to the age of 17 years, those aged 25 to 44 
years (OR: 1.83; CI: 1.42-2.36, P<.001), and aged 44 to 64 years (OR: 2.31; CI: 1.78-3.00, 
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P<.001) were associated with higher odds for discharge against medical advice. Among the payer 
type, those who were uninsured were associated with higher odds (OR: 1.56; CI: 1.27-1.91, 
P<.001) of being discharged against medical advice compared to those covered by Medicare. 
Those residing in living in ZIP codes with median household income belonging to the second 
(OR: 0.77, CI: 0.66-0.89, P=0.0003), third (OR: 0.59, CI: 0.49-0.75, P<.001), and fourth (OR: 
0.67, CI: 0.53-0.85, P<.001), quartile were associated with significantly lower odds for discharge 
against medical advice than those living in ZIP codes with first quartile median household 
income. 
Discussion 
These findings show that the majority of the ED visits were by males of 25- to 44-years-old but 
that the elderly had the highest ED charges. Consistent with common beliefs, we found that the 
uninsured incurred higher total ED charges for BH-related conditions. Because one-third of 
counties in Nebraska have no BH professional and about one-fourth counties have no EDs, it can 
be concluded that state-wide access to care is minimal, particularly in rural counties. The average 
charge levied on patients was as high as $1,854 per ED visit. Multivariate logistic regression 
modeling also suggested that patients discharged against medical advice were more likely to be 
males, between the age of 18 to 64 years, uninsured, living in low-income areas (first quartile) 
and with no unrelated comorbidities. 
 Currently, there is uncertainty for the future of healthcare coverage in the US, and an 
understanding of the economic implications of providing behavioral health services for states that 
did not expand Medicaid eligibility under the Affordable Care Act requires state-specific 
analyses. Few studies have examined the distribution of BH professionals or BH-related ED 
utilization in largely rural states. One prior study examined only the urban counties of North 
Carolina (Doren et al., 2016), while Choi et al. studied the impact of specific BH illnesses on 
non-suicidal self-injury and suicide attempts among 50-years and older ED patients (N. G. Choi 
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et al., 2015). Other studies have focused on specific subpopulations, such as adolescents (Doshi, 
Glick, & Polsky, 2006) and older adults (Pines et al., 2011). 
 One of the key findings from this study is that about $96.4 million was spent during 
2011–2013 on a total of 52,035 ED visits due to BH-related conditions, across all age groups. 
Because federal law mandates EDs to screen, diagnose and treat patients, EDs have become an 
important place for treating BH-related conditions, though at a high cost (Fahimi, Aurrecoechea, 
Anderson, Herring, & Alter, 2015). Our data show that 12 out of 93 counties in Nebraska have an 
ED but do not have any practicing BH professionals. Many BH-related conditions can be 
assessed and treated successfully in outpatient settings through the use of integrated care and 
telemental services. In addition to the high cost of ED treatment, ED staff members in rural areas 
have limited experience in detecting and treating BH-related conditions (Rhodes, 2008). This may 
further increase the costs of treating these conditions in the long run. Undiagnosed, untreated or 
delayed diagnoses of BH conditions can lead to an increased number of ED visits, require more 
intensive interventions compared to early diagnosis, or result in societal costs such as increased 
arrest and incarceration rates (Insel, 2008; Mark et al., 2007).  
 Young adults in Nebraska are the more likely to be burdened by BH disorders (18% ED 
visits), as per our study, given that they comprise only 7% of the population (Kaiser Family 
Foundation, 2017). Even though patients living in non-metropolitan areas make up for 40% of the 
population in Nebraska (Nebraska Department of Health and Human Services, 2008), urban 
population make majority of the ED visits for BH disorders. Likewise, patients covered by 
Medicare, other insurances, and the uninsured are the most burdened by BH disorders, 
considering that within Nebraska the insurance coverage for this population comprise of only 13, 
7, and 9%, respectively (Kaiser Family Foundation, 2016). Our results also suggest that a 
substantial proportion of ED patients are uninsured (23%), and the charges levied on them are the 
highest when compared to other payers. Additionally, we found that one-third of BH patients 
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using the ED are covered under either Medicare or Medicaid, despite that it is often known to be 
difficult to find a provider accepting Medicaid.  
Our data show that urban patients were levied higher ED charges than those living in 
rural towns. This may be because EDs within urban areas offer more health services and have 
more comprehensive health insurance coverage than rural residents. However, a study shows that 
BH services are provided to rural populations at lower reimbursement rates than in urban areas 
(Ziller et al., 2010). Besides, rural residents often travel long distances to procure health services, 
are less likely to be insured for BH services, may face greater social stigma, and have less 
probability to be diagnosed with BH-related illnesses than urban residents (Substance Abuse and 
Mental Health Services., 2013). This is consistent with our results depicting that there are fewer 
ED visits and charges for rural patients than those from urban areas for BH disorders.  
 The findings from our study are consistent with the literature, which reports that the 
leading causes of BH disorders are anxiety, episodic mood, and depressive disorders, and alcohol 
dependence (Hazlett et al., 2004; Huynh, Ferland, Blanchette-martin, & Me, 2016; Pines et al., 
2011; Richmond et al., 2007). In our study, patients aged 25 to 44 years, residing in low-income 
or urban areas, and with private insurance, were more likely to utilize ED for BH conditions. 
These patients are ‘high-risk', and prior studies have found similar results (Huynh et al., 2016; 
Pines et al., 2011; Smith et al., 2015). Therefore, our findings suggest the need to tailor 
interventions to address BH issues for high-risk patients.  
In the past, one study reported that one in five patients with either primary or secondary 
diagnoses of substance abuse disorders specifically were discharged against medical advice 
(Bradley & Zarkin, 1997). Specifically, chronic alcoholism and drug addiction were the common 
causes which were discharged against medical advice (Jankowski & Drum, 1977). The unwanted 
consequences of being discharged against medical advice could be high risk of revisits (in 
inpatient and outpatient departments) or even mortality (Hwang, Li, Gupta, Chien, & Martin, 
2003). Consequently, the revisits could be accompanied by greater severity of disorders. This 
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issue can also potentially increase healthcare expenditures towards what could have been a single 
episode of care. To our knowledge, in the recent years, no prior work has evaluated the problem 
of leaving ED against medical advice following primary diagnoses for BH disorders across all 
age groups, especially in rural states that offer limited healthcare services. Overall, 2.1% of our 
study population was discharged against medical advice. Our results show these patients are more 
likely to be males, uninsured, living in low-income areas (first quartile), and with no other 
unrelated comorbidities. Parents play a vital role in facilitating healthcare needs and more often 
make decisions as significant as obtaining discharge against medical needs. Hence, this could be 
the reason why children and adolescents have lower odds of leaving against medical needs. Also, 
as per expectation, those who are uninsured and have low-income status would be discharged 
against the advice of providers because financial problems and/or were refused treatment by 
hospital staff. Because there are limited such studies that have provided evidence-based research, 
our findings are not comparable and the implication of BH-related discharges against medical 
advice on policy for revisits (as inpatient stay and/or ED) and associated costs are uncertain. 
However, our findings are generalizable in similar states which are predominantly rural, and with 
shortage of BH services. By identifying the high-risk cohort, community-based health programs 
could be tailored for this group to encourage compliance to treatment and provide screenings for 
psychiatric disorders. ED-based peer coaching, education for such conditions, and counselling for 
this cohort can improve ED outcomes as well as likely reduce the discharges against medical 
advice. 
 Multiple studies have demonstrated that there are substantial geographic shortages and 
maldistribution of the BH workforce in the US (Doren et al., 2016; Hoge et al., 2009; K. C. 
Thomas, Ellis, Konrad, Holzer, & Morrissey, 2009). From Figures 1, it is evident that BH-related 
ED visits are more in areas where the numbers of BH providers are fewer. One of the reason for 
this could be that these rural regions had higher proportion of uninsured, low-income population 
with higher comorbidities. However, it should be noted that not all of these BH professionals are 
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licensed to prescribe medication. Most prescribers in Nebraska are concentrated near the major 
medical centers and state hospitals located in Nebraska’s three most populated counties (regions 
V and VI). Among those BH professionals who are board-certified to prescribe in rural areas, 
many may not be working as full-time professionals. This could be the reason why certain regions 
have greater ED use for BH services despite having moderate supply of BH professionals.  
 On the other hand, Figure 2 shows EDs in rural regions of Nebraska maybe overcrowded 
and a ‘failsafe’ healthcare setting for BH disorders because ED visits are more common in those 
regions which have fewer ED facilities (except urban regions V and VI that are home to the 
largest two big cities in Nebraska). This highlights the consequences of unmet BH needs, 
shortage of BH services and providers. ED facilities in such counties may also be expected to be 
crowded. Hence, further research must be conducted to understand the ratios of ED and outpatient 
facilities to visits for BH-related conditions, impact of the lack of access to full-time BH 
professionals, and prescribers in rural communities and its impact on preventable ED utilization.  
Region II has remarkably high proportion of ED visits for the scare population in the 
region, despite fewer ED facilities. This may be because this region has the highest proportion of 
low-income population with comorbidities and a substantial number of uninsured. However, there 
has been a 4% reduction in the numbers of BH-related ED visits between 2012 and 2013. In 
future, efforts need to be made to provide adequate services to this population.   
The Center for Medicaid and CHIP Services (CMCS), in their 2013 bulletin, 
recommended that efforts need to be made to expanded primary care access, design and 
implement programs targeting super-utilizers or high-risk cohort, and address co-morbid mental 
health and substance abuse issues (US Department of Health and Human Servives, 2013). Using 
geographic mapping to locate high ED utilizers, the States of Maine, Massachusetts, and New 
Jersey structured interdisciplinary teams including nurse care managers, social workers, and 
behavioral health workers and provided visits to patients in their homes and community settings. 
Such teams also worked with primary care practices to identify referrals and coordinate care for 
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patients (Center for Health Information and Analysis, 2015; Green, Singh, & Byrne, 2010; US 
Department of Health and Human Servives, 2013). The findings from our study can be utilized by 
region-based teams in Nebraska to target the highest utilizers and provide care coordination, 
supportive therapy, substance abuse treatment, supportive housing, and assertive community 
outreach to those routinely discharged as well as transferred to home health agencies. These 
teams can also ensure that rural residents are provided access to community-based organizations, 
or large community-based primary care practices such as federally-qualified health centers. 
 
Conclusions 
Many patients needing BH-related services seek help in EDs instead of more appropriate settings 
for psychiatric care such as primary clinics, leading to substantial and preventable healthcare 
expenditures, particularly in rural communities. Community-based interventions should be 
tailored with a goal of reducing unnecessary and expensive ED visits among high-risk patient 
groups that include those aged 25-44 years, uninsured, covered by private insurance, residing in 
low-income areas, and suffer from other comorbid conditions. Being male, between 18 to 64 
years of age, uninsured, living in low-income areas had higher odds of patient discharge against 
medical advice. Innovative rural-centric public health programs can focus on encouraging 
patients to adhere to ED-treatment and continue follow-up BH care, provide education and 
counselling, thereby, improving ED outcomes and reducing hospital revisits. Increasing BH 
workforce, especially in rural areas, can alleviate the problem and reduce the number of frequent 
ED users for BH conditions. Future studies should work towards identifying challenges to 
providing and procuring holistic BH services. 
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Table 1: Number and percent of emergency department visits stratified by diagnoses for 
behavioral health conditions, NE SEDD, 2011–2013 
Types of BH conditions ED visits (N= 52,035) 
N % 
Anxiety, dissociative and somatoform disorders 12,154  23.4 
Nondependent abuse of drugs 8,827  17.0 
Episodic mood disorders 8,115  15.6 
Depressive disorders 4,060  7.8 
History of mental disorders, family-based problems, and suicidal 
ideation 
3,244  6.2 
Alcohol dependence syndrome 3,012  5.8 
Other nonorganic psychoses 1,887  3.6 
Schizophrenic disorders 1,590  3.1 
Other specifically mental health-related conditions 1,498  2.9 
Special symptoms or syndromes not elsewhere classified  1,145  2.2 
Adjustment reaction 1,057  2.0 
Drug-induced mental disorders 971  1.9 
Alcohol-induced mental disorders 796  1.5 
Specific nonpsychotic mental disorders due to brain damage 752  1.5 
Disturbance of conduct not elsewhere classified  696  1.3 
Disturbance of emotions specific to childhood and adolescence 662  1.3 
Persistent mental disorders due to conditions classified elsewhere 604  1.2 
Acute reaction to stress 569  1.1 
Drug dependence 396  .8 
SEDD, State Emergency Department Database; BH, Behavioral health; ED, Emergency 
department 
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Table 2: Descriptive characteristics for emergency department visits related to behavioral health conditions in NE SEDD, 2011–
2013 * 
Characteristics 
Overall ED 
visits 
Region I 
(n=1,405) 
Region II 
(n=2,534) 
Region III 
(3,739) 
Region IV 
(1,747) 
Region V 
(12,886) 
Region VI 
(25,151) 
  N % N % N % N % N % N % N % 
Sex      
 
 
 
   
 
Male 26,333 50.6 667 47.5 1,206 47.6 1,728 46.2 775 44.4 6,459 50.1 13,079 52.01 
Female 25,682 49.4 728 51.8 1,320 52.1 2,011 53.8 972 55.6 6,427 49.9 12,072 47.99 
Age group (in years)             
up to 17 7,340 14.1 193 13.7 285 11.2 396 10.6 210 12.0 1,976 15.3 3,819 15.2 
18 to 24 9,396 18.1 223 15.9 450 17.8 678 18.1 281 16.1 2,293 17.8 4,434 17.6 
25 to 44 18,464 35.5 424 30.2 810 32.0 1,224 32.7 580 33.2 4,432 34.4 9,193 36.6 
45 to 64 12,356 23.7 332 23.6 658 26.0 844 22.6 348 19.9 3,027 23.5 6,115 24.3 
65 and over 4,479 8.6 233 16.6 331 13.1 597 16.0 328 18.8 1,158 9.0 1,590 6.3 
Mean age (in 
years) 
36.6 40.9 39.8 40.7 41.2 36.5 35.5 
Primary payer              
Medicare 9,317 17.9 428 30.5 609 24.0 929 24.8 478 27.4 2,506 19.4 3,953 15.7 
Medicaid 7,762 14.9 355 25.3 326 12.9 619 16.6 233 13.3 1,070 8.3 4,741 18.9 
Private 
Insurance 
20,872 40.1 462 32.9 1,077 42.5 1,525 40.8 707 40.5 6,088 47.2 8,627 34.3 
Uninsured 12,036 23.1 142 10.1 486 19.2 562 15.0 298 17.1 2,756 21.4 6,732 26.8 
Other 2,048 3.9 18 1.3 36 1.4 104 2.8 31 1.8 466 3.6 1,098 4.4 
Admission day             
Weekday  37,245 71.6 1,019 72.5 1,791 70.7 2,536 67.8 1,202 68.8 9,347 72.5 18,150 72.2 
Weekend  14,789 28.4 386 27.5 743 29.3 1,203 32.2 545 31.2 3,539 27.5 7,000 27.8 
Disposition status              
Routine  40,746 81.2 1,111 79.1 2,065 81.5 3,096 82.8 1,465 83.9 11,766 91.3 19,054 75.8 
Transfer to 
short-term 
hospital  
4,230 8.4 141 10.0 143 5.6 238 6.4 136 7.8 458 3.6 2,842 11.3 
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Transfer Other: 
Includes SNF, 
ICF, Another 
Type of Facility  
4,139 8.3 124 8.8 239 9.4 344 9.2 126 7.2 358 2.8 2,725 10.8 
Home Health 
Care (HHC)  
25 0.1 0 0.0 4 0.2 2 0.1 0 0.0 6 0.0 12 0.0 
Against 
Medical Advice 
(AMA)  
1,054 2.1 29 2.1 83 3.3 59 1.6 20 1.1 298 2.3 518 2.1 
Patient location             
Urban 36,177 70.8 0 0.0 0 0.0 0 0.0 27 1.5 9,982 77.5 23,472 93.3 
Large rural 
town 
8,014 15.7 459 32.7 1,634 64.5 2,651 70.9 630 36.1 610 4.7 1,106 4.4 
Small rural 
town 
3,835 7.5 641 45.6 557.0 22.0 357 9.5 347 19.9 1,380 10.7 238 0.9 
Isolated rural 3,093 6.1 288 20.5 286 11.3 678 18.1 725 41.5 650 5.0 143 0.6 
Median household income national quartile for patient ZIP code** 
First quartile 16,284 31.8 510 36.3 239 9.4 298 8.0 318 18.2 3,444 26.7 10,358 41.2 
Second quartile 18,757 36.6 795 56.6 2,157 85.1 3,100 82.9 1,162 66.5 4,391 34.1 5,724 22.8 
Third quartile 9,769 19.1 83 5.9 81 3.2 287 7.7 249 14.3 3,556 27.6 4,275 17.0 
Fourth quartile 6,399 12.5 0 0.0 0 0.0 1 0.0 0 0.0 1,230 9.5 4,684 18.6 
Elixhauser Unrelated Comorbidity Index measure*** 
0 42,691 82.04 1,035 73.7 1,884 74.3 2,558 68.4 1,409 80.7 10,948 85.0 21,052 83.7 
1 6,585 12.65 259 18.4 428 16.9 787 21.0 235 13.5 1,361 10.6 2934 11.7 
2 2,119 4.07 88 6.3 145 5.7 278 7.4 79 4.5 419 3.3 956 3.8 
=> 3 640 1.23 23 1.6 77 3.0 116 3.1 24 1.4 158 1.2 209 0.8 
Behavioral health-related ED visits by year 
2011 15,756 30.91 422 30.0 796 31.4 1,188 31.8 566 32.4 4,104 31.8 7,181 28.6 
2012 16,924 33.20 426 30.3 915 36.1 1249 33.4 572 32.7 4314 33.5 8,519 33.9 
2013 18,297 35.89 557 39.6 823 32.5 1,302 34.8 609 34.9 4,468 34.7 9,451 37.6 
Hospital ED charges (inflation adjusted to 2013 US dollar value) 
Mean (median) 
charges 
$1,854.48 
(1,352.00) 
$1,663.25 
(1,240) 
$1,717.25 
(1,163.25) 
$1,693.53 
(1,157.74) 
$1,486.76 
(995.28) 
$1,418.44 
(701.00) 
$2,2120.44 
(1,597.82) 
Total charges  $96,353,163.18 $2,330,214.51 $4,347,037.37 $6,330,422.39 $2,597,377.38 $18,273,816.23 $53,210,242.25 
SEDD, State Emergency Department Database; ED, Emergency department; N, Number 
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*The sum of individual counts may not add up to the total number of visits because of missing information for certain variables. 
 
** Median household income quartiles of residents in the patient’s ZIP code differ every year. The levels were $1 to $38,999 (quartile 1), 
$39,000 to $47,999 (quartile 2), $48,000 to $63,999 (quartile 3) and $64,000 or higher (quartile 4) in the year 2011. The levels were $1 to 
$38,999 (quartile 1), $39,000 to $47,999 (quartile 2), $48,000 to $62,999 (quartile 3) and $63,000 or higher (quartile 4) in the year 2012. 
The levels were $1 to $37,999 (quartile 1), $38,000 to $47,999 (Quartile 2), $48,000 to $63,999 (quartile 3) and $64,000 or higher 
(quartile 4) in the year 2013. 
 
*** Unrelated comorbid conditions comprise congestive heart failure, valvular disease, pulmonary circulation disease, peripheral vascular 
disease, paralysis, other neurological disorders, chronic pulmonary disease, diabetes without chronic complications, diabetes with chronic 
complications, hypothyroidism, renal failure, liver disease, peptic ulcer bleeding, acquired immune deficiency syndrome, lymphoma, 
metastatic cancer, solid tumor without metastasis, rheumatoid arthritis, coagulopathy, obesity, weight loss, fluid and electrolyte disorders, 
chronic blood loss anemia, and deficiency anemia. 
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Table 3: Counties served, emergency department facilities, and emergency visits for 
behavioral health disorders and providers per 10,000 population by behavioral health 
region in Nebraska. 
Behavioral 
Health 
Region 
Counties served 
ED visits 
per 10,000 
population 
Number 
of ED 
facilities  
Number of 
providers per 
10,000 
population 
1 
Sheridan, Dawes, Sioux, Box 
Butte, Morrill, Scotts Bluff, 
Banner, Cheyenne, Deuel, 
Garden, and Kimball 
 
2,072 8 38 
2 
Arthur, Chase, Dawson, Dundy, 
Frontier, Gosper, Grant, Hayes, 
Hitchcock, Hooker, Keith, 
Lincoln, Logan, McPherson, 
Perkins, Red Willow, and 
Thomas 
 
11,805 9 37 
3 
Adams, Blaine, Buffalo, Clay, 
Custer, Franklin, Furnas, 
Garfield, Greeley, Hall, 
Hamilton, Harlan, Howard, 
Kearney, Loup, Merrick, 
Nuckolls, Phelps, Valley, 
Sherman, Webster and Wheeler  
 
2,538 18 94 
4 
Antelope, Boone, Boyd, Brown, 
Burt, Cedar, Cherry, Colfax, 
Cuming, Dakota, Dixon, Holt, 
Keya Paha, Knox, Madison, 
Nance, Pierce, Platte, Rock, 
Stanton, Thurston & Wayne 
1,908 21 89 
5 
Butler, Fillmore, Gage, 
Jefferson, Johnson, Lancaster, 
Nemaha, Otoe, Pawnee, Polk, 
Richardson, Saline, Saunders, 
Seward, Thayer, and York  
 
3,015 22 83 
6 
Cass, Dodge, Douglas, Sarpy, 
and Washington  1,394 16 31 
The population estimates for behavioral health regions 1 through 6 were (1) 87,839; (2) 101,213; 
(3) 227,270; (4) 207,646; (5) 448,995; and (6) 769,678, respectively. 
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Table 4: Multivariable linear regression model for hospital-based emergency department 
charges (in dollars) due to behavioral health conditions NE SEDD, 2011–2013. a 
Parameter 
AME 
Standard 
Error 
95% Confidence 
Intervals 
P-value b 
(dollars) a Lower Upper 
Sex           
Male Reference 
Female -105.429 14.40826 -133.67 -77.19 <.001 
Age group 
0 to 17 Reference 
18 to 24 408.1 21.44 366.09 450.116 <.001 
25 to 44 472.75 19.144 435.23 510.27 <.001 
45 to 64 678.26 22.81 633.56 722.96 <.001 
65 and over 1,119.48 45.22 1030.86 1208.1 <.001 
Primary Payer           
Medicare Reference 
Medicaid 239.64 27.92 184.91 294.36 <.001 
Private Insurance 212.94 22.64 168.57 257.3 <.001 
Uninsured 317.46 25.38 267.71 367.21 <.001 
Other insurance 204.64 41.07 124.13 285.13 <.001 
Median household income national quartile for patient ZIP code** 
First quartile Reference         
Second quartile -18.76 18.85 -55.71 18.18 0.32 
Third quartile 15.91 20.68 -24.62 56.44 0.44 
Fourth quartile 313.84 27.43 260.08 367.59 <.001 
Patient Location           
Urban Reference 
Large rural town -123.44 22.61 -167.75 -79.13 <.001 
Small rural town -527.38 22.67 -571.81 -482.95 <.001 
Isolated rural -377.56 26.83 -430.14 -324.99 <.001 
Elixhauser Comorbidity Index measure ***  
0 Reference 
1 594.13 27.33 540.57 647.68 <.001 
2 929.73 53.12 825.63 1033.84 <.001 
≥3 2,015.1 133.47 1753.52 2276.69 <.001 
SEDD, State Emergency Department Database 
  a Average Marginal Effect (AME) is measured as the difference in the adjusted predicted 
outcome between reference group and comparison group. 
b P values were calculated using multivariate Log-linked Gamma Distributed Generalized Linear 
Model.  
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** Median household income quartiles of residents in the patient’s ZIP code vary by year. The 
levels were $1 to $38,999 (quartile 1), $39,000 to $47,999 (quartile 2), $48,000 to $63,999 
(quartile 3) and $64,000 or higher (quartile 4) in the year 2011. The levels were $1 to $38,999 
(quartile 1), $39,000 to $47,999 (quartile 2), $48,000 to $62,999 (quartile 3) and $63,000 or 
higher (quartile 4) in the year 2012. The levels were $1 to $37,999 (quartile 1), $38,000 to 
$47,999 (Quartile 2), $48,000 to $63,999 (quartile 3) and $64,000 or higher (quartile 4) in the 
year 2013. 
*** Unrelated comorbid conditions comprise of congestive heart failure, valvular disease, 
pulmonary circulation disease, peripheral vascular disease, paralysis, other neurological 
disorders, chronic pulmonary disease, diabetes without chronic complications, diabetes with 
chronic complications, hypothyroidism, renal failure, liver disease, peptic ulcer bleeding, 
acquired immune deficiency syndrome, lymphoma, metastatic cancer, solid tumor without 
metastasis, rheumatoid arthritis, coagulopathy, obesity, weight loss, fluid and electrolyte 
disorders, chronic blood loss anemia, and deficiency anemia. 
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Table 5: Adjusted odds ratios from multivariate logistic regression analysis of discharge 
against medical advice by patient-level characteristics, NE SEDD, 2011-2013. 
Characteristics   Estimate 
Odds ratio 
(AMA) 
95% confidence level 
P-
value 
OR  
Lower  
OR 
Upper   
Intercept -4.02    <.0001 
Sex      
Male  Reference 
Female 0.72 0.63 0.82 0.98 <.0001 
Age      
up to 17 Reference 
18 to 24 0.19 1.20 0.91 1.60 0.200 
25 to 44 0.61 1.83 1.42 2.36 <.0001 
45 to 64 0.84 2.31 1.78 3.00 <.0001 
65 and over -0.35 0.704 0.443 1.12 0.139 
Primary payer      
Medicare Reference 
Medicaid 0.03 1.03 0.80 1.33 0.829 
Private Insurance -0.08 0.92 0.74 1.14 0.457 
Uninsured 0.44 1.56 1.27 1.91 <.0001 
Other -0.21 0.81 0.53 1.25 0.340 
Median household income national quartile for patient ZIP code** 
First quartile Reference 
Second quartile -0.27 0.77 0.66 0.89 0.0003 
Third quartile -0.53 0.59 0.49 0.72 <.0001 
Fourth quartile -0.40 0.67 0.53 0.85 0.001 
Elixhauser Comorbidity Index for unrelated comorbid conditions*** 
0 Reference 
1 -0.42 0.66 0.53 0.82 0.0002 
2 -0.26 0.77 0.55 1.10 0.149 
3 or more -0.25 0.78 0.40 1.52 0.464 
AMA, Discharge against medical advice; SEDD, State Emergency Department Database 
** Median household income quartiles of residents in the patient’s ZIP code vary by year. The 
levels were $1 to $38,999 (quartile 1), $39,000 to $47,999 (quartile 2), $48,000 to $63,999 
(quartile 3) and $64,000 or higher (quartile 4) in the year 2011. The levels were $1 to $38,999 
(quartile 1), $39,000 to $47,999 (quartile 2), $48,000 to $62,999 (quartile 3) and $63,000 or 
higher (quartile 4) in the year 2012. The levels were $1 to $37,999 (quartile 1), $38,000 to 
$47,999 (Quartile 2), $48,000 to $63,999 (quartile 3) and $64,000 or higher (quartile 4) in the 
year 2013. 
*** Unrelated comorbid conditions comprise of congestive heart failure, valvular disease, 
pulmonary circulation disease, peripheral vascular disease, paralysis, other neurological 
disorders, chronic pulmonary disease, diabetes without chronic complications, diabetes with 
chronic complications, hypothyroidism, renal failure, liver disease, peptic ulcer bleeding, 
acquired immune deficiency syndrome, lymphoma, metastatic cancer, solid tumor without 
metastasis, rheumatoid arthritis, coagulopathy, obesity, weight loss, fluid and electrolyte 
disorders, chronic blood loss anemia, and deficiency anemia. 
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Figure 1: Emergency Department visits in Nebraska related to behavioral health and 
supply of behavioral health professionals per 10,000 population by designated behavioral 
health regions, NE SEDD, 2011-2013. 
 
 
SEDD, State Emergency Department Database 
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Figure 2: Emergency Department visits in Nebraska related to behavioral health and 
number of emergency departments by designated behavioral health regions, NE SEDD, 
2011-2013 
 
SEDD, State Emergency Department Database 
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CHAPTER V: EMERGENCY DEPARTMENT UTILIZATION FOR SUBSTANCE USE-
RELATED DISORDERS AND ASSESSMENT OF TREATMENT FACILITIES IN  
NEW YORK STATE, 2011- 2013 
Introduction 
Substance use disorders (SUDs), the leading cause of premature illnesses and death (Bernstein & 
D’Onofrio, 2013; Shroeder, 2007), were experienced by about 21.5 million Americans over the 
age of 12 years in 2014 (Tice, Hedden, Kennet, Lipari, & Medley, 2014), thereby, attributed as an 
important public health issue. For 2017 alone, the US Department of Health and Human Services 
allocated $2.6 billion for substance abuse treatment and $211 million for prevention of SUDs (US 
Department of Health and Human Servives, 2017).  However, the overall social and economic 
burden to society is compounded not only by the direct consequences of overuse of substances, 
but also such disorders have an effect on public safety, health, welfare, and socioeconomic status 
(Han, Sherman, Link, Wang, & Mcneely, 2017; Kosten & O’Connor, 2003; U.S. Department of 
Health and Human Services (HHS), 2016). On the other hand, from the providers perspective, 
unmanaged treatment of SUDs impact patient safety because there is a possibility of withdrawal 
while admitted to the hospital. For example, withdrawal from drugs such as opioid and its 
conjugates, alcohol, and benzodiazepines are not only lethal but also can result in unwanted 
interactions between the drug and medications (Han et al., 2017; Kosten & O’Connor, 2003). 
Thus, these disorders not only contribute to the disease burden but cost heavily to the nation. 
Over the last decade, many health policies have been introduced to address parity issues 
for mental health and SUDs. The latest amendment of 2016 to the Mental Health Parity and 
Addiction Equity Act of 2008 (MHAEA) mandates both public, including Medicaid non-
managed care and benchmark-equivalent plans, and private insurance to provide coverage for 
behavioral health conditions. To complement these policies, the Patient Protection and Affordable 
Care Act of 2010 (ACA) along with the National Drug Control Strategy have categorically 
emphasized early detection of SUDs and embraced integration of behavioral health services in 
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medical settings (Executive Office of the President, 2011; Wu et al., 2013). The increased number 
of insured Americans under the ACA present more opportunities to healthcare organizations to 
treat SUDs at primary-care level and also allows them to acquire more plausible revenue. The 
profits generated due to implementation of such Acts, help the organizations to adapt themselves 
with changes in health policies (Aletraris et al., 2017; Pfeffer & Salancik, 1978). For example, an 
ED equipped with a behavioral health professional and requisite toolkits to treat SUDs, and a 
primary care integrated with behavioral health services; can take advantage of the changes in the 
health laws for SUDs to generate pockets of revenue (Aletraris et al., 2017). By Executive Order, 
President Trump too has assembled the President’s Commission on Combating Drug Addiction 
and the Opioid Crisis, besides asking the Congress to provide funding of additional $500 million 
for state grants in the fiscal year 2018 stipulated under the 21st Century Cures Act of 2016 (H. W. 
Clark, 2017). Therefore, it would be interesting to study the effects of such rigorous, timely and 
frequently updating health policies on the utilization of various healthcare settings for SUDs. 
 Annually, 11% or 1.8 million residents of New York (NY) over 12 years of age, 
experience SUDs but only 15% of them receive treatment (The New York State Office of 
Alcoholism and Substance Abuse Services, 2012). An additional state funding of $25 million was 
approved for 2016-17 to facilitate development and implementation of prevention and support 
services, especially for individuals with heroin and opioid use disorders (DiNapoli, 2016). 
Moreover, the federal government has announced recently that 21 community health centers in 
NY will receive a total of $7.3 million in Substance Abuse Service Expansion awards to help 
address opioid abuse and heroin epidemic in the State (DiNapoli, 2016). Overall, the public 
spending for SUDs treatment has grown faster than private spending. It is noteworthy that of all 
the spending in 2013 from SUDs state and local agencies across the US, NY State has spent the 
highest of $413, 750 (The Pew Charitable Trusts and the John D. and Catherine T. MacArthur 
Foundation, 2015). Therefore, there is a pressing need to evaluate the utilization of healthcare 
spending on SUDs in NY State. 
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Previous studies have shown that among those SUD patients who receive treatment, 
many are likely to not adhere to the therapy (Heaton, Tundia, & Luder, 2013) and lack strong 
connections to primary care settings (Han, 2017; Hinkin & Barclay, 2010), which explains the 
fact that hospitalized patients have more sever SUDs in contrast to those examined in outpatient 
settings (Han et al., 2017; Holt et al., 2012). Moreover, it has been established that misuse of 
alcohol, drugs and other substances is more likely among users of emergency departments (ED) 
than non-users (Beaudoin, Baird, Liu, & Merchant, 2015; Bernstein & D’Onofrio, 2013; Blow et 
al., 2007; Cherpitel & Ye, 2012). Studies have also shown that ED utilization is 50-100% higher 
for patients with SUD than those without (Bahorik et al., 2017; Cherpitel & Ye, 2012; Frank et 
al., 2016; John & Wu, 2017).  In 2011 alone, over 5 million ED visits were made for SUD, as 
reported in the Drug Abuse Warning Network (DAWN) (Bernstein & D’Onofrio, 2013; 
Substance Abuse and Mental Health Services Administration Center forMental Health Services. 
Rockville, 2001). ED has, therefore, evolved from being a treatment setting for acute illness and 
injuries to becoming a “failsafe” site of psychiatric services. Additionally, the National Hospital 
Ambulatory Medical Care Survey revealed that 55% of the nation’s EDs “board” or hold the 
patients in the ED until they can allocate an inpatient bed for psychiatric services (Bernstein & 
D’Onofrio, 2013). It is also known that most psychiatric facilities are overcrowded and thus may 
increase reliance on EDs for SUD treatment (Chakravarthy et al., 2013; Honberg, Diehl, & 
Kimball, 2011). Also, with a rise in the number of individuals who seek care in ED for SUD, it is 
becoming essential for healthcare leaders to introduce innovative methods to encourage follow-up 
of care on discharge for SUD patients and to curb healthcare costs (Bernstein & D’Onofrio, 2013; 
Gau et al., 2005). However, the health professionals who are primarily trained in emergency 
medicine specialty to treat acute illnesses, trauma and injuries and not psychiatric care; are not 
conventional choice of professionals to diagnose and treat SUD. Also, the ratio of population to 
mental health providers for NY state is 420:1 which is much lower than the US median ratio of 
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1060:1 (Robert Wood Johnson Foundation Program and University of Wisconsin Population 
Health Institute 2016). 
Regardless of the importance of the ED as a key clinical point of care for patients at high-
risk, the relationship between ED utilization patterns and SUDs is understudied. ED utilization 
patterns and frequencies are solid predictors of subsequent death due to an overdose. Thus, it is 
important to understand the timing of overdose death with respect to ED utilization for 
identifying at-risk patients that require overdose prevention interventions. With rising cases of 
ED visits in NY State, clinical practice needs to re-evaluate their need to incorporate brief 
intervention and referrals to addiction counselors as part of emergency treatment. 
The first objective of this study was to provide estimates and rates of hospital-based ED 
visits between the years 2011 to 2013 within NY at the county-level. Secondly, the study 
evaluated the effect of patient-level characteristics (age, sex, race, ethnicity, insurance status, 
patient location, income level, and comorbid conditions) on the associated charges for SUDs 
within the State over the period of 2011-2013. Finally, the study presents the geographic 
distribution of substance use treatment centers, ED, and patient SUDs-related ED visits at the 
county-level. 
Methods 
Data Sources 
State Emergency Department Database  
This study utilized the NY State Emergency Department Database (SEDD) data for the years 
2011 to 2013 available from the Healthcare Cost and Utilization Project (HCUP). HCUP is 
sponsored by The Agency for Healthcare Research and Quality (AHRQ) and collects longitudinal 
hospital care de-identified patient information. SEDD provides census data on treat-and-release 
emergency department visits, which include more than 80% of all emergency department visits 
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(Agency for Healthcare Research and Quality. HCUP Databases., 2015). However, SEDD does 
not contain information on those emergency visits that resulted in hospitalizations. SEDD 
includes patient- and hospital-related variables such as age, sex, race, ethnicity, the presence of 
co-morbid conditions, charges, disposition status, patient location, and insurance and income. 
Emergency Medicine Network  
We used the 2013 data obtained from the Emergency Medicine Network (EMNet) to calculate the 
number of EDs in NY at county-level. EMNet collects data through the National Emergency 
Department Inventory (NEDI) that includes ongoing cross-sectional web-based surveys and 
contains data on all EDs at state, and county-level, including facility location and annual visit 
volume. NEDI has ED as a primary unit of analysis and has over an 80% response rate 
(Emergency Medicine Network., 2012). 
National Survey of Substance Abuse Treatment Services 
We used the substance abuse facilities locator that was generated by the National Survey of 
Substance Abuse Treatment Services (N-SSATS) to procure the number of substance use 
treatment centers in NY at the county-level. The annual census data from all the public and 
privately known substance abuse treatment facilities in the United States comprise N-SSATS. 
The N-SSATS conducted by the Mathematica Policy Research for the Substance Abuse and 
Mental Health Services Administration (SAMHSA). Federal, state, and local governments use the 
N-SSATS to assess treatment resources, update their inventories containing information on 
behavioral health services, and generate resource for the public to access and estimate trends in 
available services (Substance Abuse and Mental Health Services., 2017). The treatment centers 
included in this database offer services such as assessment, counseling, pharmacotherapies used, 
testing, transitional, and ancillary services (Substance Abuse and Mental Health Services., 2017). 
Measures 
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All hospital-based ED visits for patients with SUDs in the State of NY between the years 2011 to 
2013 were selected. Appendix 5 presents the list of all primary diagnoses codes used in this study. 
Disorders due to alcohol; amphetamines; cannabis; cocaine; drug-induced mental disorders; 
hallucinogens; opioids; sedatives, hypnotics, anxiolytics, tranquilizers, barbiturates; tobacco; and 
other combinations drugs were identified by the International Classification of Diseases, Ninth 
Revision, Clinical Modification (ICD-9-CM). The independent variables included in the study 
were patient-related demographic characteristics such as age, race, sex, patient location, 
disposition status, income and insurance statuses, and co-morbid conditions.   
 The comorbid burden was measured using the Elixhauser comorbidity index (ECI) 
measure, a summation of 29 binary Elixhauser comorbidity variables, which is available in the 
current HCUP Elixhauser Comorbidity Software, Version 3.7 (“Healthcare Cost and Utilization 
Project (HCUP). HCUP Comorbidity Software, Version 3.7.,” 2017). By definition, an ECI 
measure of 0 indicates the absence of co-morbid conditions. For the premise of this study, we 
computed two separate variables: related and unrelated ECI measure. Clinical conditions 
primarily responsible for emergency visits such as depression and psychoses were considered as 
related comorbidity conditions and measures for alcohol and drug-related abuse were not 
considered comorbidities. Congestive heart failure, valvular disease, pulmonary circulation 
disease, peripheral vascular disease, paralysis, other neurological disorders, chronic pulmonary 
disease, diabetes without chronic complications, diabetes with chronic complications, 
hypothyroidism, renal failure, liver disease, peptic ulcer bleeding, acquired immune deficiency 
syndrome, lymphoma, metastatic cancer, solid tumor without metastasis, rheumatoid arthritis, 
coagulopathy, obesity, weight loss, fluid and electrolyte disorders, chronic blood loss anemia, and 
deficiency anemia were considered as unrelated ECI measures. All comorbidity variables were 
determined by the International Classification of Diseases, Clinical Modification, Version 9 
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(ICD-9-CM) codes (Elixhauser A, Steiner C, Harris DR, 1998; H. Mehta, 2012; Moore et al., 
2017). 
Outcomes 
The key outcome variable for this study was the incurred hospital ED charges (in dollars) for 
hospital visits in NY State’s hospitals. In SEDD, total charges represent the amount billed for 
each hospitalization reported by the facilities. Data in SEDD on cost of care provided to patients 
or the amount of reimbursement for services rendered were not available. These charges were 
adjusted for inflation to the value of 2013 US dollars, using the Bureau of Labor Statistics 
Consumer Price Index. 
Analytical Approach 
An individual ED visit was the unit of analysis. Descriptive statistics included the number and 
rates of SUDs-related ED visits per 10,000 population in NY where the visits stratified by 
clinically diagnosed SUD conditions and patient characteristics. The population-based incidence 
rates of SUDs per 10,000 people were calculated using the 2013 US Census population estimates 
for each county. ED visits in NY were stratified at the county-level using the five-digit Federal 
Information Processing Standard code.  
 The main interest of this study was to identify important patient-related factors associated 
with ED charges. In this study, charges have non-negative values (> 10% have zero values) with 
a distribution with longer right tail and outliers when compared to normal distribution. In this 
case, using ordinary least square regression may provide inaccurate estimates of means and 
marginal/incremental effects (Manning, 2006; Manning et al., 2005; Partha et al., 2010). 
Therefore, total charges were estimated using a generalized linear model (GLM) with a gamma 
distribution and log-link function which best fits our data structure and is a common method in 
cases where the log-transformed dependent variables do not have heavy tails (N. G. Choi et al., 
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2015; J. A. Singh & Yu, 2016; Thompson & Nixon, 2005). The log-link function accounts for the 
non-normal distributional characteristics of the total charges data (Kazley et al., 2014; Malehi et 
al., 2015; Manning et al., 2005). The gamma distribution was selected based on the recommended 
diagnostic test (λ = 2) for the GLM family, called the modified Park Test, to examine the 
distributional characteristics of the residuals (S. D. Case et al., 2011; Malehi et al., 2015; 
Manning et al., 2005). For interpretability, coefficients were converted to average marginal 
effects (AME) which measures the difference in adjusted predicted outcomes between the 
reference group and the comparison groups after adjusting for other covariates. Statistical 
significance was assessed at a level of 0.05. 
 All of the descriptive analyses were carried out using SAS version 9.4 (SAS Institute Inc, 
Cary, NC), whereas log-linked Gamma distributed Generalized Linear model analyses were 
conducted using Stata (StataCorp, College Station, TX). Geographic information system (GIS) 
maps were created using ArcGIS software, version 10.4 (Esri, Redlands, CA). The University of 
Nebraska Medical Center IRB deemed this study exempt from human subject protocol. 
Results 
Patient Characteristics 
Table 1 is a compilation of SUDs-related ED visits in NY stratified by patient characteristics over 
the study period. The majority (74.3%) of the ED visits for SUD were made by males. While the 
mean age of patients admitted in the ED for SUDs was 41 years, over 41% of the visits were 
made by those aged between 45 to 64 years, followed by adults within the 25 to 44 years age 
group (38.2%). Young adults belonging to the 17 to 24 years old age group represented 15% of 
the ED visits for SUD. About 41% of patients who visited the ED for SUDs were White, 
followed by 23.6% of Black patients and 19.1% were Hispanic. About 77% of these patients had 
non-Spanish or non-Hispanic ethnicity. The majority were covered by Medicaid (42%) uninsured 
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(31%). Only 15% of these patients were privately insured and less than 9% were covered by 
Medicare.  
Table 1 also shows that about 95% ED visits were made by patients living in urban areas 
with about 57% of ED visits occurred in patients living in zip codes with the first (38%) and 
second (19%) quartile median household income. However, about a quarter of ED visits 
comprised of those patients living in zip codes within the fourth quartile. Using the ECI measure, 
the present study found that 93% of the ED visits for SUDs were made by patients who had zero 
related comorbidities. However about 7% had 1 or 2 related comorbid conditions such as 
depression and psychoses. The present study categorized ECI measures for unrelated comorbid 
conditions and found that 86% ED visits for SUDs comprised of patients who did not suffer from 
any related comorbid condition, but there were 13% of visits made by patients who had 1 to 2 
unrelated comorbid conditions.   
NY’s EDs reported a total of 492,419 ED visits for a primary diagnosis of SUDs during 
2011 to 2013, as shown in Table 2. There was an overall reduction in the number of ED visits for 
SUD (9% from 2011 to 2012 and 6% from 2011 to 2013). In our study, we found that the most 
common causes of SUDs-related ED visits were made for abuse of alcohol (72.5%), opioids 
(7.9%), combination of drugs (7.8%), and drugs (5.5%). While rates of ED visits for some types 
SUDs reduced, rates for drug-induced mental disorders increased. Specifically, the rates of drug-
related ED visits increased from 4.0 in 2011 to 5.0 in 2013 per 10,000 population. However, rates 
of ED visits for alcohol abuse (61.9 in 2011 to 61.8 in 2013 per 10,000 population); 
amphetamines (0.1 per 10,000 population through 2011-2013); sedatives, hypnotics, anxiolytics, 
tranquilizers, barbiturates (0.37 per 10,000 population through 2011-2013); and tobacco use (3 
per 10,000 population through 2011-2013) have remained steady. Interestingly, rates of ED visits 
due to abuse of cannabis (4.0 vs. 12.6), cocaine (3.5 vs.1.6 per 10,000 population) opioids (75.8 
vs. 61.8 per 10,000 population), and abuse of combination of drugs (6.9 vs. 6.2 per 10,000 
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population) have decreased from 2011 to 2013. But cases of disorders caused due to drug induced 
mental disorders (4.0 vs. 4.9) has increased over the three years. (Table 1).  
Table 3 shows that SUDs visits caused by alcohol, opioids, combination of drugs, and 
drugs-induced mental disorders are most prevalent. Over the study period, in NY State, for 
alcohol abuse-related disorders have had the highest rates of ED visits across all age groups. 
Among those under the age of 18 years had alcohol as the main cause of ED visits with the rate of 
3.2 per 10,000 population. But it is the most common cause among those aged between 45 to 64 
years (83.6 per 10,000 population), followed 25 to 44 years (62.5 per 10,000 population), and 18 
to 24 years (24.1 per 10,000 population) age groups. Interestingly, among the elderly ED visit 
rates for alcohol-abuse is the predominant cause as 90 out 100 per 10,000 population are admitted 
for this type of SUDs.  
The second most common type of SUD that had high rates of ED visits was opioid use. 
Specifically, among all ages, those aged between 25 to 44 years (9.6 per 10,000 population) had 
higher rates of ED visits for opioid abuse, followed by age groups of 45 to 64 years (6.1 per 
10,000 population) and 18 to 24 (3.8 per 10,000) years. Use of drugs as mixtures or in 
combination was the third leading cause of ED visits in NY State over the study period. Similarly, 
those between 25 to 44 years (9.7 per 10,000 population) had the highest rates of ED visits, 
followed by those between 45 to 64 years (5.3 per 10,000 population) and 18 to 24 years (4.0 per 
10,000 population) of age for abuse of combination of drugs. Among those patients who are 25 to 
44 years old, high rates of ED visits for drug-induced mental disorders (6.9 per 10,000 
population) and abuse of cocaine (3.3 per 10,000 population) were the other common causes. It is 
noteworthy that those between 45 to 64 years (103.1 per 10,000) of age had the most ED visit 
rates among all age groups for SUDs. 
Hospital ED Charges for SUD 
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After adjusting hospital ED charges for inflation to the value of 2013 US dollars, the aggregated 
ED charges have increased by 9% from $276 million in 2011 to approximately $300 million in 
2013. The total ED charges incurred from SUD in the state of NY was $856 million with an 
average ED visit charge of $1,764 (Table 1). As seen in Figure 2, the number of ED visits for 
SUD decreased from 2011 (172,958) to 2012 (153,444) and then increased to 162,522 in 2013. 
From 2011 to 2013, both total ED charges and average ED charges for SUDs-related visits 
showed a substantial increase after inflation adjusted to 2013 US dollars. The average hospital 
ED charges increased from $1,658 in 2011 to $1,845 in 2013. 
 Table 4 represents the findings of the effect of patient-related factors on hospital-based 
ED charges for SUDs using a multivariate log-linked gamma distributed GLM. As indicated by 
average marginal effects (AME), the total charges for females are significantly higher than males 
by $64. Interestingly, ED visits made by patients below the ages of 17 years were charged higher 
than all other age groups. Adults between the ages of 45-64 years incurred hospital ED charges of 
SUD lower than children under the age of 17 years by $278. Race was significantly associated 
with hospital ED charges for SUDs. White patients incurred higher ED charges than all other 
races. Asians and Pacific Islanders incurred ED charges $178 lower than Whites for SUDs. 
Privately insured patients had ED charges higher by $36 than those covered by Medicare. 
However, those patients covered by other insurance types that includes CHAMPUS/VA were 
charged $272 less than those covered by Medicare. Patients covered by Medicaid also had $148 
less than those covered by Medicare. Patients whose median household income at the ZIP code 
level fell into the fourth quartile had significantly higher ED charges than those living in the first, 
second and third quartile by $569, $591 and $368, respectively. The regression model also 
indicates that patient location is significantly associated with ED charges for SUDs. Patients 
residing in large, small and isolated rural towns had higher ED charges for SUD by $327, $158 
and $297 more than those residing in urban areas. Additionally, ED charges are also significantly 
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associated with an ECI measure for unrelated comorbid conditions. Hospital ED charges for 
SUDs increased with an increase in the index measure, with ED charges being $1064 higher for 
those patients with 3 or more unrelated comorbid conditions than those with no unrelated 
comorbid conditions.  
GIS Analysis Results  
Overall, the maps depict geographic patterns of ED admission for SUDs and explore potential 
reasons for geographic variations by plotting available distribution of EDs and substance abuse 
treatment centers. Figure 2 presents the distribution of population-based estimates of ED visits for 
SUDs and the available treatment centers for SUDs in NY by county during 2011-2013. The 
majority of the substance abuse treatment centers were clustered in the urban five boroughs area 
(Greater NY City) comprised of the Richmond, Kings, Queens, New York, and Bronx counties 
which had also experienced high number of ED visits (>over 400 per 10,000 population) for 
SUDs. In contrast, some rural counties had a moderate proportion of ED visits for SUDs but less 
than 5 treatment centers (e.g., Schenectady and Broome: 201-400 ED visits per 10,000 
population) or zero treatment centers (Chemung, Schuyler and Delaware: 101-200 400 ED visits 
per 10,000 population). Interestingly, even urban counties (Washington, Herkimer, and Tioga) 
had 0-1 treatment centers but their residents made <100 ED visits per 10,000 population for SUD. 
Figure 3 shows the distribution of population-based estimates of ED visits for SUDs and 
the distribution of EDs in NY by county between 2011 and 2013. Within the five-borough region, 
there are most number of EDs. Also, the neighboring urban counties of Suffolk, Nassau, and 
Westchester have between 11-15 EDs. In contrast, their neighboring urban county of Richmond 
had fewer EDs (3-5). Even though, the urban counties of Broome, Schenectady, and Rensselaer 
counties had high rates of ED visits for SUDs, they had only 1-2 ED facilities. Interestingly, 
counties such as Saratoga and Rensselaer were moderately populated and urban, but had only 1 
ED whereas urban county of Tioga had no ED. Moreover, there were 20 other counties that had 
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only 1-2 EDs. Markedly, rural counties of Greene, and Hamilton had no EDs although their 
residents had between 80-200 visits per 10,000 population for SUDs. 
Discussion 
The racially and culturally diverse NY State happens to be predominantly urban (Hevesi, 2004; 
RLS Demographics, 2011), adopted Medicaid expansion under ACA, and its state substance 
abuse agency had the highest spending per capita in the US. These facts make NY an important 
state to evaluate regarding their healthcare utilization for SUDs at both the EDs and treatment 
centers. To our knowledge, this study is the first to examine hospital-based ED visits for all ten 
types of SUDs in NY. Researchers have examined ED visits for misuse of cannabis, alcohol, 
heroin and opioid-related disorders. For example, Schmidt et al. analyzed ED utilization for 
cannabis abuse in California (Schmidt, Behar, Cordova, & Beckum, 2017), while Campbell and 
Bahorik examined specifically encounters in ED for alcohol, cannabis, and opioid use disorders 
(Bahorik et al., 2017; Campbell, Bahorik, Kline-simon, & Satre, 2017). John and Wu (2017) have 
evaluated nationwide utilization of ED and inpatient hospitalization for only alcohol use among 
individuals with cannabis use disorders (John & Wu, 2017). However, after implementation of 
ACA, there are no data published examining the burden of ED visits in NY for all ten SUDs 
categories. 
 This study indicated that a total of 492,419 ED visits for SUDs occurred during the study 
period resulting in total ED charges of close to $856 million. Most ED visits across all age groups 
were made for alcohol abuse. Nevertheless, it is noteworthy that 90% of the ED visits made by 
elderly were for alcohol abuse resulting in alcohol-induced delirium, amnesia and sleep disorders 
which is common among elderly.  
Considering that SUDs are conventionally treated at substance abuse treatment centers, 
rehabilitation centers, and at outpatient clinics; average ED spending of $285 million per year for 
SUDs is alarming. Moreover, considering that ED staff usually do not have behavioral health 
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providers on their team for treating SUDs, the approach to treat SUDs may lack definitive 
diagnoses and is rather symptomatic which may delay the required line of treatment.  
Based on the demographic distribution in NY State, males; patients who were between 
25-64 years old; of Black, Hispanics and other racial minorities; Medicaid and uninsured; urban 
residents are the most burdened with SUDs. Consistent with previous literature, this study shows 
that males (Bohnert, Tracy, & Galea, 2012; Fahimi et al., 2015; Meiman, Tomasallo, & Paulozzi, 
2015a), mostly adults who are 25-64 years old, and Whites represent a substantial proportion of 
ED visits for SUDs (DiNapoli, 2016; Tice et al., 2014; Wu et al., 2013; Xie et al., 2014). A 
sizeable proportion of ED visits for SUDs were made by those patients covered by Medicaid 
which has been the case nationally (U.S. Department of Health and Human Services (HHS), 
2016; Weiss, Barrett, Heslin, & Stocks, 2016). Additionally, about 57% of the SUDs-related ED 
visits occurred in patients living in zip codes with the first and second quartile median household 
income. This finding explains that more SUDs occur among those living urban but low-income 
areas. However, unlike the national-level studies, the second largest number of ED visits were 
made by uninsured (31.3%) in NY followed by those privately insured (14.9%). Other studies 
have also reported that most of the ED visits for SUDs occurred over weekdays (Fahimi et al., 
2015) and were routinely discharged (Mark et al., 2010; Schildhaus et al., 2013). Similar to 
published reports, we that urban or metropolitan population (Meiman, Tomasallo, & Paulozzi, 
2015b; Schildhaus et al., 2013; Schroeder & Leigh-peterson, 2017), had a greater proportion of 
ED visits. EDs are located more in urban and densely populated areas, especially the five 
boroughs region in NY.  
This study was able to identify high-risk cohorts who are likely to visit an ED for SUDs 
and have higher ED charges in the NY. Specifically, females, >17 years of age, Whites, those 
privately insured, and living in low-income areas had higher ED charges. Few studies have 
reported that behavioral disorders-related ED charges for adolescents, pediatrics, and young 
adults have been expensive (Akosa Antwi, Moriya, & Simon, 2015; Torio, Encinosa, Berdahl, 
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McCormick, & Simpson, 2015). However, there are no epidemiologic studies that have presented 
comparison on ED charges between children, adolescents and adults with which the present 
findings could be compared, and more research is needed to further explore this area. A high 
proportion (95%) of ED visits for SUDs were made by urban patients who could be due to an 
array of parameters including acceptance of risky substance use as ‘normal’ by the communities 
(Center on Addiction and Substance Abuse Columbia, 2013). Efforts need to be made by 
policymakers and healthcare administrators to implement preventative behavioral health 
programs targeted towards these individuals. Also, because there are unmet behavioral healthcare 
needs in low-income quartile areas, primary care settings must pursue to be integrated with 
behavioral health services.   
SAMHSA reported that the highest spending by payer for SUDs with and without the 
impact of ACA, is by Medicaid and private insurance companies, followed by the uninsured (U.S. 
Department of Health and Human Services, 2016). This study shows that, even though there are 
statistically significant changes in the proportion of charges covered by payers, overall, the 
population covered by Medicaid, the uninsured, and the privately insured contributed to a 
substantial proportion of ED visits for SUD. These findings for NY differ from those at the 
national level (Fahimi et al., 2015; U.S. Department of Health and Human Services, 2016), and 
those for the states of California (Bahorik et al., 2017; Campbell, Bahorik, Kline-simon, & Satre, 
2017b), and North Carolina (Doren et al., 2016) suggesting, that state-specific studies should be 
performed. In NY, most substance abuse services (including all outpatient services) and mental 
health services were excluded from its managed care benefit package. These services were only 
offered on a fee-for-service basis or as an optional Medicaid benefit. However, on expanding 
Medicaid under the ACA, NY State’s Medicaid program offered to include substance abuse 
services to the benefits package along with comprehensive behavioral health services (Bachrach, 
Boozang, & Lipson, 2015; Boozang, Bachrach, & Detty, 2014). On identifying high-risk cohorts, 
this evidence-based research, can help policymakers examine the state reimbursement policies 
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may negatively impact access to behavioral health services. Furthermore, despite the ACA’s 
expansion of SUDs treatment coverage and reduction in the number of ED visits from 2011 to 
2013, the average hospital ED charges for SUDs increased. This proposes that the ED-level 
spending for SUDs needs to be re-evaluated by introducing cost-effective programs that use 
screening, intervention, and referral toolkits, and peer-SUDs-afflicted coaches on the ED staff to 
direct patients with SUDs to appropriate healthcare settings.  
  Figures 2 and 3 display the ED utilization pattern for SUDs across the geographic regions 
in NY indicating that visits are higher in areas with more treatment facilities and EDs. This could 
be because of the greater number of low-income and uninsured population in these urban 
counties. Also, in our study, ED visits were mainly made by those who are living in low-income 
areas and covered by Medicaid and the uninsured. This indicates that despite the availability of 
treatment centers, this population maybe limited in their access to these facilities and ultimately 
seek help in ED. US DHHS projected a shortage of behavioral health professionals in 2025 (U.S. 
Department of Health and Human Services, 2016). Subsequently, there is a possibility of 
insufficient behavioral healthcare with sustained health disparities in NY. In addition, the maps 
displayed that the ED utilization pattern for SUD across the geographic regions in NY. Counties 
that form the five boroughs region such as Kings, Queens, New York, Richmond, and Bronx 
counties had high rates of ED rates and high proportion of the high-risk cohort that belonged to 
29-44 years old age group. Contrastingly, even though Suffolk and Westchester counties had high 
proportion of high-risk age group (29- 44 years) because of the high numbers of treatment centers 
their rates of ED visits were low (less than 200 ED visits per 10,000 population). Therefore, from 
the figures, there is clear evidence that the SUD-related ED visits are higher in urban areas with 
more substance abuse treatment facilities and EDs. This could be because of the greater number 
of low-income and uninsured population in these counties (mostly urban five boroughs region). 
Also, in our study, ED visits are majorly made by those who are living in low-income areas and 
covered by Medicaid and the uninsured. This also reinstates that access of EDs drives their 
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utilization. Subsequently, dearth of treatment centers compels both urban and urban residents to 
seek healthcare services for SUDs in EDs, which maybe because his population may be limited in 
their access to these facilities. Further studies need to be performed to understand the severity of 
disorders among SUD-related ED visitors.  
Health systems need to emphasize educating the population in NY about available 
provisions for behavioral healthcare and unwanted outcomes of substance abuse. According to a 
report by the US Department of Health and Human Services, there will be a projected shortage of 
psychiatrists; clinical, counseling, and school psychologists; and mental health and substance 
abuse social workers in 2025 (U.S. Department of Health and Human Services, 2016). This 
indicates that there is a possibility of deteriorating behavioral health care and sustained health 
disparities in behavioral health care access in NY. Specifically, Broome, Schenectady, Albany, 
Richmond, Tompkins and Rensselaer and Cortland counties need treatment facilities. Also, 
policymakers need to design policies that could improve access to integrated or segregated 
behavioral healthcare and reduce ED visits and deaths due to SUD. For illustration, to avoid 
readmissions in inpatient or emergency departments, especially among the high-risk cohorts, 
integrated behavioral health services must be provided by the ED hospital staff. Allocation of a 
CPT code for follow-ups, reminders, peer-coaching and adherence to therapy for patients with 
SUDs will encourage the healthcare professionals and hospital staff to participate in supportive 
community outreach and procure reimbursements for delivering patient-centered and coordinated 
care with primary care providers. New York State can adopt such Patient-centered approach from 
predominantly urban states with similar demography such as New Jersey, Massachusetts, and 
Oregon. These states manage the social, behavioral, and medical needs of those individuals with 
high charges of ED visits for SUDs by including the hospital administrators and policymakers on 
their interdisciplinary teams. It could be anticipated that combined efforts from patients, providers 
and policymakers can break the harmful and costly cycle of inappropriate and costly ED and/or 
inpatient admissions. 
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Conclusions 
This study provides estimates of characteristics of patients across all ages that make ED visits in 
the State of NY for ten types of SUD. This study also examined the significant changes in the 
proportion of charges covered by Medicaid, the uninsured and those privately insured due to the 
impact of altering health policies in NY. Treatment charges are significantly higher for females, 
children, privately insured and patients in rural areas. The study identified that males, Whites, 
those aged 25-64 years, uninsured, covered by Medicaid and private insurance, and residing in 
low-income areas and belonging to urban areas were at high-risk in the State of NY. Additionally, 
despite sufficient access to behavioral healthcare services in urban areas, more substance use-
related problems exist, especially in the five boroughs areas of NY. On the other hand, there are 
counties in NY that have no EDs or have insufficient substance abuse treatment centers available 
implying high numbers of unmet behavioral health needs. In the future, studies should be 
conducted to better understand the barriers to access for behavioral healthcare at the primary 
level, especially among high-risk groups. These findings emphasize that it is essential to design 
state-specific preventive health policies and programs to improve access to care and reduce 
dependence on ED for treatment of SUD. We anticipate that the findings will provide evidence to 
psychiatric healthcare providers and policymakers.  
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Table 1: Emergency Department visits for substance use disorders stratified by patient 
characteristics in NY SEDD, 2011 – 2013. * 
Characteristics Number (Percent) 
Sex 
Male 365,693 (74.3) 
Female 126,694 (25.7) 
  
Age group (in years) 
up to 17 9,093 (1.9) 
17 to 24 73,594 (15.0) 
25 to 44 188,233 (38.2) 
45 to 64 201,771 (41.0) 
65 and over 19,728 (4.0) 
Mean Age (years) 41.00 
  
Race  
White 200,656 (41.0) 
Black 115,735 (23.6) 
Hispanic 93,744 (19.1) 
Asian and Pacific Islander 8,247 (1.7) 
Other (includes NA) 71,509 (14.6) 
  
Ethnicity*  
Spanish/Hispanic origin 93,744 (19.9) 
Non-Spanish/Non-Hispanic 378,502 (76.9) 
  
Primary payer 
Medicare 43,014 (8.7) 
Medicaid 209,005 (42.5) 
Private Insurance 73,462 (14.9) 
Uninsured 153,862 (31.3) 
Other (includes No charge) 12,928 (2.6) 
  
Admission Day 
Weekday 336,863 (68.41) 
Weekend 155,556 (31.59) 
  
Disposition status 
Routine 459,855 (93.42) 
Transfer to short-term hospital 3,926 (0.80) 
Transfer Other: Includes SNF, ICF, Another Type 
of Facility 
6,874 (1.40) 
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Home Health Care (HHC) 1,310 (0.27) 
Against Medical Advice (AMA) 20,270 (4.12) 
Died in hospital 36 (0.01) 
Missing 148 
  
Patient Location 
Urban 451,330 (95.09) 
Large rural town 14,093 (2.97) 
Small rural town 5,365 (1.13) 
Isolated rural 3,850 (0.81) 
Median household income national quartile for patient ZIP code** 
First quartile 181,819 (38.20) 
Second quartile 89,468 (18.80) 
Third quartile 85,610 (17.99) 
Fourth quartile 119,047 (25.01) 
Elixhauser Comorbidity Index 
Related comorbid conditions a  
0 457,219 (92.9) 
1 34,025 (6.9) 
2 1,175 (0.2) 
Unrelated comorbid conditions b  
0 423, 338 (86.0) 
1 51,930 (10.6) 
2 13, 987 (2.8) 
3 or more 3, 164 (0.6) 
 
Hospital ED charges (inflation adjusted to 2013 US dollars) 
2011 $276,123,421.00 
2012 $280,069,900.00 
2013 $299,824,373.00 
Total charges $856,017,694 
Mean (median) charges $1,764.4 ($1,266.7) 
ED, emergency department; SEDD, State Emergency Department Database; NA, Native 
Americans; SNF, Skilled Nursing Facility; ICF, Intermediate Care Facility.  
 
* The sum of individual counts may not add up to the total number of visits because of missing 
information for certain variables. 
 
** Median household income quartiles of residents in the patient’s ZIP code vary by year.  
The levels were $1 to $38,999 (quartile 1), $39,000 to $47,999 (quartile 2), $48,000 to $63,999 
(quartile 3) and $64,000 or higher (quartile 4) in the year 2011.  
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The levels were $1 to $38,999 (quartile 1), $39,000 to $47,999 (quartile 2), $48,000 to $62,999 
(quartile 3) and $63,000 or higher (quartile 4) in the year 2012.  
The levels were $1 to $37,999 (quartile 1), $38,000 to $47,999 (Quartile 2), $48,000 to $63,999 
(quartile 3) and $64,000 or higher (quartile 4) in the year 2013. 
 
a Count of related comorbid conditions from 2011 to 2013 which includes depression and 
psychoses. 
 
b Count of unrelated comorbid conditions from 2011 to 2013 which comprises of a count of one 
for congestive heart failure, valvular disease, pulmonary circulation disease, peripheral vascular 
disease, paralysis, other neurological disorders, chronic pulmonary disease, diabetes without 
chronic complications, diabetes with chronic complications, hypothyroidism, renal failure, liver 
disease, peptic ulcer bleeding, acquired immune deficiency syndrome, lymphoma, metastatic 
cancer, solid tumor without metastasis, rheumatoid arthritis, coagulopathy, obesity, weight loss, 
fluid and electrolyte disorders, chronic blood loss anemia, and deficiency anemias. 
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Table 2: Number, percent and rates of substance use disorders-related emergency department visits per 10,000 population by year 
in New York, SEDD 2011 – 2013.  
Type of SUD 2011 2012 2013 Total 
N % R N % R N % R N % R 
Alcohol 120,591 69.7 61.95 114,844 73.3 58.7 121,413 74.6 61.8 356,848 72.5 182.4 
Amphetamines 226 0.1 0.12 237 0.2 0.1 262 0.2 0.1 725 0.1 0.4 
Cannabis 7,759 4.5 3.99 2,520 1.6 1.3 2,481 1.5 1.3 12,760 2.6 6.5 
Cocaine 6,755 3.9 3.47 3,379 2.2 1.7 3,198 2.0 1.6 13,332 2.7 6.8 
Drug-induced mental 
disorders 
7,889 4.6 4.05 9,463 6.0 4.8 9,691 6.0 4.9 27,043 5.5 13.8 
Hallucinogens 294 0.2 0.15 166 0.1 0.1 138 0.1 0.1 598 0.1 0.3 
Opioids 14,763 8.5 7.58 11,990 7.7 6.1 12,136 7.5 6.2 38,889 7.9 19.9 
Sedatives, hypnotics, 
anxiolytics, 
tranquilizers, 
barbiturates  
710 0.4 0.36 639 0.4 0.3 730 0.4 0.4 2,079 0.4 1.1 
Tobacco  499 0.3 0.26 506 0.3 0.3 568 0.3 0.3 1,573 0.3 0.8 
Other 13,472 7.8 6.92 12,980 8.3 6.6 12,120 7.4 6.2 38,572 7.8 19.7 
Total 172,958 100.0 88.85 156,724 100.0 80.1 162,737 100.0 82.8 492,419 100.0 251.7 
 
 ED, emergency department; SEDD, State Emergency Department Database; SUD, Substance Use Disorders; N, Number R, Rate 
Note: Rate is calculated using population estimates of New York to be 19,465,197 in 2011; 19,570,261 in 2012; and 19,651,127 in 2013. 
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Table 3: Number, percent and rates of substance use disorders-related emergency department visits per 10,000 population by age 
groups in New York, SEDD 2011 – 2013.  
Types of SUD 
Age in years 
Total 
1 to 17 18 to 24 25 to 44 45 to 64 65 and more 
N (%) R N (%) R N (%) R N (%) R N (%) R N (%) R 
Alcohol 
6,190 
(68.1) 
3.2 
47,088 
(64.0) 
24.1 
122,193 
(64.9) 
62.5 
163,625 
(81.1) 
83.6 
17,752 
(90.0) 
9.1 
356,848 
(72.5) 
182.4 
Amphetamines 26 (0.3) 0.0 254 0.1 
368 
(0.02) 
0.2 75 (0.0) 0.0 
89.98 
(0.5) 
0.0 
725 
(0.1) 
0.4 
Cannabis 
1,324 
(14.6) 
0.7 
4,121  
(5.6) 
2.1 
5,790 
(3.1) 
3.0 
1,497 
(0.7) 
0.8 
28 
(0.1) 
0.0 
12,760 
(2.6) 
6.5 
Cocaine 
31 
 (0.3) 
0.0 
971  
(1.3) 
0.5 
6,447 
(3.4) 
3.3 
5,753 
(2.9) 
2.9 
130 
(0.7) 
0.1 
13,332 
(2.7) 
6.8 
Drug-induced 
mental disorders 
383  
(4.2) 
0.2 
4,921  
(6.7) 
2.5 
13,545 
(7.2) 
6.9 
7,435 
(3.7) 
3.8 
759 
(3.8) 
0.4 
27,043 
(5.5) 
13.8 
Hallucinogens 
22 
(0.2) 
0.0 
254  
(0.3) 
0.1 
278 
(0.1) 
0.1 43 (0.0) 0.0 1 (0.0) 0.0 
598 
(0.1) 
0.3 
Opioids 
135  
(1.5) 
0.1 
7,413  
(10.1) 
3.8 
18,818 
(10.0) 
9.6 
12,019 
(6.0) 
6.1 
504 
(2.6) 
0.3 
38,889 
(7.9) 
19.9 
Sedatives, 
hypnotics, 
anxiolytics, 
tranquilizers, 
barbiturates 
46  
(0.5) 
0.0 
408  
(0.6) 
0.2 
1,011 
(0.5) 
0.5 
559 
(0.3) 
0.3 
55 
(0.3) 
0.0 
2,079 
(0.4) 
1.1 
Tobacco 
18  
(0.2) 
0.0 
315  
(0.4) 
0.2 
725 
(0.4) 
0.4 
459 
(0.2) 
0.2 
56 
(0.3) 
0.0 
1573 
(0.3) 
0.8 
Other 
combinations 
918  
(10.1) 
0.5 
7,849  
(10.7) 
4.0 
19,058 
(10.1) 
9.7 
10,306 
(5.1) 
5.3 
441 
(2.2) 
0.2 
38,572 
(7.8) 
19.7 
Total 9,093 4.6 73,594 37.6 188,233 96.2 201771 103.1 19,728 10.1 492,419 251.7 
ED, emergency department; SEDD, State Emergency Department Database; SUD, Substance Use Disorders; N, Number R, Rate 
Note: Rate is calculated using average population estimates of New York to be 19,562,195 between 2011 and 2013. 
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Table 4: Multivariate generalized linear model of hospital-based emergency department 
charges due to substance use disorders, NY SEDD 2011 – 2013. 
 
Parameter 
 
AME 
(dy/dx) in 
dollars 
Standard 
Error 
 
95% Confidence 
Intervals 
P-
value 
Lower Upper 
Sex  
Male Reference 
Female 64.41 5.09 54.44 74.39 <.0001 
Age group  
0 to 17 Reference 
18 to 24 -250.83 18.48 -287.05 -214.60 <.001 
25 to 44 -194.43 18.16 -230.02 -158.83 <.001 
45 to 64 -277.87 18.16 -313.47 -242.27 <.001 
65 and over -210.63 21.70 -253.16 -168.10 <.001 
Race  
White Reference 
Black -169.92 5.91 -181.50 -158.34 <.001 
Hispanic -81.76 6.34 -94.18 -69.34 <.001 
Asian and Pacific Islander -178.29 16.02 -209.68 -146.90 <.001 
Other (includes NA) -155.74 6.67 -168.81 -142.68 <.001 
Primary Payer  
Medicare Reference 
Medicaid -148.00 9.18 -165.99 -130.01 <.001 
Private Insurance 35.91 10.71 14.92 56.90 0.001 
Uninsured -75.09 9.54 -93.78 -56.40 <.001 
Other insurance -271.78 14.67 -300.53 -243.03 <.001 
Median household income national quartile for patient ZIP code** 
Fourth quartile Reference 
First quartile -568.76 6.54 -581.58 -555.93 <.001 
Second quartile -590.47 7.15 -604.47 -576.46 <.001 
Third quartile -367.66 7.41 -382.19 -353.42 <.001 
Patient Location  
Urban Reference 
Large rural town 327.40 15.36 297.28 357.51 <.001 
Small rural town 157.62 22.20 114.11 201.13 <.001 
Isolated rural 296.62 27.96 241.83 351.42 <.001 
Elixhauser Comorbidity Index Measure for Unrelated Comorbid Conditions*** 
0 Reference 
1 476.16 8.52 459.46 492.87 <.001 
2 582.23 16.80 549.31 615.15 <.001 
=> 3 1063.56 42.43 980.40 1146.73 <.001 
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NY SEDD, NY State Emergency Department Database; AME, Average marginal effects; NA, 
Native Americans. 
 
** Median household income quartiles of residents in the patient’s ZIP code vary by year. The 
levels were $1 to $38,999 (quartile 1), $39,000 to $47,999 (quartile 2), $48,000 to $63,999 
(quartile 3) and $64,000 or higher (quartile 4) in the year 2011. The levels were $1 to $38,999 
(quartile 1), $39,000 to $47,999 (quartile 2), $48,000 to $62,999 (quartile 3) and $63,000 or 
higher (quartile 4) in the year 2012. The levels were $1 to $37,999 (quartile 1), $38,000 to 
$47,999 (Quartile 2), $48,000 to $63,999 (quartile 3) and $64,000 or higher (quartile 4) in the 
year 2013. 
 
 
***Count of unrelated comorbid conditions from 2011 to 2013 which comprises of a count of one 
for congestive heart failure, valvular disease, pulmonary circulation disease, peripheral vascular 
disease, paralysis, other neurological disorders, chronic pulmonary disease, diabetes without 
chronic complications, diabetes with chronic complications, hypothyroidism, renal failure, liver 
disease, peptic ulcer bleeding, acquired immune deficiency syndrome, lymphoma, metastatic 
cancer, solid tumor without metastasis, rheumatoid arthritis, coagulopathy, obesity, weight loss, 
fluid and electrolyte disorders, chronic blood loss anemia, and deficiency anemias. 
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Figure 1: Number of ED visits and average Emergency Department charges* for Substance 
Use Disorders, NY SEDD 2011–2013. 
 
 
 
* Hospital ED charges– inflation adjusted to 2013 US dollar value 
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Figure 2: Emergency department visits per 10,000 population for substance use disorders 
and their treatment centers in the New York State using NY SEDD, 2011–2013 and  
SAMHSA 2013. 
 
 
SAMHSA, Substance Abuse and Mental Health Agency; SEDD, State Emergency Department 
Database 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
111 
 
Figure 3: Emergency department visits per 10,000 population for substance use disorders 
and the distribution of emergency departments in the State of New York using NY SEDD, 
2011– 2013 and EMNet 2013. 
 
 
SEDD, State Emergency Department Database; EMNet, Emergency Medicine Network 
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CHAPTER VI: DISCUSSION AND CONCLUSIONS 
Studies outlined in this dissertation project examined three different aspects of behavioral health 
(BH) services in the United States (US). Each of these three independent studies have addressed 
vital questions based on healthcare utilization for BH services, available access to care, and the 
implications of healthcare reforms and the mandated policies. The findings of this dissertation 
will benefit policymakers who are developing the American Health Care Act of 2017 and shaping 
the President Trump’s Commission on Combating Drug Addiction and the Opioid Crisis. In 
addition, the findings of this dissertation laid down salient features that will enable hospital 
administrators and providers to recognize high-risk population suffering from BH conditions, and 
design methods to curb charges and costs of hospitalization as well as rates and costs of 
readmissions. Subsequently, the actions by policymakers and health administrators will aid public 
health program developers to design community outreach to address the problem of BH 
conditions that can eventually be advantageous to patients.  
The first study of this dissertation analyzed the rates, costs and relapses of 30-day 
unplanned all-cause readmissions following index hospitalizations for alcohol-related disorders 
(ARD) among US adults. The conclusions derived from this study will help policymakers, budget 
and discharge protocol designers at hospitals, and eventually patients. The second study examined 
the incidence of emergency department (ED) visits and the corresponding incurred charges for 
BH disorders as well as predicted cohorts that have higher odds of leaving against medical 
advice, and correlation BH workforce in Nebraska between 2011 and 2013. The findings from 
this study will depict ED outcomes among high-risk cohort and also highlight that BH provider 
shortages are responsible for high number of ED visits and charges for BH disorders, despite 
limited availability of EDs in rural Nebraska. The third study examined the frequency of ED 
visits and the hence incurred charges for substance use disorders (SUD) in New York between 
2011 and 2013 during the adoption of Medicaid expansion under Patient Protection and 
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Affordable Care Act (ACA). The results from this study explained that there is a need to develop 
policies and increase access to primary care clinics or substance abuse treatment centers despite 
New York being a predominantly urban state. This concluding section of the dissertation will 
briefly discuss the findings of the three studies, policy implications, and suggest few new ideas 
for future research.  
All three studies used data from the Healthcare Cost and Utilization Project (HCUP) 
database maintained and curated by the Agency for Healthcare Research and Quality. The first 
study used 2014 Nationwide Readmissions Database to obtain patient and hospital-level 
characteristics and discharges (index hospitalizations and readmissions) for ARD. Although NRD 
contains information from 22 states, national-level estimates that produce nationally 
representative results. HCUP’s 2011-2013 Nebraska State Emergency Department Database 
(SEDD) was queried for the second study for number of cases for all BH-related disorders, 
patient-level characteristics, and charges for ED visits, etc at BH regions. Similarly, for the third 
study, 2011-2013 New York SEDD was retrieved for ED visits on SUD. In addition, for the 
second study data on BH workforce and availability of EDs at county-level were provided by the 
Health Professionals Tracking Services (HPTS). National Emergency Department Inventories 
(NEDI) and National Survey of Substance Abuse Treatment Services (N-SSATS) provided 
information locations of EDs and substance abuse treatment centers, respectively, for the third 
study.  
Summary of the Study Findings 
Hospitalizations principally due to alcohol-related disorders (ARD) are at high-risk of 30-
day unplanned all-cause readmissions. However, national estimates of the overall economic 
burden of index hospitalizations for ARD, factors associated with readmissions and their costs; 
have not been studied considering the recent policies for readmissions under the Patient 
Protection and Affordable Care Act. The first study examines the frequency and distribution of 
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readmissions following index discharges due to ARD; patient and hospital-level predictors of 
readmissions; and costs for readmissions with and without recurrences of ARD. 2014 NRD 
representing over 49% of all the US hospitalizations, was used for this study. ARD were 
identified through ICD-9 Clinical Classification Software Code 660 for inpatient hospital stays. 
Chi-square test was used for descriptive analysis to calculate frequency of index hospitalizations 
with ARD and the proportion that had at least one 30-day readmissions. Multivariate logistic 
regression was used to estimate patient and hospital-level characteristics that are predictors for 
the 30-day readmissions for index hospitalizations for ARD. Two-part models (2PM) were used 
to estimate the incremental and predicted costs of the immediate all-cause readmissions among 
patients with index hospitalizations for ARD after adjusting for predisposing, enabling, need-
related factors selected based on the Anderson Healthcare Behavior Model. Additionally, costs of 
readmissions with and without relapses for ARD from the 2PM were estimated. All analyses were 
analyzed at significance level of ≤0.05. About 286,655 index hospitalizations were made for 
ARD out of which 54,092 (18.9%) hospitalizations resulted into at least one 30-days unplanned 
all-cause readmissions. Index hospitalizations with ARD among patients who were males, 
between 45-64 years old, covered by Medicaid, belonging to urban and low-income areas, with 1-
2 unrelated but zero related comorbidities measure using Elixhauser Comorbidity Index were at 
high-risk to 30-day readmissions. Similarly, patients admitted in hospitals that are privately 
controlled for not-profit, had high number of beds, located in large metropolitan areas, and with 
metropolitan teaching status had high proportions of readmissions. Those index stays that resulted 
in readmissions had a higher average cost of $8,840 versus those without readmissions ($8,036). 
However, those patients who were between 25-64 years old, with multiple unrelated 
comorbidities and admitted in hospitals with medium or large number of beds had statistically 
higher odds of readmissions. Predicted mean costs for readmissions on index stay with ARD was 
greater among those with recurrence of ARD ($2,520), males ($1,798), between 45-64 years old 
($1,908), covered by Medicare ($2,132), rural residents ($1,841), high-income ($1,877), 4 or 
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more unrelated comorbidities ($2,415), average length of stay of 5 days ($1,966); and admitted in 
hospitals in large metropolitan areas ($2,032), large number of beds ($1,551), non-federal 
government owned ($2,109), and with low volume of cases for ARD ($2,154). Patients with 
recurrences of ARD, 45-64 years old, and 4 or more unrelated comorbidities had greater 
readmission costs by $919 and $1,608 than those without recurrences for ARD. Similarly, 
patients readmitted in large metropolitan areas, large number of beds, non-federal government 
hospitals, and low volume of cases for ARD had readmission costs higher by $1,002, $413, $567, 
and $489 than admissions in micropolitan areas, small number of beds, private investor-owned 
hospitals, and with high volume of cases for ARD. However, hospitals that are non-federal 
government, located in large metropolitan areas and have high number of beds, offer 
comparatively reduced readmission costs to recurrences with ARD than non-recurrence cases. 
Overall costs of index hospitalizations primarily for ARD was $2.3 billion in 2014, of which 
$512 million were spent on those stays that resulted in at least one 30-day readmissions. Also, 
this study predicts that $136 million were spent on those readmissions that were for recurrences 
to ARD. Although, readmission rates did not significantly decline after the implementation of 
ACA, the study estimates that greater readmissions costs were amounted in 2014, especially 
among those with relapses to ARD. Therefore, there is a need to develop and implement more 
sustainable policies to reduced readmission rates and costs among individuals with ARD. 
Using Aday and Andersen model for healthcare utilization, the second study estimated 
hospital-based emergency department (ED) visits and the incurred charges for BH conditions, 
including mental health and substance abuse disorders, within Nebraska between 2011and 2013. 
The study also focused on correlating behavioral workforce distribution in Nebraska with ED 
utilization. The 2011-2013 Nebraska SEDD provided information on utilization of services in 
ED, charges, diagnoses, and demographic variables, such as age, sex, patient location, health 
insurance, and income status. The 2013 HPTS annual survey database provided the number of 
EDs and the distribution of BH professionals in Nebraska by region. The study population was 
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comprised of patients within Nebraska who had visited the ED for BH-related conditions. To 
examine the effect of patient characteristics on the outcome variable ED charges, multivariate 
linear regression model was used. $96.4 million was spent on 52,035 ED visits for BH-related 
conditions over three years. Of these, 35% were between 25- and 44-years-old. Private insurance 
covered 40% of these patients. ED charges were significantly greater for patients who were male, 
older, uninsured, and residing in rural areas. Males, those between 18 to 64 years of age, 
uninsured, living in low-income areas, with no unrelated comorbidity had higher odds of obtained 
discharge against medical advice following ED visits for primary diagnoses of BH disorders.  
This explains that a majority of Nebraskan regions have BH provider shortages and limited 
availability of EDs. Health policies are needed to increase access to BH services in the rural areas 
of Nebraska.  
 Using the utilization model, the third study examines hospital-based emergency 
department (ED) visits due to SUD and the corresponding incurred charges within the state of 
New York during 2011 to 2013. HCUP’s New York SEDD provided information on utilization of 
services in emergency departments, charges, diagnoses, and discharge, as well as demographic 
variables such as age, race, sex, patient location, health insurance and income status. All patients 
within New York who had visited the ED for SUD comprised the study population. The 
distribution of EDs and Substance Abuse treatment centers at county-level was obtained from 
NEDI and N-SSATS, respectively. To examine the effect of patient characteristics on the 
outcome variable ED charges, we used a multivariate log-linked Gamma Distributed Generalized 
Linear Model. A total of 492,419 SUD ED visits were reported between the years 2011 to 2013. 
These findings show that a substantial proportion (38%) of patients belonged to the age group of 
25 to 44 years. About 74% ED visits were made by males. Whites comprised forty-one percent of 
ED visits. Medicaid covered forty-two percent of patients, and sixty-eight percent of visits were 
made on weekdays. Over three years, $856 million was spent in treating SUD in EDs, with an 
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average charge of $1,764 per case. ED charges spent were significantly greater for those patients 
who were white, male, less than 18 years of age, covered by private insurance, and residing in 
urban areas. Patients who are males, aged 25 – 44 years, covered by private insurance and 
residing in urban areas are identified to be at high-risk. The geographical analyses displayed that 
access of EDs drives their utilization. Also, paucity of treatment centers compels both urban and 
urban residents to seek healthcare services for SUDs in EDs, which maybe because his population 
maybe limited in their access to these facilities. There is a need to develop health policies and 
programs to improve access to care for substance-use disorders in urban states. 
Contribution to Existing Literature 
Although some studies have shown the correlation between patient-level factors on readmissions, 
no other study has shown the combined impact of hospital and patient characteristics on both 
index stays and readmissions among US adults. Also, the first study is a unique study that has 
produced nation level estimates for hospitalizations due to primary diagnoses for ARD, whereas 
previous studies have results with ARD as a comorbidity. Moreover, unlike other studies, the first 
study has provided readmissions-related rates, costs, predictors, forecast of economic burden and 
recurrences of ARD, post-ACA mandated programs. 
 Results from the second study has proven the association between ED charges and 
patient-level characteristics for BH disorders, in the absence of Medicaid expansion in Nebraska. 
For predominantly rural and agrarian state of Nebraska, dearth of BH providers compel residents 
to seek care in the ED. Also, the study is the first to plot the availability of ED and BH workforce 
by region, thereby weighing the supply of facilities and providers against the demand (proportion 
of unmet) of treatment for BH conditions. Moreover, this is a unique study that studied the ED 
outcomes and identified high-risk patients that discharged against medical advice. 
 In the largely urban State of New York that expanded Medicaid under ACA and has 
rising number of cases for SUD, the findings from the last study will be the first to identify ED 
charges accounted for ten types of SUD. Also, findings from the plotted maps showing the 
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distribution of primary level care available (substance abuse treatment centers) and emergency 
care (ED) will show access of care with change in health policies. Yet the results show the high 
proportion of unmet behavioral healthcare needs even in urban states. 
Study Limitations 
Despite the notable strengths that the first study present, the findings should be 
interpreted in light of a number of limitations. This study uses administrative database that does 
not contain information on pathological tests performed during treatment that could describe the 
severity of ARD and the patients-to-doctor ratios. Also, individuals admitted to the hospital for 
ARD may suffer from mental health-related conditions that result into excessive alcohol use. 
Even though, this study carefully excludes the comorbidity index measure for related 
comorbidities (such as depression, drug-related, and psychoses disorders) from analytical models 
as they contribute to collinearity, the results do not estimate for predisposing factors such as 
mental health disorders that may cause ARD and lead to admissions. NRD being an 
administrative data does not provide information on reasons (diagnostic or causality) that 
influenced the decision for admission but only the primary and secondary diagnosis on admission. 
Moreover, the study excludes non-residents of states in this study as the NRD only captures 
readmissions in a given state and does not provide state identifiers. Hence, the results are likely to 
be underestimated for those patients whose index admission and readmissions occurred in their 
out-of-state hospitals which maybe their temporary location of residency. In addition, the NRD 
does not contain information on the distance traveled by the patients to the hospital to seek 
medical help. The findings are, hence, underestimated for those living on the state borders and 
were admitted in nearby hospitals in neighboring state. Because NRD had discharge-level 
weights, the univariate and bivariate analysis of patient and hospital-level characteristics 
performed at an individual level cannot be weighted. This applies to all weighted results that are 
to be interpreted at discharge level (single episodes of care) and not individual patient-level, 
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thereby, limiting derivation of the results to the overall cost of care per individual at other than 
inpatient settings. Additionally, NRD does not include race/ethnicity and education status-related 
results which restricts the interpretation of the findings in the context of health disparities. 
Finally, the discharge records may not have been assigned proper ICD-9-CM codes- a 
phenomenon called non-differential misclassification of diagnoses in data. Also, it is possible that 
there could be differences in coding practices across providers and states. Nevertheless, even if 
the estimates were biased due to misclassification, it is likely that we underestimated rather than 
overestimated the number of index hospitalizations for ARD and resulting readmissions. 
Findings from the second study must be interpreted in the context of some limitations. 
Although Nebraska SEDD contains detailed information on healthcare utilization, there is a 
possibility that the discharge records may not have been assigned proper ICD-9-CM codes. This 
is a commonly occurring research phenomenon called non-differential misclassification of 
diagnoses in data. However, even if the estimates were biased due to misclassification, it is still 
likely that we underestimated rather than overestimated the number of ED visits related to BH 
disorders. It is also possible that there could be differences in coding practices across providers in 
Nebraska that cannot be accounted for. The Nebraska data does not include race and ethnicity for 
patients, which limits the interpretation of the findings regarding disparities. Moreover, SEDD 
data did not provide information on patient’s education level and homelessness, which may be 
associated with BH utilization. Also, HCUP's SEDD contains information on only those 
emergency visits that did not eventually result in hospitalizations. Finally, we were unable to 
establish causality between availability of BH professionals and ED utilization for BH-related 
care. 
The third study also has a retrospective design because it uses secondary datasets presents 
certain limitations. Firstly, the information in this study is about the use of ED visits for SUD and 
does not include the resulting inpatient hospitalizations, if any. Consequently, this study 
underestimates the total amount of ED charges due to primary admission in ED. Secondly, the 
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HCUP SEDD dataset informs us about the primary diagnoses and not the actual cause of the ED 
admission. Finally, SEDD does not provide any information on events or health outcomes after 
discharging the patients. Hence, future studies need to be conducted regarding emergency visits 
made by patients in substance abuse treatment centers, primary outpatient clinics or rehabilitation 
and therapy centers.  
Future Research Directions  
The ACA has introduced policies focusing on reducing readmissions, and so more longitudinal 
studies must be performed understanding the readmission rates before and after these programs 
was implemented. Like the study on Nebraska, research must be conducted on other rural states 
that adopted to expand Medicaid to see the effect of rurality. Similarly, urban states without 
Medicaid expansion but with higher number of ED visits for all types SUD of must be studied to 
see the impact of available access to care. Impact of ACA will bring more insurance-covered 
patients at various healthcare settings. However, to further improvise on the ACA’s BH-related 
policies, the following amendments can be recommended: (1) offering team-based BH services at 
primary care clinics, (2) providing BH-related training to social workers so that they can 
participate in BH interventions, and (3) expanding federal education loan repayment initiatives 
for BH practitioners to work in rural areas.    
With upcoming and anticipated changes in health policies under the administration of 
President Trump, future studies should monitor differential changes in healthcare utilization for 
BH-related disorders across primary and emergency care. In addition, efforts must be made to 
understand readmissions-related costs, rates and economic burden for other behavioral disorders 
other than ARD such as drug-related disorders, depression, and anxiety, which are widely 
prevalent.  
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APPENDIX 1: ICD-9-CM diagnosis codes defining alcohol-related disorders 
ICD-9-CM diagnosis 
codes Description 
291 Alcohol withdrawal delirium  
291.1 Alcohol-induced persisting amnestic disorder  
291.2 Alcohol-induced persisting dementia  
291.3 Alcohol-induced psychotic disorder with hallucinations  
291.4 Idiosyncratic alcohol intoxication  
291.5 Alcohol-induced psychotic disorder with delusions  
291.8 Other specified alcohol-induced mental disorders  
291.81 Alcohol withdrawal  
291.82 Alcohol-induced sleep disorders  
291.89 Other alcohol-induced disorders  
291.9 Unspecified alcohol-induced mental disorders  
303.00–303.03  Acute alcohol intoxication  
303.90–303.93  Other and unspecified alcohol dependence  
305.00–305.03  Alcohol abuse  
357.5 Alcoholic polyneuropathy  
425.5 Alcoholic cardiomyopathy  
535.30, 535.31  Alcoholic gastritis  
571 Alcoholic fatty liver  
571.1 Acute alcoholic hepatitis  
571.2 Alcoholic cirrhosis of liver  
571.3 Alcoholic liver damage, unspecified  
760.71 Alcohol affecting fetus or newborn via placenta or breast milk 
980 Toxic effects of ethyl alcohol 
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APPENDIX 2: Results of two-part model of factors associated with total cost of readmissions for alcohol-related disorders, NRD 
2014. 
Variable  
Logit GLM with Gamma log-link 
Coeff SE 
P-
value 
95% confidence level 
Coeff SE 
P-
value 
95% confidence level 
Lower Upper  Lower  Upper  
Intercept -2.144 0.113 <.0001 -2.366 -1.922 8.844 0.176 <.0001 8.499 9.189 
Revisit for ARD          
No Reference Reference 
Yes 0.425 0.024 <.0001 0.378 0.472 0.124 0.026 <.0001 0.074 0.174 
Sex           
Male Reference Reference 
Female -0.070 0.022 0.001 -0.113 -0.027 0.031 0.023 0.192 -0.015 0.076 
AGE            
18 to 24 Reference Reference 
25 to 44 0.638 0.088 <.0001 0.465 0.812 0.074 0.163 0.651 -0.246 0.393 
45 to 64 0.748 0.087 <.0001 0.577 0.918 0.141 0.163 0.387 -0.179 0.461 
65 and over 0.382 0.099 <.0001 0.187 0.576 0.262 0.169 0.122 -0.070 0.594 
Primary Payer          
Medicare Reference Reference 
Medicaid -0.045 0.030 0.132 -0.104 0.014 0.025 0.029 0.395 -0.032 0.082 
Private Insurance -0.577 0.034 <.0001 -0.643 -0.511 0.009 0.034 0.798 -0.059 0.076 
Uninsured -0.439 0.049 <.0001 -0.535 -0.344 -0.161 0.037 <.0001 -0.233 -0.089 
No charge -0.312 0.064 <.0001 -0.437 -0.186 -0.272 0.071 <.0001 -0.411 -0.133 
Other -0.432 0.072 <.0001 -0.573 -0.291 -0.056 0.052 0.281 -0.158 0.046 
Patient location          
Urban Reference Reference 
Rural -0.186 0.048 <.0001 -0.279 -0.092 0.186 0.072 0.01 0.044 0.327 
Median household income national quartile for patient ZIP code** 
First quartile Reference Reference 
Second quartile -0.011 0.031 0.731 -0.072 0.050 0.049 0.029 0.093 -0.008 0.107 
Third quartile -0.092 0.033 0.005 -0.156 -0.028 0.079 0.032 0.012 0.017 0.141 
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Fourth quartile -0.092 0.036 0.01 -0.162 -0.022 0.151 0.034 <.0001 0.084 0.218 
Elixhauser Comorbidity Index for unrelated comorbid conditions 
0 Reference Reference 
1 0.078 0.028 0.005 0.0238 0.1331 0.109 0.034 0.001 0.042 0.176 
2 0.168 0.031 <.0001 0.1075 0.2291 0.196 0.032 <.0001 0.132 0.260 
3 0.246 0.037 <.0001 0.1746 0.3180 0.314 0.036 <.0001 0.245 0.384 
4 or more 0.352 0.039 <.0001 0.2758 0.4275 0.385 0.039 <.0001 0.309 0.460 
Length of stay -0.016 0.017 0.373 -0.050 0.019 0.178 0.016 <.0001 0.146 0.209 
Hospital urban-rural designation         
Large metropolitan areas  Reference Reference 
Small metropolitan areas  -0.104 0.038 0.007 -0.179 -0.029 -0.190 0.030 <.0001 -0.250 -0.131 
Micropolitan areas -0.244 0.079 0.002 -0.399 -0.090 -0.416 0.076 <.0001 -0.566 -0.266 
Not metropolitan or 
micropolitan 
-0.312 0.101 0.002 -0.510 -0.113 -0.428 0.088 <.0001 -0.601 -0.254 
Bedsize of hospital 
Small Reference Reference 
Medium 0.092 0.043 0.031 0.008 0.176 -0.026 0.037 0.486 -0.097 0.046 
Large 0.164 0.042 <.0001 0.082 0.246 0.106 0.038 0.005 0.032 0.180 
Hospital control/ ownership 
Government, nonfederal Reference Reference 
Private, non-profit -0.010 0.063 0.87 -0.134 0.114 -0.166 0.047 <.0001 -0.258 -0.073 
Private, invest-own 0.034 0.069 0.624 -0.102 0.170 -0.340 0.057 <.0001 -0.451 -0.229 
Hospital volume          
Low Reference Reference 
Medium -0.018 0.039 0.637 -0.094 0.057 -0.137 0.038 <.0001 -0.210 -0.063 
High  0.028 0.037 0.45 -0.045 0.102 -0.279 0.035 <.0001 -0.349 -0.210 
NRD, Nationwide Readmissions Database; Coeff, Coefficient; SE, standard error; GLM, Generalized linear regression model 
**Median household income quartiles of residents’ ZIP code for 2014 are: (1) $1 - $39,999; (2) $40,000 - $50,999; (3) $51,000 - $65,999; 
and (4) $66,000 or more. 
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APPENDIX 3: Diagnoses used in the analysis of behavioral health disorders in Nebraska 
and their corresponding codes as per International Classification of Diseases, Ninth 
Revision, Clinical Modification. 
Mental Disorders    
Category  Codes  
Dementias 290.0, 290.10, 290.11, 290.12, 290.13, 290.20, 290.21, 
290.3, 290.40, 290.41, 290.42, 290.43, 290.8, 290.9 
Transient mental disorders due to 
conditions classified elsewhere  
293.0, 293.1, 293.82, 293.83, 293.84, 293.89, 293.9 
Persistent mental disorders due to 
conditions classified elsewhere 
294.0, 294.10, 294.11, 294.20, 294.21, 294.8, 294.9 
Schizophrenic disorders  295.02, 295.04, 295.10, 295.11, 295.12, 295.13, 
295.14, 295.20, 295.22, 295.24, 295.30, 295.31, 
295.32, 295.33, 295.34, 295.35, 295.40, 295.42, 
295.44, 295.50, 295.54, 295.60, 295.62, 295.63, 
295.64, 295.65, 295.70, 295.71, 295.72, 295.73, 
295.74, 295.75, 295.80, 295.82, 295.83, 295.84, 
295.90, 295.92, 295.94 
Episodic mood disorders 296.00, 296.01, 296.03, 296.04, 296.10, 296.20, 
296.21, 296.22, 296.23, 296.24, 296.25, 296.26, 
296.30, 296.31, 296.32, 29633, 296.34, 296.35, 296.36, 
296.40, 296.41, 296.42, 296.43, 296.44, 296.45, 
296.46, 296.50, 296.51, 296.52, 296.53, 29654, 29655, 
296.56, 296.60, 296.61, 296.62, 296.63, 296.64, 
296.65, 296.66, 296.7, 296.80, 296.81, 296.82, 296.89, 
296.90, 296.99 
Delusional disorders  297.0, 297.1, 297.3, 297.8, 297.9 
Other nonorganic psychoses 298.0, 298.1, 298.2, 298.3, 298.4, 298.8, 298.9 
Pervasive developmental disorders 299.00, 299.01, 299.80, 299.90 
Anxiety, dissociative and somatoform 
disorders  
300.00, 300.01, 300.02, 300.09, 300.10, 300.11, 
300.12, 300.13, 300.14, 300.15, 300.16, 300.19, 
300.20, 300.21, 300.23, 300.29, 300l3, 300.4, 300.5, 
300.6, 300.7, 300.81, 300.82, 300.89, 300.9 
Personality Disorders 301.0, 301.13, 301.22, 301.3, 301.4, 301.51, 301.6, 
301.7, 301.81, 301.83, 301.89, 301.9 
Sexual and gender identity disorders 302.2, 302.85, 302.89, 302.9 
Physiological malfunctions arising from 
mental factors 
306.0, 306.1, 306.2, 306.4, 306.8, 306.9 
Special Symptoms not elsewhere 
classified  
307.0, 307.1, 307.20, 307.23, 307.41, 307.42, 307.47, 
307.50, 307.51, 307.54, 307.59, 307.7, 307.80, 307.81, 
307.9 
Acute reactions to stress 308.0, 308.2, 308.3, 308.9 
Adjustment reaction 309.0, 309.1, 309.21, 309.24, 309.28, 309.29, 309.3, 
309.4, 309.81, 309.89, 309.9 
Specific nonpsychotic mental disorders 
due to brain damage 
310.0, 310.1, 310.2, 310.8, 310.89, 310.9 
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Depressive disorder, not elsewhere 
classified 
311 
Disturbances of conduct  312.00, 312.30, 312.31, 312.32, 312.34, 312.4, 312.81, 
312.82, 312.89, 312.9 
Disturbances of emotions specific to 
childhood and adolescents 
313.81, 313.89 
Hyperkinetic syndrome of childhood  314.00, 314.01 
Specific delays in development 315.8, 315.9 
Intellectual diabilities and Psychic factors 
associated with diseases classified 
elsewhere 
317, 318.0, 318.1-318.2, 319 
Other ill-defined and unknown causes of 
morbidity and mortality 
799.2, 799.21, 799.22, 799.24, 799.25, 799.29, 799.59 
V Codes  
V11.8, V61.10, V61.20, V62.83, V62.84, V62.85, 
V70.1, V70.2, V71.01, V71.02, V71.09    
  
  
  
      
Substance Disorders    
Category  Codes 
Alcohol-Induced mental disorders  
291.0, 291.1, 291.2, 291.3, 291.5, 291.81, 291.89, 
291.9 
Drug-Induced mental disorders 292.0, 292.11, 292.12, 292.2, 292.81, 292.82, 292.84, 
292.85, 292.89, 292.9 
Alcohol Dependence Syndrome 303.00, 303.01, 303.02, 303.03, 303.90, 303.91, 
303.92, 303.93 
Drug Dependence Syndrome 304.00, 304.01, 304.10, 304.11, 304.20, 304.21, 
304.22, 304.30, 304.31, 304.40, 304.41, 304.42, 
304.43, 304.60, 304.61, 304.62, 304.70, 304.71, 
304.73, 304.80, 304.81, 304.83, 304.90, 304.91 
Non-dependent Drug Abuse 305.00, 305.01, 305.02, 305.03, 305.1, 305.20, 305.21, 
305.23, 305.30, 305.40, 305.41, 305.50, 305.51, 
305.52, 305.53, 305.60, 305.61, 305.62, 305.70, 
305.71, 305.72, 305.80, 305.90, 305.91 
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APPENDIX 4: Behavioral health regions and major cities in Nebraska. 
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APPENDIX 5: Diagnoses related to substance use disorders used in the analysis and their 
corresponding codes as per International Classification of Diseases, Ninth Revision, Clinical 
Modification 
 
Category 
number 
ICD-9-CM diagnosis codes 
Description 
1 Alcohol  
 291 Alcohol withdrawal delirium 
 291.1 Alcohol-induced persisting amnestic disorder 
 291.2 Alcohol-induced persisting dementia 
 291.3 Alcohol-induced psychotic disorder with 
hallucinations 
 291.4 Idiosyncratic alcohol intoxication 
 291.5 Alcohol-induced psychotic disorder with 
delusions 
 291.8 Other specified alcohol-induced mental 
disorders 
 291.81 Alcohol withdrawal 
 291.82 Alcohol-induced sleep disorders 
 291.89 Other alcohol-induced disorders 
 291.9 Unspecified alcohol-induced mental disorders 
 303.00–303.03 Acute alcohol intoxication 
 303.90–303.93 Other and unspecified alcohol dependence 
 305.00–305.03 Alcohol abuse 
2 Amphetamines  
 304.40–304.43 Amphetamines dependence 
 305.70–305.73 Nondependent amphetamine abuse 
3 Cannabis  
 304.30–304.33 Cannabis dependence 
 305.20–305.23 Nondependent cannabis abuse 
4 Cocaine  
 304.20–304.23 Cocaine dependence 
 305.60–305.63 Nondependent cocaine abuse 
5 Drug-induced mental disorders  
 292 Drug withdrawal 
 292.11 Drug-induced psychotic disorder with 
delusions 
 292.12 Drug-induced psychotic disorder with 
hallucinations 
 292.2 Pathological drug intoxication 
 292.81 Drug-induced delirium 
 292.82 Drug-induced persistent dementia 
 292.83 Drug-induced persistent amnestic disorder 
 292.84 Drug-induced mood disorder 
 292.85 Drug-induced sleep disorders 
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 292.89 Other drug-induced mental disorder 
 292.9 Unspecified drug-induced mental disorder 
6 Hallucinogens  
 304.50–304.53 Hallucinogen dependence 
 305.30–305.33 Nondependent hallucinogen abuse 
 969.6 Poisoning by hallucinogens (psychodysleptics) 
7 Opioids  
 304.00–304.03 Opioid type dependence 
 304.70–304.73 Combinations of opioids with any other 
 305.50–305.53 Nondependent opioid abuse 
8 Sedatives, hypnotics, anxiolytics, tranquilizers, barbituates 
 304.10–304.13 Sedatives, hypnotics, or anxiolytic dependence 
 305.40–305.43 Nondependent sedative, hypnotic, or 
anxiolytic abuse 
9 Tobocco   
 305.00–305.13 Nondependent tobacco use disorder 
       10 Other   
 304.60–304.63 Other, specified drug dependence 
 304.80–304.83 Combinations excluding opioids 
 304.90–304.93 Unspecified drug dependence 
  305.90–305.93 Other, mixed or unspecified drug abuse 
 
SUD, substance use disorders. 
 
 
 
 
 
 
